https://www.lmi.no/2023/11/28/drug-safety-forum-hosten-2023/ 2023-11-28T15:51:34+00:00 https://www.lmi.no/2023/11/29/overraskende-kritikk-av-bivirkningswebinar-fra-lmi/ 2023-11-29T09:21:07+00:00 https://www.lmi.no/2022/09/07/takeda-selger-fabrikken-i-asker-til-nextpharma/ 2023-11-29T09:22:47+00:00 https://www.lmi.no/2023/11/29/politikerne-faller-lett-for-fristelsen-til-a-bryte-egne-spilleregler/ 2023-11-29T09:25:01+00:00 https://www.lmi.no/2023/11/29/tilsvar-fra-lmi-oppsiktsvekkende-fra-relis-om-bivirkninger/ 2023-11-29T09:44:26+00:00 https://www.lmi.no/wp-content/uploads/2023/11/Skjermdump-tilsvar-DM-bivirkninger.png https://www.lmi.no/wp-content/uploads/2023/11/Linn-Camilla-Svenningsen_portrett-scaled.jpg https://www.lmi.no/wp-content/uploads/2021/01/MargreteB.jpg https://www.lmi.no/wp-content/uploads/2023/11/Ina_crop.jpg https://www.lmi.no/wp-content/uploads/2023/11/Skjermdump-tilsvar-DM-bivirkninger.png https://www.lmi.no/2023/11/29/primus-motor/ 2023-11-29T10:05:09+00:00 https://www.lmi.no/wp-content/uploads/2023/11/Skjermbilde-2023-11-29-110333.png https://www.lmi.no/wp-content/uploads/2023/11/Magma-side.png https://www.lmi.no/wp-content/uploads/2023/11/Magma-side-2.png https://www.lmi.no/2023/11/29/prisen-pa-et-liv/ 2023-11-29T10:13:32+00:00 https://www.lmi.no/2023/11/29/diabetesforbundet-etterlyser-innstramminger-fra-myndighetene/ 2023-11-29T10:26:24+00:00 https://www.lmi.no/2023/11/30/legemiddelanbud-gir-tilgang-til-flere/ 2023-11-30T08:02:05+00:00 https://www.lmi.no/2023/11/30/sykehusinnkjop-fastslar-uaktuelt-med-apne-priser-pa-patenterte-medisiner/ 2023-11-30T08:04:21+00:00 https://www.lmi.no/2023/11/30/lmi-sjefen-apne-priser-vil-gi-pasientene-darligere-tilgang-pa-medisiner/ 2023-11-30T08:06:35+00:00 https://www.lmi.no/2023/11/30/novo-nordisk-ut-mot-studie-etter-borsfall/ 2023-11-30T08:12:40+00:00 https://www.lmi.no/2023/11/30/fda-undersoker-om-det-er-risiko-for-ny-kreft-etter-car-t-behandling/ 2023-11-30T08:15:44+00:00 https://www.lmi.no/2023/11/30/skymoen-til-healthtalk-apne-priser-vil-gi-pasientene-darligere-tilgang-pa-medisiner/ 2023-11-30T09:31:20+00:00 https://www.lmi.no/wp-content/uploads/2023/11/Skjermbilde-2023-11-30-102141.png https://www.lmi.no/wp-content/uploads/2023/11/Skjermbilde-2023-11-30-102141.png https://www.lmi.no/2023/12/01/begrenset-kapasitet-star-i-veien-for-banebrytende-terapi-mot-blodkreft/ 2023-12-01T08:25:38+00:00 https://www.lmi.no/2023/12/01/abbvie-kjoper-kreftselskap/ 2023-12-01T08:31:44+00:00 https://www.lmi.no/2023/12/01/antibiotikabruken-er-pa-niva-med-for-pandemien/ 2023-12-01T08:40:39+00:00 https://www.lmi.no/2023/12/01/novo-nordisk-vurderer-fleksibel-prissetting-for-fedmemiddel/ 2023-12-01T08:44:17+00:00 https://www.lmi.no/2023/12/01/en-trist-dag-for-ms-syke-i-norge/ 2023-12-01T08:48:51+00:00 https://www.lmi.no/2023/12/01/nevrologer-bor-ogsa-vaere-habile/ 2023-12-01T09:05:42+00:00 https://www.lmi.no/2023/12/01/fremmet-norge-som-livsvitenskapsnasjon/ 2023-12-01T11:15:04+00:00 https://www.lmi.no/wp-content/uploads/2023/11/NLS-Days-norsk-stand-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/NLS-days-ambasadebesok-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/Nykode-Agnete-Fredriksen-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/NLS-Days-norsk-stand-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/NLS-Days-Link-Sissel-Andresen-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/NLS-Days-BioArctic-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/NLS-Days-Curida-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/NLS-Days-skilt-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/NLS-days-abmassador-side-event-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/Nortrials-scaled.jpg https://www.lmi.no/2023/12/01/fremmet-norge-som-livsvitenskapsnasjon-2/ 2023-12-01T11:16:39+00:00 https://www.lmi.no/wp-content/uploads/2023/11/NLS-Days-norsk-stand-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/NLS-days-ambasadebesok-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/Nykode-Agnete-Fredriksen-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/NLS-Days-norsk-stand-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/NLS-Days-Link-Sissel-Andresen-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/NLS-Days-BioArctic-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/NLS-Days-Curida-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/NLS-Days-skilt-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/NLS-days-abmassador-side-event-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/Nortrials-scaled.jpg https://www.lmi.no/2023/12/01/dm-arena-nar-vi-kjenner-til-de-medisinske-fremskrittene-kunne-norske-pasienter-hatt-det-bedre-hvis-legene-kunne-velge-de-nyeste-innovasjonene/ 2023-12-01T11:46:19+00:00 https://www.lmi.no/wp-content/uploads/2023/12/IMG_6676-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/12/IMG_6676-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/12/IMG_6671-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/12/IMG_6630-scaled.jpeg https://www.lmi.no/2023/12/04/ingen-kunne-vite-at-drapene-skulle-bli-verdt-sin-vekt-i-gull-bak-betalingsmur/ 2023-12-04T09:03:44+00:00 https://www.lmi.no/2023/12/04/kreftforeningen-frykter-omorganisering-skal-gi-lengre-ventetid-pa-nye-medisiner/ 2023-12-04T09:04:00+00:00 https://www.lmi.no/2023/12/04/frykter-at-lave-priser-pa-legemidler-gir-darligere-tilgang-for-pasientene/ 2023-12-04T09:04:56+00:00 https://www.lmi.no/2023/12/04/legemiddelverkets-sjef-skal-lede-nytt-direktorat-fra-nyttar-slik-blir-endringene/ 2023-12-04T09:05:34+00:00 https://www.lmi.no/2023/12/04/biotek-tungvektere-etablerer-nytt-selskap/ 2023-12-04T09:06:18+00:00 https://www.lmi.no/2023/12/04/derfor-er-det-grunn-til-a-vaere-skeptisk-mot-anbud-pa-blaresept/ 2023-12-04T09:08:31+00:00 https://www.lmi.no/2023/12/04/kampen-mot-falske-medisiner/ 2023-12-04T09:27:41+00:00 https://www.lmi.no/wp-content/uploads/2023/12/Fight-the-fakes-week-Nomvec.jpg https://www.lmi.no/wp-content/uploads/2023/12/Fight-the-fakes-week-Nomvec.jpg https://www.lmi.no/2023/12/04/salgstall-fra-farmastat-for-november-2023/ 2023-12-04T09:40:55+00:00 https://www.lmi.no/wp-content/uploads/2020/04/hero.jpg https://www.lmi.no/2023/12/04/nextpharma-onsker-a-sikre-fremtiden-viste-seg-frem-for-unge-lovende/ 2023-12-04T14:42:33+00:00 https://www.lmi.no/wp-content/uploads/2023/12/NextPharma-laerlinger-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/12/NextPharma-elever-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/12/NextPharma-ute-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/12/NextPharma-laerlinger-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/12/NextPharma-Christian-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/12/NP-8.jpg https://www.lmi.no/wp-content/uploads/2023/12/NP-3.jpeg https://www.lmi.no/wp-content/uploads/2023/12/NP-4.jpg https://www.lmi.no/wp-content/uploads/2023/12/NP-12.jpg https://www.lmi.no/wp-content/uploads/2023/12/NextPharma-kontrollrom-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/12/NP-11.jpeg https://www.lmi.no/wp-content/uploads/2023/12/NP-10.jpg https://www.lmi.no/wp-content/uploads/2015/06/Bj%C3%B8rn.gif https://www.lmi.no/2023/12/05/alle-piler-peker-oppover-slik-sa-salget-av-legemidler-ut-i-november/ 2023-12-05T10:13:21+00:00 https://www.lmi.no/2023/12/05/ny-rsv-vaksine-na-tilgjengelig-i-norge/ 2023-12-05T10:14:11+00:00 https://www.lmi.no/2023/12/05/flere-oppgaver-og-mer-ansvar-for-nye-direktoratet-for-medisinske-produkter/ 2023-12-05T10:15:03+00:00 https://www.lmi.no/2023/12/05/bleiesensorselskap-onsker-samarbeid-med-legemiddelindustrien/ 2023-12-05T10:15:48+00:00 https://www.lmi.no/2023/12/05/ema-fortsetter-sikkerhetsgransking-av-glp-1-midler/ 2023-12-05T10:16:32+00:00 https://www.lmi.no/2023/12/05/sv-gir-regjeringen-flertall-for-anbud-pa-blareseptlegemidler/ 2023-12-05T10:22:25+00:00 https://www.lmi.no/2023/12/05/oppdatering-om-anbud-pa-bla-resept/ 2023-12-05T11:47:26+00:00 https://www.lmi.no/wp-content/uploads/2023/02/48973585938_88eb09a699_o-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/48973585938_88eb09a699_o-scaled.jpg https://www.lmi.no/wp-content/uploads/2020/06/ErlingUlltveit_portrett-scaled-e1605100056652.jpg https://www.lmi.no/2023/12/05/lmi-arrangerte-dialogmote-med-referansegruppen-for-pasientforeninger-om-arbeidet-med-ny-prioriteringsmelding/ 2023-12-05T13:54:32+00:00 https://www.lmi.no/wp-content/uploads/2023/12/chris-montgomery-smgTvepind4-unsplash-scaled.jpg https://www.lmi.no/2023/12/06/blaresept-anbud-blir-innfort-etter-budsjett-enighet-vil-kunne-bidra-til-svekket-tilgang-pa-legemidler/ 2023-12-06T09:28:24+00:00 https://www.lmi.no/2023/12/06/alle-parter-ma-bidra-og-vi-ma-utnytte-oss-av-helsenaeringen/ 2023-12-06T09:30:33+00:00 https://www.lmi.no/2023/12/06/ma-vente-flere-ar-pa-forsinket-studie-var-opplevelse-er-at-systemet-er-viktigere-enn-pasientene/ 2023-12-06T09:36:55+00:00 https://www.lmi.no/2023/12/06/astrazeneca-signerer-kreftavtale-med-ki-selskap/ 2023-12-06T09:48:35+00:00 https://www.lmi.no/2023/12/06/rapport-eldre-saerlig-utsatt-for-rs-virus/ 2023-12-06T09:49:41+00:00 https://www.lmi.no/2023/12/07/legemiddelanbud-og-tilgang/ 2023-12-07T08:00:54+00:00 https://www.lmi.no/2023/12/07/gedeon-richter-far-ja-fra-ema-for-endometriose-legemiddel/ 2023-12-07T08:21:43+00:00 https://www.lmi.no/2023/12/07/studie-pa-circios-kreftvaksine-besto-sikkerhetstest-apner-for-full-rekruttering/ 2023-12-07T08:22:45+00:00 https://www.lmi.no/2023/12/07/hod-om-blaresept-anbud-pasienter-har-ingenting-a-frykte/ 2023-12-07T08:23:53+00:00 https://www.lmi.no/2023/12/07/sjokkerende-pfizer-norge-reagerer-pa-svs-ja-til-blaresept-anbud/ 2023-12-07T08:25:28+00:00 https://www.lmi.no/2023/12/07/lmi-i-healthtalk-dette-sier-industrien-om-flertall-for-blaresept-anbud/ 2023-12-07T08:34:31+00:00 https://www.lmi.no/wp-content/uploads/2021/09/Erling-Stortinget-1.jpg https://www.lmi.no/2023/12/07/et-forsok-pa-a-tenke-nytt-rundt-bruk-av-et-samfunnsperspektiv-i-helseprioriteringer/ 2023-12-07T13:30:09+00:00 https://www.lmi.no/wp-content/uploads/2023/09/FC39AB1C-7100-451F-AF6A-6FA9199C98E9-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/FC39AB1C-7100-451F-AF6A-6FA9199C98E9-scaled.jpeg https://www.lmi.no/2023/12/08/rapport-4800-sykehusinnleggelser-blant-eldre-kan-skyldes-rs-viruset/ 2023-12-08T10:27:48+00:00 https://www.lmi.no/2023/12/08/artbio-henter-industri-veteraner-til-toppledelsen/ 2023-12-08T10:28:58+00:00 https://www.lmi.no/2023/12/08/diabetesforbundet-er-bekymret-mener-mye-er-uklart-om-blaresept-anbud/ 2023-12-08T10:31:19+00:00 https://www.lmi.no/2023/12/08/floskelsvar-frp-langer-ut-mot-blaresept-forsikringer-fra-hod/ 2023-12-08T10:36:03+00:00 https://www.lmi.no/2023/12/08/kreftlegemidler-opp-i-beslutningsforum/ 2023-12-08T10:37:02+00:00 https://www.lmi.no/2023/12/11/lmi-i-referansegruppemote-for-nye-metoder/ 2023-12-11T14:50:45+00:00 https://www.lmi.no/wp-content/uploads/2023/01/KK-Katrine-Bryne-Karoline-Knutsen-5884-scaled.jpg https://www.lmi.no/2023/12/12/moderna-og-msd-starter-fase-3-lungekreftstudie/ 2023-12-12T10:33:04+00:00 https://www.lmi.no/2023/12/12/beslutningsforum-11-desember-godkjenner-forenklet-prosess-for-immunterapi/ 2023-12-12T10:33:45+00:00 https://www.lmi.no/2023/12/12/forbyr-leger-a-skrive-ut-slankesproyter-slik-svarer-norge/ 2023-12-12T10:34:37+00:00 https://www.lmi.no/2023/12/12/norsk-industri-er-pa-plass-i-san-diego-for-ash-en-ypperlig-plattform/ 2023-12-12T10:35:34+00:00 https://www.lmi.no/2023/12/13/avtaler-for-apenhet-og-bedre-samarbeid/ 2023-12-13T09:10:33+00:00 https://www.lmi.no/wp-content/uploads/2023/12/Skjermbilde-2023-12-13-100421.png https://www.lmi.no/wp-content/uploads/2023/12/Skjermbilde-2023-12-13-100611.png https://www.lmi.no/2023/12/13/pfizer-gjor-organisasjonsendringer-og-far-gront-lys-for-kjempeoppkjop/ 2023-12-13T09:23:06+00:00 https://www.lmi.no/2023/12/13/eu-utpeker-over-200-legemidler-som-kritiske/ 2023-12-13T09:23:59+00:00 https://www.lmi.no/2023/12/14/ny-studie-om-benmargskreft-forandrer-hva-som-er-standard-behandling/ 2023-12-14T09:24:40+00:00 https://www.lmi.no/2023/12/14/navamedic-inngar-lisensavtale-med-finsk-legemiddelselskap-om-parkinson-legemiddel/ 2023-12-14T09:25:18+00:00 https://www.lmi.no/2023/12/14/nykode-utvider-kreftvaksine-portefolje/ 2023-12-14T09:25:56+00:00 https://www.lmi.no/2023/12/15/novo-nordisk-kaller-bidens-lovgivning-for-et-historisk-brudd-pa-den-amerikanske-grunnloven/ 2023-12-15T09:28:52+00:00 https://www.lmi.no/2023/12/15/nykode-forventer-a-starte-klinisk-studie-med-ny-vaksinekandidat-i-2025/ 2023-12-15T09:29:36+00:00 https://www.lmi.no/2023/12/15/bioarctic-grunder-og-forsker-bak-alzheimer-legemidlet-forventer-godkjenning-i-europa/ 2023-12-15T09:30:27+00:00 https://www.lmi.no/2023/12/15/eu-kommisjonen-norge-bor-inn-i-eus-helseunion-lmi-kommenterer/ 2023-12-15T09:30:49+00:00 https://www.lmi.no/2023/12/14/europakommisjonen-positiv-til-a-starte-forhandlinger-med-norge-om-helseberedskap/ 2023-12-15T09:49:53+00:00 https://www.lmi.no/wp-content/uploads/2023/12/Illustrasjon-EU-Norge.png https://www.lmi.no/wp-content/uploads/2023/12/Illustrasjon-EU-Norge.png https://www.lmi.no/wp-content/uploads/2023/03/Leif-Rune-Skymoen_portrett-nytt-scaled.jpg https://www.lmi.no/2023/12/18/sigrid-skanland-er-karet-til-arets-forsker-2023/ 2023-12-18T08:20:48+00:00 https://www.lmi.no/2023/12/18/ultimovacs-prostatakreftvaksine-nar-primaerendepunkt-i-fase-1-studie/ 2023-12-18T08:21:43+00:00 https://www.lmi.no/2023/12/18/ultimovacs-prostatakreft-vaksine-nar-primaerendepunkt-i-fase-1-studie/ 2023-12-18T09:49:12+00:00 https://www.lmi.no/2023/12/18/eisai-og-biogen-lanserer-alzheimer-medisin-i-japan-om-kort-tid/ 2023-12-18T09:51:42+00:00 https://www.lmi.no/2023/12/18/livmorkreft-frykter-sen-innforing-av-medisin-2025-er-helt-uakseptabelt/ 2023-12-18T09:52:24+00:00 https://www.lmi.no/2023/12/18/horingssvar-om-endring-i-regelverket-for-trinnprislegemidler/ 2023-12-18T10:00:23+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2023/12/19/pfizer-dobler-onkologi-portefoljen-ved-a-ferdigstille-oppkjop-av-seagen/ 2023-12-19T07:53:45+00:00 https://www.lmi.no/2023/12/19/ema-anbefaler-at-legemidler-trekkes-fra-markedet/ 2023-12-19T07:54:13+00:00 https://www.lmi.no/2023/12/19/agilera-sjefen-enormt-vekstpotensial-for-radiofarmasi/ 2023-12-19T10:44:14+00:00 https://www.lmi.no/wp-content/uploads/2023/12/radiofarmasoytisk_produksjon_foto-agilera.jpg https://www.lmi.no/wp-content/uploads/2023/12/Leif-Rune-og-Erik-Flatmark-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/12/radiofarmasoytisk_produksjon_foto-agilera.jpg https://www.lmi.no/wp-content/uploads/2023/12/Radiofarmasi_Produksjon_foto-agilera.jpg https://www.lmi.no/wp-content/uploads/2023/12/Radiofarmasi_Produksjon-2-foto-agilera.jpg https://www.lmi.no/wp-content/uploads/2023/12/Erik-Flatmark-scaled.jpg https://www.lmi.no/2023/12/19/made-in-overhalla-norway/ 2023-12-19T11:01:35+00:00 https://www.lmi.no/2023/12/19/farmasoytisk-arbeidsplass-pharma/ 2023-12-19T11:03:25+00:00 https://www.lmi.no/2023/12/19/lmis-work-with-market-access-insights-and-highlights-of-2023/ 2023-12-20T09:15:23+00:00 https://www.lmi.no/wp-content/uploads/2023/12/Prio-mediesaker-hosten-2023.jpg https://www.lmi.no/wp-content/uploads/2023/08/84B38382-AAAC-41B6-AFC6-8B666D4398D5-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/0B6CF7F8-428B-43A7-8585-A82C771B77D0-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/6EC86233-5929-4D5A-8182-9070485CB536-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/03/IMG_3080-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/IMG_3096-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/09/A1837698-825D-4455-8C5F-31225E7361B9-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/4D5791DF-B353-45E5-BE95-6B29F05CB303-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/03C5F231-AC56-4ACE-AA57-C7E2434F0BD1-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/11/IMG_6244-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/11/IMG_6144-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/11/IMG_6202-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/12/Prio-mediesaker-hosten-2023.jpg https://www.lmi.no/2023/12/20/mener-gsk-kan-fa-medisin-mot-livmorkreft-hurtiginnfort-trenger-ikke-ta-lang-tid/ 2023-12-20T09:24:47+00:00 https://www.lmi.no/2023/12/20/ny-medisin-fullstendig-banebrytende/ 2023-12-20T09:26:20+00:00 https://www.lmi.no/2023/12/20/ge-fabrikken-pa-lindesnes-far-mer-kraft/ 2023-12-20T09:29:40+00:00 https://www.lmi.no/2023/12/20/data-power-and-moonshots-lmi-deltar/ 2023-12-20T11:51:19+00:00 https://www.lmi.no/2023/12/20/kronikk-farmasoyter-kan-redde-liv-og-redusere-presset-pa-helsetjenesten/ 2023-12-20T12:39:29+00:00 https://www.lmi.no/wp-content/uploads/2023/12/kronikk-voksenvaksinasjon-nft-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/12/kronikk-voksenvaksinasjon-nft-scaled.jpg https://www.lmi.no/2023/12/20/frp-foreslar-ny-vurdering-av-terskelverdien/ 2023-12-20T15:34:39+00:00 https://www.lmi.no/wp-content/uploads/2023/12/DSF2930-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/12/DSF2930-scaled.jpg https://www.lmi.no/2023/12/20/ga-innspill-i-legeforeningens-rundebordsmote/ 2023-12-20T15:50:21+00:00 https://www.lmi.no/wp-content/uploads/2023/12/IMG_0435-002.jpg https://www.lmi.no/wp-content/uploads/2023/12/IMG_0435-002.jpg https://www.lmi.no/2023/12/21/det-beste-fra-ash-2023-verdens-storste-hematologikongress/ 2023-12-21T08:34:31+00:00 https://www.lmi.no/2023/12/21/lmi-terskelverdien-ma-ikke-fungere-som-et-rent-sparetiltak/ 2023-12-21T08:35:14+00:00 https://www.lmi.no/2023/12/21/lmi-aret-2023/ 2023-12-21T09:47:07+00:00 https://www.lmi.no/wp-content/uploads/2023/12/Leif-Rune-julebrev.png https://www.lmi.no/wp-content/uploads/2023/12/julebrev-2023-forside-2.png https://www.lmi.no/2023/12/22/frp-vil-betale-mer-for-et-godt-levear/ 2023-12-22T08:52:06+00:00 https://www.lmi.no/2023/12/22/navamedic-fornyer-avtale-med-medisinsk-ernaeringsselskap/ 2023-12-22T08:53:26+00:00 https://www.lmi.no/2023/12/22/amerikanske-myndigheter-advarer-mot-falsk-diabetesmedisin/ 2023-12-22T08:57:40+00:00 https://www.lmi.no/2023/12/22/digitalis-tar-juleferie-2/ 2023-12-22T09:00:11+00:00 https://www.lmi.no/wp-content/uploads/2023/12/juleill.png https://www.lmi.no/wp-content/uploads/2023/12/juleill.png https://www.lmi.no/2023/12/22/vaksine-mot-foflekkreft-kan-vaere-klar-om-noen-ar/ 2023-12-22T09:03:27+00:00 https://www.lmi.no/2022/12/12/skal-virkelig-livsviktig-antibibiotika-vaere-billigere-enn-kaffe/ 2024-01-02T13:37:04+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Christine-Ardal-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/12/Christine-Ardal-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/12/Sverrison-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/12/Nakstad-og-Arabi-scaled.jpg https://www.lmi.no/2024/01/02/slik-blir-det-nye-helsedirektoratet/ 2024-01-02T14:04:01+00:00 https://www.lmi.no/2024/01/02/rapport-interessen-for-radiofarmaka-oker/ 2024-01-02T14:06:03+00:00 https://www.lmi.no/2024/01/02/helge-lund-styrer-den-danske-mirakelmedisinen/ 2024-01-02T14:13:08+00:00 https://www.lmi.no/2024/01/02/farmasi-eventyret-i-halden/ 2024-01-02T14:14:56+00:00 https://www.lmi.no/2024/01/02/novo-nordisk-onsker-a-bygge-gigafabrikk-i-irland/ 2024-01-02T14:17:48+00:00 https://www.lmi.no/2024/01/02/store-legemiddelselskaper-tar-ofte-navn-fra-grunnleggerne/ 2024-01-02T14:19:21+00:00 https://www.lmi.no/2024/01/02/kari-elisabeth-kaski-gjester-revmapodden/ 2024-01-02T14:21:10+00:00 https://www.lmi.no/2024/01/02/diabetes-er-blant-landets-ti-dyreste-sykdommer/ 2024-01-02T14:24:21+00:00 https://www.lmi.no/2024/01/02/hvordan-kan-norge-fa-mer-ut-av-helsedata-2/ 2024-01-02T14:31:15+00:00 https://www.lmi.no/wp-content/uploads/2023/11/Banner-Livsvitenskapskonferansen_crlp.png https://www.lmi.no/wp-content/uploads/2023/11/Banner-Livsvitenskapskonferansen.png https://www.lmi.no/2023/12/13/kronikk-i-altinget-enkle-grep-i-kampen-mot-antibiotikaresistens/ 2024-01-03T09:08:56+00:00 https://www.lmi.no/wp-content/uploads/2023/12/Skjermbilde-2023-12-13-091832.png https://www.lmi.no/wp-content/uploads/2023/12/Skjermbilde-2023-12-13-091832.png https://www.lmi.no/2024/01/03/klager-pa-skjevfordelte-konkuransefortrinn-i-stamfisksektoren/ 2024-01-03T10:21:54+00:00 https://www.lmi.no/2024/01/03/russiske-selskaper-far-lisens-til-piratkopi-av-novo-nordisk-diabeteslegemiddel/ 2024-01-03T10:22:50+00:00 https://www.lmi.no/2024/01/04/salgstall-fra-farmastat-for-desember-2023/ 2024-01-04T14:20:23+00:00 https://www.lmi.no/wp-content/uploads/2020/04/hero.jpg https://www.lmi.no/2024/01/05/novo-nordisk-inngar-milliardsamarbeid-med-amerikanske-biotekselskaper/ 2024-01-05T10:29:43+00:00 https://www.lmi.no/2024/01/05/forste-genterapi-ja-for-pfizer/ 2024-01-05T11:14:25+00:00 https://www.lmi.no/2024/01/05/livmorkreft-gsks-kreftkombinasjon-nar-hovedmalet-i-senfase-studie/ 2024-01-05T11:15:51+00:00 https://www.lmi.no/2024/01/05/uavklart-om-omorganiseringen-i-pfizer/ 2024-01-05T11:18:35+00:00 https://www.lmi.no/2024/01/05/norske-christian-far-global-rolle-i-selskap-med-over-100-000-ansatte/ 2024-01-05T11:21:36+00:00 https://www.lmi.no/2024/01/05/nytt-rekordar-for-oslo-myelomatosesenter-nesten-150-pasienter-inkludert-i-kliniske-studier/ 2024-01-05T11:22:31+00:00 https://www.lmi.no/2024/01/08/lytix-partner-har-fullfort-pasientrekrutteringen/ 2024-01-08T11:24:14+00:00 https://www.lmi.no/2024/01/08/msd-prover-seg-pa-fedme-og-diabetesmarkedet/ 2024-01-08T11:25:28+00:00 https://www.lmi.no/2024/01/08/asamedic-med-ny-salgsavtale-for-hjerteinfarkt-produkt/ 2024-01-08T11:26:26+00:00 https://www.lmi.no/2024/01/08/novartis-utvider-radiofarmasi-produksjonen-med-kjempefabrikk-i-usa/ 2024-01-08T11:27:21+00:00 https://www.lmi.no/2024/01/08/lmi-til-healthtalk-det-ser-ut-til-at-myndighetene-har-snudd-dette-til-a-handle-om-pris-snarere-enn-a-handle-om-raskere-tilgang/ 2024-01-08T12:43:49+00:00 https://www.lmi.no/wp-content/uploads/2024/01/Skjermbilde.jpg https://www.lmi.no/2024/01/09/jj-kjoper-kreftselskap-i-milliardklassen/ 2024-01-09T08:19:15+00:00 https://www.lmi.no/2024/01/09/msd-kjoper-biotekselskap-etter-ryktestorm/ 2024-01-09T08:20:14+00:00 https://www.lmi.no/2024/01/09/eu-ja-til-bayers-behandling-for-oyesykdom/ 2024-01-09T08:22:49+00:00 https://www.lmi.no/2024/01/09/meld-deg-pa-varens-lov-og-bransjekurs-3/ 2024-01-09T08:31:29+00:00 https://www.lmi.no/wp-content/uploads/2020/02/Lovkurs-2020-DIGFORSIDE-uten-tekst.jpg https://www.lmi.no/2024/01/09/na-helseministeren-far-innspill-fra-helsebransjen-i-arbeidet-med-ny-prioriteringsmelding/ 2024-01-09T10:58:57+00:00 https://www.lmi.no/2024/01/09/lmis-horingssvar-om-helseberedskapsmeldingen/ 2024-01-09T13:55:58+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2024/01/09/lmi-i-horing-om-helseberedskapsmeldingen/ 2024-01-09T14:11:12+00:00 https://www.lmi.no/wp-content/uploads/2024/01/erling-horing4.png https://www.lmi.no/wp-content/uploads/2024/01/erling-horing4.png https://www.lmi.no/2024/01/09/en-prioriteringsmelding-for-hele-helsetjenesten/ 2024-01-09T14:21:23+00:00 https://www.lmi.no/wp-content/uploads/2024/01/IMG_0638-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/01/IMG_0638-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/01/IMG_0647.jpg https://www.lmi.no/2024/01/09/lmis-nye-utvalg-er-oppnevnt/ 2024-01-10T07:54:05+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Leif-Rune-Skymoen-glad-5942-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Leif-Rune-Skymoen-glad-5942-scaled.jpg https://www.lmi.no/2024/01/10/ge-healthcare-kjoper-ki-utvikler/ 2024-01-10T08:11:46+00:00 https://www.lmi.no/2024/01/10/helsetopp-advarer-mot-a-innfore-et-a-og-b-lag-blant-norske-pasienter/ 2024-01-10T08:13:23+00:00 https://www.lmi.no/2024/01/10/alzheimer-legemiddel-har-fatt-godkjenning-i-kina/ 2024-01-10T08:14:34+00:00 https://www.lmi.no/2024/01/10/lmi-til-healthtalk-systemet-ma-ikke-bli-et-prisforhandlingsverktoy-for-kun-legemidler/ 2024-01-10T08:17:50+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Katrine-Bryne-5836-scaled.jpg https://www.lmi.no/2024/01/10/presisering-fra-dmp-om-fiskal-import/ 2024-01-10T09:40:29+00:00 https://www.lmi.no/wp-content/uploads/2020/08/Penger-legemidler-scaled.jpeg https://www.lmi.no/wp-content/uploads/2020/08/Penger-legemidler-scaled.jpeg https://www.lmi.no/2024/01/10/horing-endringer-i-regelverket-for-folketrygdens-finansiering/ 2024-01-10T10:13:54+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2024/01/10/referat-fra-kontaktmote-med-hod-4/ 2024-01-10T10:18:34+00:00 https://www.lmi.no/wp-content/uploads/2023/03/hodbygget_315x177-1.webp https://www.lmi.no/wp-content/uploads/2023/03/hodbygget_315x177-1.webp https://www.lmi.no/2024/01/10/prioriteringsmeldingen-er-utsatt-til-2025/ 2024-01-10T11:55:07+00:00 https://www.lmi.no/2024/01/10/den-norske-pfizer-direktoren-blir-toppsjef-for-pfizer-i-norden/ 2024-01-10T11:56:43+00:00 https://www.lmi.no/2024/01/10/meld-deg-pa-varens-reklamekurs-3/ 2024-01-10T13:21:23+00:00 https://www.lmi.no/wp-content/uploads/2019/02/Reklamekurs_digforside2019_uten-tekst.jpg https://www.lmi.no/2024/01/11/legemiddelfirmaer-samler-seg-i-genom-allianse/ 2024-01-11T08:24:32+00:00 https://www.lmi.no/2024/01/11/godkjenner-hoy-dose-versjon-av-bayers-oyemedisin-eylea/ 2024-01-11T09:42:49+00:00 https://www.lmi.no/2024/01/12/eisai-forventer-eu-avgjorelse-om-alzheimermedisin-i-andre-kvartal/ 2024-01-12T08:45:58+00:00 https://www.lmi.no/2024/01/12/innspill-til-styrekandidater-i-lmi-4/ 2024-01-12T13:00:58+00:00 https://www.lmi.no/wp-content/uploads/2023/01/banner-styremedlemmer-lmi-3.jpg https://www.lmi.no/2024/01/12/angell-til-lmi/ 2024-01-12T13:55:27+00:00 https://www.lmi.no/wp-content/uploads/2024/01/Bjornar-Angell-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/01/Bjornar-Angell-scaled.jpg https://www.lmi.no/2024/01/15/benmargskreft-norske-gunhild-betalte-fem-millioner-kroner-for-genterapi-i-tyskland/ 2024-01-15T09:02:24+00:00 https://www.lmi.no/2024/01/15/benmargskreft-norske-kreftpasienter-betaler-millioner-for-genterapi-i-utlandet/ 2024-01-15T09:04:08+00:00 https://www.lmi.no/2024/01/15/legemiddelselskaper-etterforskes-for-brudd-pa-konkurranseloven/ 2024-01-15T11:38:17+00:00 https://www.lmi.no/2024/01/16/oncoinvent-direktoren-om-arets-jp-morgan-konferanse-veldig-tett-timeplan/ 2024-01-16T08:22:31+00:00 https://www.lmi.no/2024/01/16/medisintabbene-du-bor-unnga-%e2%88%92-vanlig-a-gjore-feil-felleskatalogen-no-anbefales/ 2024-01-16T08:23:10+00:00 https://www.lmi.no/2024/01/16/novartis-norge-og-zyberia-skal-samarbeide-om-helseapp/ 2024-01-16T08:23:48+00:00 https://www.lmi.no/2024/01/16/lmi-gjester-i-nrks-ekko-om-voksenvaksinasjonsprogram/ 2024-01-16T08:25:25+00:00 https://www.lmi.no/wp-content/uploads/2024/01/Ekko-vaksiner-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/01/Ekko-vaksiner-scaled.jpg https://www.lmi.no/2024/01/03/lmi-gjester-i-nrks-ekko/ 2024-01-16T08:26:58+00:00 https://www.lmi.no/wp-content/uploads/2024/01/Anne-Margrethe-i-EKKO_crop.jpg https://www.lmi.no/wp-content/uploads/2024/01/Anne-Margrethe-i-EKKO.jpg https://www.lmi.no/2024/01/17/resultater-fra-ultimovacs-studie-er-snart-klare/ 2024-01-17T13:47:21+00:00 https://www.lmi.no/2024/01/18/eu4health-med-ambisios-plan-for-nye-helseprosjekter-i-2024/ 2024-01-18T09:16:36+00:00 https://www.lmi.no/wp-content/uploads/2024/01/DALL%C2%B7E-2024-01-18-10.13.45-An-illustration-representing-the-EU4Health-program-in-a-21_15-format-similar-to-the-second-image-provided-earlier-with-a-blue-background.-The-image-s.png https://www.lmi.no/wp-content/uploads/2024/01/DALL%C2%B7E-2024-01-18-10.12.23-An-illustration-representing-the-EU4Health-program-showcasing-a-modern-collaborative-healthcare-theme.-Include-symbols-like-a-medical-cross-the-Eur.png https://www.lmi.no/2024/01/18/circio-far-ettergitt-ti-ar-gammelt-lan-pa-712-millioner-kroner/ 2024-01-18T09:21:28+00:00 https://www.lmi.no/2024/01/18/eli-lilly-planlegger-lansering-av-fedmemiddel-i-europa-i-ar/ 2024-01-18T09:22:17+00:00 https://www.lmi.no/2024/01/18/apotek-saken-vokser-selskapene-som-eier-nesten-1000-apoteker-er-involvert-i-etterforskning/ 2024-01-18T09:22:54+00:00 https://www.lmi.no/2024/01/18/arctic-bioscience-studie-er-fullrekruttert-avlesing-om-seks-maneder/ 2024-01-18T09:24:10+00:00 https://www.lmi.no/2024/01/18/plikt-til-a-beredskapssikre-legemidler/ 2024-01-18T09:44:29+00:00 https://www.lmi.no/wp-content/uploads/2024/01/Beredskapslagre-av-Dall-E.png https://www.lmi.no/wp-content/uploads/2024/01/DALL%C2%B7E-2024-01-18-10.35.40-An-illustration-in-a-21_15-format-depicting-emergency-stockpiles-of-medicines-at-pharmaceutical-wholesalers-similar-to-the-previously-provided-images.png https://www.lmi.no/2019/03/19/har-en-kule-a-takke/ 2024-01-19T13:19:45+00:00 https://www.lmi.no/wp-content/uploads/2019/03/tom-whitehead.jpg https://www.lmi.no/wp-content/uploads/2019/03/hanne-sofie-pedersen.jpg https://www.lmi.no/wp-content/uploads/2019/03/bokoverlevering.jpg https://www.lmi.no/2024/01/22/kamerun-starter-verdens-forste-vaksineprogram-mot-malaria/ 2024-01-22T09:54:54+00:00 https://www.lmi.no/2024/01/22/astrazeneca-har-lagt-frem-resultater-pa-ny-behandling-mot-levekreft/ 2024-01-22T09:56:15+00:00 https://www.lmi.no/2024/01/22/magisk-teppe-av-legemiddelsoppel/ 2024-01-22T10:01:31+00:00 https://www.lmi.no/2024/01/22/behandler-deprimerte-med-ketamin-forstar-at-det-finnes-en-viss-skepsis/ 2024-01-22T10:05:42+00:00 https://www.lmi.no/2024/01/22/forskningen-til-bodo-legen-har-forlenget-livet-til-kreftsyke-elisabeth-58-utrolig-mye-a-takke-dem-for/ 2024-01-22T10:12:24+00:00 https://www.lmi.no/2024/01/22/mistenkes-for-to-tiar-med-ulovlig-prissamarbeid/ 2024-01-22T10:22:44+00:00 https://www.lmi.no/2024/01/23/prostatakreft-derfor-sa-beslutningsforum-ja-til-en-medisin-og-nei-til-en-annen/ 2024-01-23T08:34:48+00:00 https://www.lmi.no/2024/01/23/anbefalt-av-trump-medisinen-kan-ha-fort-til-okt-koronadodelighet/ 2024-01-23T08:45:36+00:00 https://www.lmi.no/2024/01/23/leger-og-forskere-slik-skal-ai-redde-liv/ 2024-01-23T09:01:54+00:00 https://www.lmi.no/2024/01/23/styreleder-i-roche-vi-ma-bort-fra-tankegangen-om-antibiotika-som-et-massemarked/ 2024-01-23T09:05:43+00:00 https://www.lmi.no/2024/01/23/dette-er-nykodes-hemmelige-investor/ 2024-01-23T09:09:49+00:00 https://www.lmi.no/2024/01/23/gront-lys-for-sma-behandling-til-spedbarn-i-norge/ 2024-01-23T09:12:28+00:00 https://www.lmi.no/2024/01/23/benchmark-og-stim-er-til-salgs-hvem-vil-kjope-og-hvorfor/ 2024-01-23T09:17:08+00:00 https://www.lmi.no/2024/01/10/voksenvaksinasjon-tema-pa-folkehelseforeningens-frokostmote/ 2024-01-23T11:44:10+00:00 https://www.lmi.no/wp-content/uploads/2020/02/Sykehusillustrasjon_adobe-stock.jpeg https://www.lmi.no/wp-content/uploads/2024/01/am-vaksine5.png https://www.lmi.no/2023/08/16/voksenvaksinasjonsprogram-kommer-trolig-i-2025/ 2024-01-23T11:45:59+00:00 https://www.lmi.no/wp-content/uploads/2023/08/E5327128-4ACF-4F75-A31C-055633232BAE-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/E5327128-4ACF-4F75-A31C-055633232BAE-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/6587319E-B306-45F2-9B4B-7FC6ACB5E2E7-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/DBDBA597-0668-4410-AEB5-1ACA13C4D9E5-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/E4C0EE77-1C51-402D-AEE4-028C34C5F745-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/Anbefalte-vaksiner-fhi.png https://www.lmi.no/2023/06/29/kjerkol-svarte-om-voksenvaksinasjonsprogram/ 2024-01-23T11:46:35+00:00 https://www.lmi.no/wp-content/uploads/2023/06/Spm-bjo-ing-kopi-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/06/Spm-bjo-ing-kopi-scaled.jpg https://www.lmi.no/2023/06/07/helvetesild-er-mye-mer-utbredt-enn-tidligere-antatt/ 2024-01-23T11:47:05+00:00 https://www.lmi.no/wp-content/uploads/2023/06/Figur-helvetesild.png https://www.lmi.no/wp-content/uploads/2023/06/GSK-og-statssekretaeren-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/06/figur-2-helvetesild.png https://www.lmi.no/2023/05/03/kronikk-et-stikk-for-folkehelsen/ 2024-01-23T11:48:00+00:00 https://www.lmi.no/wp-content/uploads/2023/05/Skymoen-Lund-Sverresdatter.jpg https://www.lmi.no/wp-content/uploads/2023/05/Lill-Sverresdatter-Larsen_crop.jpg https://www.lmi.no/wp-content/uploads/2023/05/Per_T_Lund_crop2.jpg https://www.lmi.no/wp-content/uploads/2023/05/Leif-Rune-Skymoen_portrett-halvnaert-scaled.jpg https://www.lmi.no/2023/04/25/det-handler-ikke-om-det-ene-eller-det-andre-de-ulike-innsatsfaktorene-ma-spille-hverandre-gode/ 2024-01-23T11:48:39+00:00 https://www.lmi.no/wp-content/uploads/2023/04/folkehelse-ikke-smitsomme-sykdommer-4454-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/folkehelse-ikke-smitsomme-sykdommer-4454-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/folkehelse-ikke-smitsomme-sykdommer-4324-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/folkehelse-ikke-smitsomme-sykdommer-4340-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/folkehelse-ikke-smitsomme-sykdommer-4466-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/folkehelse-ikke-smitsomme-sykdommer-4385-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/folkehelse-ikke-smitsomme-sykdommer-4321-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/folkehelse-ikke-smitsomme-sykdommer-4485-scaled.jpg https://www.lmi.no/2023/03/24/debatt-voksenvaksinasjonsprogram-hvorfor-venter-vi-fortsatt/ 2024-01-23T11:49:15+00:00 https://www.lmi.no/2022/11/30/sverige-innforer-vaksinasjonsprogram-mot-pneumokokker/ 2024-01-23T11:49:39+00:00 https://www.lmi.no/wp-content/uploads/2022/11/lungebetennelse-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/11/Pneumokokkvaksine-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/11/lungebetennelse-scaled.jpeg https://www.lmi.no/2022/11/08/visste-du-at-det-finnes-vaksiner-mot-helvetesild/ 2024-01-23T11:50:00+00:00 https://www.lmi.no/wp-content/uploads/2022/11/Helvetesild_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/11/Helvetesild_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2022/07/voksenvaks4.jpg https://www.lmi.no/2022/10/06/nok-et-statsbudsjett-uten-voksenvaksinasjonsprogram/ 2024-01-23T11:50:42+00:00 https://www.lmi.no/wp-content/uploads/2022/04/Per-Aabakken_crop.png https://www.lmi.no/wp-content/uploads/2019/12/Voksen-f%C3%A5r-vaksine.jpeg https://www.lmi.no/wp-content/uploads/2022/04/Per-Aabakken_crop.png https://www.lmi.no/2022/05/18/fhi-vil-ha-nytt-vaksinasjonsprogram-for-voksne/ 2024-01-23T11:51:46+00:00 https://www.lmi.no/wp-content/uploads/2022/05/forsidebilde-voksenvaks.png https://www.lmi.no/wp-content/uploads/2022/04/Line-Rondan_farger.jpg https://www.lmi.no/wp-content/uploads/2020/12/AdobeStock_covid-vaksine-scaled.jpeg https://www.lmi.no/2021/02/23/lmi-om-vaksinevedtak-i-stortinget-vi-er-veldig-skuffet/ 2024-01-23T11:52:35+00:00 https://www.lmi.no/wp-content/uploads/2020/01/inge-p%C3%A5-kontoret-1.jpg https://www.lmi.no/2020/06/24/sv-foreslar-voksenvaksinasjonsprogram/ 2024-01-23T11:54:23+00:00 https://www.lmi.no/wp-content/uploads/2019/12/Voksen-f%C3%A5r-vaksine.jpeg https://www.lmi.no/wp-content/uploads/2019/12/Voksen-f%C3%A5r-vaksine.jpeg https://www.lmi.no/2019/04/05/voksenvaksinasjon-lite-adressert-i-folkehelsemeldingen/ 2024-01-23T11:55:28+00:00 https://www.lmi.no/wp-content/uploads/2019/04/DSC_8326.jpg https://www.lmi.no/wp-content/uploads/2019/04/DSC_8326.jpg https://www.lmi.no/wp-content/uploads/2019/04/elen-h%C3%B8eg.jpg https://www.lmi.no/wp-content/uploads/2018/04/Inge-2.jpg https://www.lmi.no/2024/01/23/ge-healthcare-legger-ned-prosjekt/ 2024-01-23T11:59:27+00:00 https://www.lmi.no/2024/01/25/holocares-losning-lanseres-pa-fem-europeiske-sykehus/ 2024-01-25T08:42:50+00:00 https://www.lmi.no/2024/01/25/disse-skal-lede-nyetablerte-calluna-pharma/ 2024-01-25T08:46:35+00:00 https://www.lmi.no/2024/01/25/trenger-studiedeltakere-til-studie-om-forebygging-av-langtidsplager-etter-covid/ 2024-01-25T08:55:23+00:00 https://www.lmi.no/2024/01/25/forxiga-og-jardiance-pa-bla-resept/ 2024-01-25T08:56:01+00:00 https://www.lmi.no/2024/01/25/sanofi-kjoper-biotek-selskap-for-22-milliarder-dollar/ 2024-01-25T10:09:45+00:00 https://www.lmi.no/2024/01/26/kronikk-vaksiner-informere-eller-ikke-informere/ 2024-01-26T06:57:38+00:00 https://www.lmi.no/wp-content/uploads/2024/01/kronikk-dm-vaksiner.png https://www.lmi.no/wp-content/uploads/2024/01/kronikk-dm-vaksiner.png https://www.lmi.no/2024/01/26/genterapi-under-utvikling-lyktes-med-a-behandle-medfodt-horselstap-hos-en-pasient/ 2024-01-26T08:51:02+00:00 https://www.lmi.no/2024/01/26/stor-okning-i-medisinbruk-mot-hoyt-kolesterol/ 2024-01-26T08:53:53+00:00 https://www.lmi.no/2024/01/26/supermetode-mot-eksem-95-prosent-effekt/ 2024-01-26T09:07:13+00:00 https://www.lmi.no/2024/01/26/prioriteringsmeldingen-nodvendig-at-vi-prioriterer-helsehjelp-til-pasienter-i-arbeidsfor-alder/ 2024-01-26T09:08:45+00:00 https://www.lmi.no/2024/01/26/ekko-hvilke-vaksiner-er-det-vi-ma-friske-opp-igjen-og-hvorfor/ 2024-01-26T09:52:35+00:00 https://www.lmi.no/2024/01/26/dmp-overtar-ansvaret-for-nye-vaksiner/ 2024-01-26T12:28:44+00:00 https://www.lmi.no/wp-content/uploads/2024/01/Andreassen-dm-arena-vaksiner-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/01/Andreassen-dm-arena-vaksiner-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/01/Line-i-vaksinepanel-2-scaled.jpg https://www.lmi.no/2024/01/26/innspill-til-hod-en-prioriteringsmelding-for-hele-helsetjenesten/ 2024-01-26T14:02:16+00:00 https://www.lmi.no/wp-content/uploads/2023/03/hodbygget_315x177-1.webp https://www.lmi.no/wp-content/uploads/2024/01/IMG_0638-scaled.jpg https://www.lmi.no/2024/01/29/oppsummering-4-kvartal-2023-faggruppen-for-regulatory-og-pharmacovigilance/ 2024-01-29T08:32:09+00:00 https://www.lmi.no/wp-content/uploads/2020/02/Lovkurs-2020-DIGFORSIDE-uten-tekst.jpg https://www.lmi.no/wp-content/uploads/2022/12/Faggruppen-for-regulatory-og-pharmacovigilance-scaled.jpg https://www.lmi.no/2024/01/29/viktig-med-tydelig-skille-mellom-anbefalte-vaksiner-og-tilgjengelige-vaksiner/ 2024-01-29T11:40:05+00:00 https://www.lmi.no/2024/01/29/chmp-anbefaler-nye-legemidler-og-indikasjonsutvidelser/ 2024-01-29T11:46:16+00:00 https://www.lmi.no/2024/01/29/roche-om-immunterapi-onsker-okt-prioritering-til-nyvinninger/ 2024-01-29T11:50:04+00:00 https://www.lmi.no/2024/01/30/astrazeneca-vil-oke-antall-ansatte-i-danmark-med-40-prosent/ 2024-01-30T08:50:44+00:00 https://www.lmi.no/2024/01/30/skal-vi-virkelig-prioritere-rike-og-friske-framfor-fattige-og-syke/ 2024-01-30T08:59:55+00:00 https://www.lmi.no/2024/01/30/sanofi-blar-opp-40-millioner-dollar-for-immunologi-avtale/ 2024-01-30T09:25:55+00:00 https://www.lmi.no/2024/01/31/krevende-med-god-vaksine-informasjon/ 2024-01-31T07:59:45+00:00 https://www.lmi.no/2024/01/31/eu-forhandler-omstridt-legemiddelreform-kan-bli-utsatt-til-2025/ 2024-01-31T08:04:25+00:00 https://www.lmi.no/2024/01/31/apotekene-bor-gi-mer-vaksineinformasjon/ 2024-01-31T08:09:34+00:00 https://www.lmi.no/2024/01/31/arcticzymes-far-godkjent-stempel-pa-hovedprodukt/ 2024-01-31T08:17:05+00:00 https://www.lmi.no/2024/01/31/nei-vi-skal-ikke-prioritere-de-rike-og-friske-framfor-fattige-og-syke/ 2024-01-31T08:23:36+00:00 https://www.lmi.no/2023/11/15/lmis-innspill-til-de-tre-ekspertgruppene/ 2024-01-31T10:22:27+00:00 https://www.lmi.no/wp-content/uploads/2023/01/KK-Katrine-Bryne-Karoline-Knutsen-5884-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/KK-Katrine-Bryne-Karoline-Knutsen-5884-scaled.jpg https://www.lmi.no/2023/10/10/lmi-har-gitt-innspill-og-presentert-for-ekspertgruppen-i-apenhet/ 2024-01-31T10:22:50+00:00 https://www.lmi.no/wp-content/uploads/2023/01/KK-Katrine-Bryne-Karoline-Knutsen-5884-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/KK-Katrine-Bryne-Karoline-Knutsen-5884-scaled.jpg https://www.lmi.no/2023/11/07/lmi-har-gitt-innspill-og-presentert-for-tilgangs-ekspertgruppen/ 2024-01-31T10:23:20+00:00 https://www.lmi.no/wp-content/uploads/2023/11/IMG_28721.jpeg https://www.lmi.no/wp-content/uploads/2023/11/IMG_28721.jpeg https://www.lmi.no/2023/11/08/lmi-presenterte-for-ekspertgruppen-som-skal-vurdere-perspektiv-og-prioriteringer/ 2024-01-31T10:23:49+00:00 https://www.lmi.no/wp-content/uploads/2023/11/Katrine_Ostby-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/Katrine_Ostby-scaled.jpg https://www.lmi.no/2024/01/31/nei-vi-skal-ikke-prioritere-de-rike-og-friske-framfor-fattige-og-syke-2/ 2024-01-31T11:06:18+00:00 https://www.lmi.no/wp-content/uploads/2024/01/skjermdump-healthtalk-2.png https://www.lmi.no/wp-content/uploads/2024/01/skjermbilde-healthtalkdebatt.png https://www.lmi.no/2024/02/01/kjerkol-har-mest-makt-i-helse-norge/ 2024-02-01T08:44:49+00:00 https://www.lmi.no/2024/02/01/forste-kvinne-pa-topp-pa-helsemaktlista/ 2024-02-01T08:49:09+00:00 https://www.lmi.no/2024/02/01/norge-blant-landene-som-far-mest-forskningspenger-fra-eu/ 2024-02-01T08:55:41+00:00 https://www.lmi.no/2024/02/01/vellykket-industrinettverkstreff/ 2024-02-01T09:03:31+00:00 https://www.lmi.no/2024/02/02/brystkreftmedisinen-enhertu-kan-fa-godkjenning-er-allerede-i-bruk-pa-privat-norsk-kreftklinikk/ 2024-02-02T08:41:26+00:00 https://www.lmi.no/2024/02/02/pfizer-i-norge-sier-opp-18-ansatte/ 2024-02-02T08:49:18+00:00 https://www.lmi.no/2024/02/02/biogen-dropper-omdiskutert-alzheimers-medisin/ 2024-02-02T08:54:55+00:00 https://www.lmi.no/2024/02/02/andreea-mocofan-ny-daglig-leder-i-msd/ 2024-02-02T11:46:31+00:00 https://www.lmi.no/wp-content/uploads/2024/02/Andreea-Mocofan.jpg https://www.lmi.no/wp-content/uploads/2024/02/Andreea-Mocofan.jpg https://www.lmi.no/2024/02/05/alzheimer-medisiner-mot-hoyt-kolesterol-kan-dempe-forverring/ 2024-02-05T12:05:55+00:00 https://www.lmi.no/2024/02/05/flere-unge-sliter-med-sovn-bruken-av-reseptbelagte-sovemedisiner-oker/ 2024-02-05T12:08:05+00:00 https://www.lmi.no/2024/02/05/ultimovacs-far-hurtigbehandling-i-usa/ 2024-02-05T12:10:24+00:00 https://www.lmi.no/2024/02/05/nye-og-billigere-slankemedisiner-kan-komme-i-2024/ 2024-02-05T12:19:37+00:00 https://www.lmi.no/2024/02/06/novo-holdings-kjoper-kontraktprodusent-og-selger-fabrikker-til-novo-nordisk/ 2024-02-06T08:31:40+00:00 https://www.lmi.no/2024/02/06/blar-opp-13-milliarder-dollar-msd-animal-health-kjoper-elanco-aqua/ 2024-02-06T08:32:28+00:00 https://www.lmi.no/2024/02/06/naeringsministeren-og-helse-og-omsorgsministeren-legger-frem-eksportsatsing-pa-helsenaeringen/ 2024-02-06T13:23:59+00:00 https://www.lmi.no/wp-content/uploads/2024/02/Veikart-fremleggelse-bredde.jpg https://www.lmi.no/wp-content/uploads/2024/02/Veikart-fremleggelse.jpg https://www.lmi.no/2024/02/06/mer-legemiddelproduksjon-gir-okt-beredskap-og-verdiskapning/ 2024-02-06T14:40:37+00:00 https://www.lmi.no/wp-content/uploads/2024/02/IMG_0805.jpg https://www.lmi.no/wp-content/uploads/2024/02/IMG_0805.jpg https://www.lmi.no/wp-content/uploads/2024/02/IMG_0784.jpg https://www.lmi.no/2024/02/07/i-dag-gar-startskuddet-for-digitalt-pakningsvedlegg-kampanjen/ 2024-02-07T08:00:00+00:00 https://www.lmi.no/wp-content/uploads/2024/02/Facebook-Ad-karusell-1080-x-1080-px-AM.png https://www.lmi.no/wp-content/uploads/2024/02/Facebook-Ad-karusell-1080-x-1080-px-AM.png https://www.lmi.no/wp-content/uploads/2024/02/Facebook-Ad-karusell_1080x1080-SIDE-2-310124.png https://www.lmi.no/2024/02/07/norge-er-darligst-i-norden-pa-a-publisere-studieresultater-medwatch/ 2024-02-07T10:37:19+00:00 https://www.lmi.no/2024/02/07/novo-nordisk-sjefen-overrasket-over-forbrukernes-betalingsvillighet-for-slankemedisin/ 2024-02-07T10:37:53+00:00 https://www.lmi.no/2024/02/07/curida-sjefen-satte-skapet-pa-plass-det-blir-mye-prat-og-lite-handling/ 2024-02-07T10:38:27+00:00 https://www.lmi.no/2024/02/07/lmi-maner-til-storre-tempo-i-utviklingen-av-norsk-helseindustri/ 2024-02-07T10:39:06+00:00 https://www.lmi.no/2024/02/08/svakere-astrazeneca-resultat-enn-ventet/ 2024-02-08T08:25:16+00:00 https://www.lmi.no/2024/02/08/roche-blir-pa-bryn-signerer-femarsavtale/ 2024-02-08T08:25:50+00:00 https://www.lmi.no/2024/02/08/direktorat-vil-fjerne-sprakkrav-til-pakningsvedlegg-i-medisinpakkene/ 2024-02-08T08:26:32+00:00 https://www.lmi.no/2024/02/05/stor-nedgang-i-kliniske-studier-men-ingen-grunn-til-a-gi-opp/ 2024-02-08T10:03:50+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Ina-Kathrine-Dahlsveen-5755-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Ina-Kathrine-Dahlsveen-5755-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/Kristin-Loseth-portrett-1.jpg https://www.lmi.no/wp-content/uploads/2021/05/Nicolas.jpg https://www.lmi.no/2024/02/08/klare-forventninger-til-eksportstrategien/ 2024-02-08T11:40:20+00:00 https://www.lmi.no/wp-content/uploads/2024/02/DSF2923-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/DSF2923-scaled.jpg https://www.lmi.no/2024/02/08/pasienter-kan-vaere-trygge-pa-at-industrien-publiserer-studieresultater/ 2024-02-08T14:45:05+00:00 https://www.lmi.no/wp-content/uploads/2024/02/Hilde-Enserink_edited.jpg https://www.lmi.no/wp-content/uploads/2024/02/Hilde-Enserink_edited.jpg https://www.lmi.no/wp-content/uploads/2024/02/Ina-Dahlsveen_portrett_edited.jpg https://www.lmi.no/wp-content/uploads/2023/05/Pasientbrosjyre-Kliniske-studier-2023-V5-01.png https://www.lmi.no/2024/02/09/en-livsviktig-eksportsatsing/ 2024-02-09T11:18:57+00:00 https://www.lmi.no/wp-content/uploads/2024/02/Kronikk-E24-eksportsatsing.png https://www.lmi.no/wp-content/uploads/2024/02/Fronten-E24-kronikk-eksportsatsing.png https://www.lmi.no/2024/02/09/eksportstrategien-en-gledens-dag/ 2024-02-09T11:40:08+00:00 https://www.lmi.no/wp-content/uploads/2024/02/leif-rune-skjermbilde.png https://www.lmi.no/2024/02/09/satser-storstilt-pa-bedre-behandling-av-blodkreft/ 2024-02-09T11:46:53+00:00 https://www.lmi.no/2024/02/09/det-haster-med-en-kraftig-justering-pa-sjeldenfeltet/ 2024-02-09T11:47:38+00:00 https://www.lmi.no/2024/02/09/hvordan-handtere-kostnader-til-dyre-legemidler-ved-ultrasjeldne-tilstander/ 2024-02-09T11:48:29+00:00 https://www.lmi.no/2024/02/09/lmi-om-eksport-av-helsenaering-skatt-er-elefanten-i-rommet/ 2024-02-09T11:49:14+00:00 https://www.lmi.no/2024/02/09/60197/ 2024-02-09T12:47:40+00:00 https://www.lmi.no/wp-content/uploads/2024/02/cathrine-thomassen-skjermdump.png https://www.lmi.no/2024/02/09/15-konkrete-tiltak-for-okt-helseeksport/ 2024-02-09T13:29:36+00:00 https://www.lmi.no/wp-content/uploads/2024/02/EksportsatsingHelse-7-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/EksportsatsingHelse-48-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/EksportsatsingHelse-23-1-scaled.jpg https://www.lmi.no/2024/02/09/se-bildene-fra-lanseringen/ 2024-02-09T14:32:49+00:00 https://www.lmi.no/wp-content/uploads/2024/02/EksportsatsingHelse-32-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/EksportsatsingHelse-25-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/EksportsatsingHelse-32-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/EksportsatsingHelse-33-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/EksportsatsingHelse-51-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/EksportsatsingHelse-24-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/EksportsatsingHelse-16-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/EksportsatsingHelse-15-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/EksportsatsingHelse-45-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/EksportsatsingHelse-49-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/EksportsatsingHelse-7-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/EksportsatsingHelse-22-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/EksportsatsingHelse-44-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/EksportsatsingHelse-37-1-scaled.jpg https://www.lmi.no/2024/02/12/bli-med-som-partner-i-arendalsuka-2024/ 2024-02-12T11:00:57+00:00 https://www.lmi.no/wp-content/uploads/2023/08/A85B847D-3C85-4672-BDA6-CB6AABF47844-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/A85B847D-3C85-4672-BDA6-CB6AABF47844-scaled.jpeg https://www.lmi.no/2024/02/12/lmi-til-healthtalk-etter-forskningsavsloring-industrien-publiserer-studieresultater/ 2024-02-12T11:55:00+00:00 https://www.lmi.no/wp-content/uploads/2024/02/skjermdump-healthtalk-ina.png https://www.lmi.no/wp-content/uploads/2024/02/skjermdump-healthtalk-ina.png https://www.lmi.no/2024/02/12/ema-skal-undersoke-mulige-konsekvenser-av-novo-nordisks-oppkjop-av-fabrikker-fra-catalent/ 2024-02-12T12:03:48+00:00 https://www.lmi.no/2024/02/12/vil-styrke-samarbeidet-mellom-norske-og-svenske-oppstartsselskaper-astrazeneca-i-spissen-for-ny-avtale/ 2024-02-12T12:04:45+00:00 https://www.lmi.no/2024/02/12/forst-i-verda-testar-ut-medisin-mot-long-covid/ 2024-02-12T12:08:12+00:00 https://www.lmi.no/2024/02/12/fornoyd-at-norge-vil-satse-strategisk-pa-helsenaeringen-som-eksport/ 2024-02-12T12:09:47+00:00 https://www.lmi.no/2024/02/12/innovasjon-norge-direktoren-vi-er-for-darlige-pa-reisen-fra-ide-til-faktura/ 2024-02-12T12:11:09+00:00 https://www.lmi.no/2024/02/12/dmp-vil-oke-bruken-av-digitale-pakningsvedlegg/ 2024-02-12T12:12:33+00:00 https://www.lmi.no/2024/02/12/lmi-onsker-innspill-til-stortingsmelding-om-akuttmedisinske-tjenester/ 2024-02-12T12:41:01+00:00 https://www.lmi.no/wp-content/uploads/2024/02/Ambulanse-Ahus-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/Ambulanse-Ahus-scaled.jpg https://www.lmi.no/2024/02/12/bruker-helsedata-for-a-oke-kunnskapen-om-lipoprotein-a/ 2024-02-12T21:25:40+00:00 https://www.lmi.no/wp-content/uploads/2024/02/Sigrid-Blom-Novartis.jpg https://www.lmi.no/wp-content/uploads/2024/02/Sigrid-Blom-Novartis.jpg https://www.lmi.no/wp-content/uploads/2024/02/Bjorn_Olav_Asvold_Foto_GeirMogen_NTNU.jpg https://www.lmi.no/2024/02/13/nettapoteket-farmasiet-tapte-rettsak-mot-staten/ 2024-02-13T10:52:55+00:00 https://www.lmi.no/2024/02/13/erling-braut-haaland-kjoper-aksjer-i-nykode/ 2024-02-13T10:54:26+00:00 https://www.lmi.no/2024/02/13/bms-fornoyde-med-beslutningsforums-hurtigspor/ 2024-02-13T10:55:30+00:00 https://www.lmi.no/2024/02/13/rapport-om-norske-helsedata-alternativkostnadene-som-folger-med-passivitet-er-alvorlige/ 2024-02-13T10:57:06+00:00 https://www.lmi.no/2024/02/13/ventetiden-pa-nye-medisiner-har-blitt-enda-lengre/ 2024-02-13T10:58:05+00:00 https://www.lmi.no/2024/02/13/norway-life-science-2024-er-i-gang/ 2024-02-13T12:06:25+00:00 https://www.lmi.no/wp-content/uploads/2024/02/mq3.webp https://www.lmi.no/2024/02/13/bcg-rapport-dette-skal-til-for-at-norge-blir-ledende-pa-helsedata/ 2024-02-13T12:06:41+00:00 https://www.lmi.no/wp-content/uploads/2024/02/LVK-Panelet-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/LVK-Panelet-scaled.jpg https://www.lmi.no/2024/02/14/lmi-direktoren-om-norsk-svensk-samarbeid-nettopp-dette-vi-ma-gjore/ 2024-02-14T10:35:15+00:00 https://www.lmi.no/wp-content/uploads/2024/02/Skjermbilde-2024-02-14-112057.png https://www.lmi.no/wp-content/uploads/2024/02/Skjermbilde-2024-02-14-112057.png https://www.lmi.no/2024/02/14/ultimovacs-teller-ned-til-mars-har-penger-ut-aret/ 2024-02-14T10:36:16+00:00 https://www.lmi.no/2024/02/14/prisreduksjon-pa-kreftbehandling-kuttet-saksbehandlingstid-til-kun-fire-dager/ 2024-02-14T10:37:30+00:00 https://www.lmi.no/2024/02/14/nedgang-i-forsyningsproblemer-i-2023/ 2024-02-14T10:38:54+00:00 https://www.lmi.no/2024/02/14/finland-slik-kan-ogsa-norge-bli-verdensledende-pa-helsedata/ 2024-02-14T11:02:03+00:00 https://www.lmi.no/wp-content/uploads/2024/02/paivi-skjermdump.png https://www.lmi.no/2024/02/15/hurtiginnforing-av-immunterapi-disse-selskapene-har-blitt-med/ 2024-02-15T09:49:22+00:00 https://www.lmi.no/2024/02/15/pci-biotech-har-halvert-driftsunderskuddet/ 2024-02-15T09:52:01+00:00 https://www.lmi.no/2024/02/15/the-life-science-cluster-henter-driftssjef-fra-biogen/ 2024-02-15T09:56:06+00:00 https://www.lmi.no/2024/02/15/tror-piller-kan-forsinke-aldring-lovende/ 2024-02-15T09:59:49+00:00 https://www.lmi.no/2024/02/15/slik-vil-de-fa-kontroll-med-reseptjukset/ 2024-02-15T10:01:56+00:00 https://www.lmi.no/2024/02/15/norsk-studie-ny-supervaksine/ 2024-02-15T10:04:48+00:00 https://www.lmi.no/2024/02/15/cmv-jubler-for-ja-til-medisin-mot-infeksjon-etter-transplantasjon/ 2024-02-15T10:12:38+00:00 https://www.lmi.no/2024/02/15/store-fordeler-for-norge-hvis-dere-satser-pa-helsedata/ 2024-02-15T11:56:02+00:00 https://www.lmi.no/wp-content/uploads/2024/02/Andrew-Morris.png https://www.lmi.no/2024/02/15/medwatch-haper-pa-en-apen-og-bred-prioriteringsdebatt/ 2024-02-15T12:18:29+00:00 https://www.lmi.no/wp-content/uploads/2024/02/Skjermbilde-2024-02-15-131653.png https://www.lmi.no/wp-content/uploads/2024/02/Skjermbilde-2024-02-15-131653.png https://www.lmi.no/2024/02/15/kjerkol-tok-imot-ekspertgruppenes-rapporter/ 2024-02-15T12:18:57+00:00 https://www.lmi.no/wp-content/uploads/2024/02/Ekspertgrupper_Prioriteringsmelding-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/Ekspertgrupper_Prioriteringsmelding-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/IMG_0932.jpg https://www.lmi.no/2024/02/16/kjerkol-fikk-ekspertrad-om-prioritering/ 2024-02-16T09:30:21+00:00 https://www.lmi.no/2024/02/16/vil-ha-fire-nye-inn-i-beslutningsforum/ 2024-02-16T09:31:39+00:00 https://www.lmi.no/2024/02/16/ekspertgruppe-vil-ogsa-prioritere-pasienter-som-kan-bidra-til-verdiskapingen-i-samfunnet/ 2024-02-16T09:34:14+00:00 https://www.lmi.no/2024/02/16/frp-forventer-at-anbefalingen-om-brukere-og-legers-stemmerett-i-beslutningsforum-folges-opp/ 2024-02-16T09:35:28+00:00 https://www.lmi.no/2024/02/16/navamedic-omsatte-for-en-halv-milliard-i-2023/ 2024-02-16T09:36:40+00:00 https://www.lmi.no/2024/02/16/dette-mener-de-om-ekspertgruppenes-innspill-til-ny-prioriteringsmelding/ 2024-02-16T10:00:59+00:00 https://www.lmi.no/wp-content/uploads/2024/02/DM.png https://www.lmi.no/wp-content/uploads/2024/02/DM.png https://www.lmi.no/2024/02/19/ultimovacs-kreftvaksine-far-orphan-drug-status-i-europa/ 2024-02-19T08:25:48+00:00 https://www.lmi.no/2024/02/19/brystkreftmedisin-under-lupen-ser-ut-til-a-ha-darligere-overlevelse/ 2024-02-19T08:37:09+00:00 https://www.lmi.no/2024/02/19/voksne-bor-fa-vaksiner/ 2024-02-19T08:45:19+00:00 https://www.lmi.no/2024/02/20/norske-ozempic-priser-klart-lavest-i-skandinavia/ 2024-02-20T09:02:09+00:00 https://www.lmi.no/2024/02/20/fda-godkjenner-roche-behandling-mot-matallergi/ 2024-02-20T12:29:30+00:00 https://www.lmi.no/2024/02/20/foreslar-tiltak-for-et-bedre-marked-for-leverandorer-av-lavprislegemidler/ 2024-02-20T12:37:23+00:00 https://www.lmi.no/2024/02/21/medisinene-som-gir-mest-alvorlige-bivirkninger/ 2024-02-21T08:19:30+00:00 https://www.lmi.no/2024/02/19/vi-ma-vaere-forberedt-pa-det-utenkelige/ 2024-02-21T08:29:02+00:00 https://www.lmi.no/2024/02/20/felleskatalogen-er-fremst-i-europa-nar-det-kommer-til-digitale-pakningsvedlegg/ 2024-02-21T08:37:49+00:00 https://www.lmi.no/wp-content/uploads/2024/02/Skjermbilde-2024-02-21-093204.png https://www.lmi.no/2024/02/21/er-vi-enige-om-hva-som-ikke-skal-prioriteres/ 2024-02-21T08:41:05+00:00 https://www.lmi.no/2024/02/22/lmi-reagerer-pa-lang-saksbehandling-det-gar-for-sakte/ 2024-02-22T09:16:59+00:00 https://www.lmi.no/2024/02/22/helge-lund-innstilt-til-a-fortsette-som-novo-nordisk-styreleder/ 2024-02-22T09:27:39+00:00 https://www.lmi.no/2024/02/22/artbio-inngar-naert-samarbeid-med-kinesisk-selskap/ 2024-02-22T09:29:32+00:00 https://www.lmi.no/2024/02/22/trenger-vi-et-nordata/ 2024-02-22T09:32:29+00:00 https://www.lmi.no/2024/02/22/nye-metoder-lege-usikker-dokumentasjon-og-astronomiske-priser-pa-nye-legemidler/ 2024-02-22T09:38:29+00:00 https://www.lmi.no/2024/02/22/uten-vaksinehandling-fra-regjeringen-vil-flere-do/ 2024-02-22T09:44:07+00:00 https://www.lmi.no/2024/02/23/i-mange-land-er-vaksinen-mot-helvetesild-gratis-i-norge-koster-den-flere-tusen-kroner/ 2024-02-23T07:21:53+00:00 https://www.lmi.no/2024/02/23/svarer-pa-kritikken-aldri-for-har-vi-hatt-sa-mange-leveranser-til-nye-metoder/ 2024-02-23T07:25:30+00:00 https://www.lmi.no/2024/02/21/slik-kan-norge-ta-i-bruk-finsk-helsedata-oppskrift/ 2024-02-23T08:13:02+00:00 https://www.lmi.no/2024/02/23/astrazeneca-har-sluttfort-oppkjopet-av-kinesisk-celleterapi-selskap/ 2024-02-23T08:19:52+00:00 https://www.lmi.no/2024/02/26/bor-ikke-norske-pasienter-fa-tilgang-til-nye-medisiner/ 2024-02-26T10:45:37+00:00 https://www.lmi.no/wp-content/uploads/2024/02/Skjermbilde-2024-02-26-114317.png https://www.lmi.no/wp-content/uploads/2024/02/Skjermbilde-2024-02-26-114317.png https://www.lmi.no/2024/02/26/betennelsessykdommer-ny-norsk-forskning-kan-sikre-bedre-behandling/ 2024-02-26T10:47:46+00:00 https://www.lmi.no/2024/02/26/snur-om-brystkreftmedisin-forskjell-i-totaloverlevelse/ 2024-02-26T10:50:52+00:00 https://www.lmi.no/2024/02/26/ny-studie-kan-gi-hap-har-bedre-livskvalitet/ 2024-02-26T10:51:43+00:00 https://www.lmi.no/2024/02/13/norge-trenger-et-vaksinasjonsprogram-for-voksne-na/ 2024-02-26T11:24:02+00:00 https://www.lmi.no/wp-content/uploads/2024/02/Skjermbilde-2024-02-13-123029.png https://www.lmi.no/2024/02/26/ferdig-i-pfizer-norge-etter-ti-ar/ 2024-02-26T11:55:22+00:00 https://www.lmi.no/2024/02/01/varens-market-access-kurs/ 2024-02-26T16:37:59+00:00 https://www.lmi.no/wp-content/uploads/2024/02/Ill.-helseokonomi.png https://www.lmi.no/wp-content/uploads/2024/02/Ill.-helseokonomi.png https://www.lmi.no/2024/02/27/voksenvaksinasjonsprogram-veldig-bra-at-sa-mange-engasjerer-seg-na/ 2024-02-27T09:56:31+00:00 https://www.lmi.no/wp-content/uploads/2024/02/Faksimiler-voksenvaksinasjonsprogram.png https://www.lmi.no/wp-content/uploads/2024/02/Faksimiler-voksenvaksinasjonsprogram.png https://www.lmi.no/wp-content/uploads/2023/01/anne-margrethe-crop-2-scaled-e1748933566845.jpg https://www.lmi.no/wp-content/uploads/2024/02/Line-Storesund-Rondan-2023.jpg https://www.lmi.no/2024/02/27/50-apotek-skal-kartlegge-legemiddelmangel/ 2024-02-27T10:35:01+00:00 https://www.lmi.no/2024/02/27/rootwelt-om-immunterapi-kritikk-et-raskere-ja-er-positivt/ 2024-02-27T10:35:43+00:00 https://www.lmi.no/2024/02/27/jusprofessor-kritiserer-hurtiginnforing-av-immunterapi-systemet-bor-endres/ 2024-02-27T10:36:21+00:00 https://www.lmi.no/2024/02/27/medlemsmote-om-oppfolging-av-ekspertgruppenes-anbefalinger/ 2024-02-27T11:38:43+00:00 https://www.lmi.no/wp-content/uploads/2024/02/IMG_2514-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/IMG_2514-scaled.jpg https://www.lmi.no/2024/02/19/prioritering-ma-vi-fa-inn-samfunnsperspektivet-jeg-har-flere-reservasjoner/ 2024-02-27T13:51:23+00:00 https://www.lmi.no/2024/02/29/lmi-om-beredskap-pa-dagsrevyen/ 2024-02-29T08:08:06+00:00 https://www.lmi.no/wp-content/uploads/2024/02/Dagsrevyen-beredskap-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/Dagsrevyen-beredskap-scaled.jpg https://www.lmi.no/2024/02/29/nykode-direktoren-om-den-brede-pipelinen-ma-gjore-beinharde-prioriteringer/ 2024-02-29T08:36:12+00:00 https://www.lmi.no/2024/02/29/arctic-bioscience-alle-pasienter-dosert-i-psoriasis-studie/ 2024-02-29T08:36:58+00:00 https://www.lmi.no/2024/02/29/lmi-i-panelsamtale-om-eu4health/ 2024-02-29T12:55:02+00:00 https://www.lmi.no/wp-content/uploads/2024/02/Panelsamtale.jpg https://www.lmi.no/wp-content/uploads/2024/02/Panelsamtale.jpg https://www.lmi.no/2024/02/29/stilling-ledig-i-lmi/ 2024-02-29T13:10:58+00:00 https://www.lmi.no/wp-content/uploads/2024/02/LMI-generelt-med-stortingGF2024.jpg https://www.lmi.no/2024/03/01/ytterligere-kutt-i-pfizer-norge-medisinsk-direktor-slutter/ 2024-03-01T08:05:58+00:00 https://www.lmi.no/2024/03/01/vil-norge-fortsette-a-feile-pa-sjeldenfeltet/ 2024-03-01T08:06:29+00:00 https://www.lmi.no/2024/03/01/klasseforskjell-i-sjelden-behandling/ 2024-03-01T08:07:02+00:00 https://www.lmi.no/2024/03/04/har-eksplodert-blant-unge/ 2024-03-04T09:12:32+00:00 https://www.lmi.no/2024/03/04/studie-om-ungdom-og-smertestillende-vi-finner-en-klar-sammenheng/ 2024-03-04T09:16:58+00:00 https://www.lmi.no/2024/03/04/kompani-lauritzen-fryktet-kronisk-sykdom-ville-spolere/ 2024-03-04T09:18:30+00:00 https://www.lmi.no/2024/03/04/studie-velkjent-medisin-kan-behandle-matvareallergi/ 2024-03-04T09:21:51+00:00 https://www.lmi.no/2024/03/04/nyfodtscreening-slik-oppdages-potensielt-sjeldne-sykdommer-hos-nyfodte/ 2024-03-04T09:24:23+00:00 https://www.lmi.no/2024/03/04/eli-lilly-ruster-opp-med-flere-ansatte-i-norden-for-nye-lanseringer/ 2024-03-04T09:27:14+00:00 https://www.lmi.no/2024/03/04/helse-og-samhandlingsplanen-begraver-en-innbygger-en-journal/ 2024-03-04T09:28:20+00:00 https://www.lmi.no/2024/03/04/arctic-bioscience-gar-inn-i-2024-med-100-millioner-pa-bok/ 2024-03-04T09:29:47+00:00 https://www.lmi.no/2024/03/04/ny-nasjonal-helse-og-samhandlingsplan-fra-regjeringen/ 2024-03-04T10:47:29+00:00 https://www.lmi.no/wp-content/uploads/2024/03/Skjermbilde-2024-03-04-114603.png https://www.lmi.no/wp-content/uploads/2024/03/Skjermbilde-2024-03-04-114603.png https://www.lmi.no/2024/03/05/lmi-styrker-samarbeidet-med-biotek-selskaper/ 2024-03-05T08:28:38+00:00 https://www.lmi.no/wp-content/uploads/2024/03/gruppe-biotek-jpg.webp https://www.lmi.no/wp-content/uploads/2024/03/gruppe-biotek-jpg.webp https://www.lmi.no/2024/03/05/redde-en-pasient-eller-redde-budsjettet-andreas-ma-ta-det-umulige-valget-flere-ganger-hvert-ar/ 2024-03-05T09:54:38+00:00 https://www.lmi.no/2024/03/05/etablerer-biotek-gruppe-i-lmi/ 2024-03-05T09:55:31+00:00 https://www.lmi.no/2024/03/05/subjekts-debattredaktor-skeptisk-til-koronavaksiner/ 2024-03-05T10:09:58+00:00 https://www.lmi.no/2024/03/05/unn-nestorer-vil-samle-kreftbehandling-hvis-ikke-det-offentlige-gjor-det-gjor-det-private-det/ 2024-03-05T10:13:46+00:00 https://www.lmi.no/2024/03/06/fedmemedisin-kan-reglene-endres/ 2024-03-06T10:12:32+00:00 https://www.lmi.no/2024/03/06/uklart-om-internasjonale-kutt-rammer-bayer-i-norge/ 2024-03-06T10:13:35+00:00 https://www.lmi.no/2024/03/06/oppdrag-til-sykehusinnkjop-skal-bidra-internasjonalt-innen-etisk-handel-og-miljo/ 2024-03-06T10:15:37+00:00 https://www.lmi.no/2024/03/06/dmp-om-hods-180-dagers-krav-vi-vil-fortsette-a-jobbe-med-forbedringer/ 2024-03-06T10:17:01+00:00 https://www.lmi.no/2024/03/06/hod-metodevurderinger-skal-fullfores-innen-180-dager/ 2024-03-06T10:19:31+00:00 https://www.lmi.no/2024/03/06/sarsia-skal-hente-700-millioner-til-nytt-fond/ 2024-03-06T10:20:26+00:00 https://www.lmi.no/2024/03/06/bayer-vil-eget-hierarki-til-livs-innforer-ny-driftsmodell-og-varsler-omfattende-nedbemanning/ 2024-03-06T11:10:55+00:00 https://www.lmi.no/2024/03/06/1300-fastleger-har-fatt-opplaering-en-til-en-i-hormoner-i-overgangsalderen/ 2024-03-06T11:13:34+00:00 https://www.lmi.no/2024/03/06/eli-lilly-haler-innpa-novo-nordisk-pa-fedmemarkedet/ 2024-03-06T11:16:02+00:00 https://www.lmi.no/2024/03/06/vil-hindre-ny-pandemi-oker-vaksineproduksjon-i-det-globale-sor/ 2024-03-06T11:19:36+00:00 https://www.lmi.no/2024/03/06/esoc-kongressen-i-basel-presenterer-norge-som-studieland/ 2024-03-06T12:05:15+00:00 https://www.lmi.no/wp-content/uploads/2024/03/Basel_wikipediafoto-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/03/Basel_wikipediafoto-scaled.jpeg https://www.lmi.no/2024/03/07/har-lyttet-til-lmi-pa-tvers-av-politiske-skillelinjer/ 2024-03-07T16:09:03+00:00 https://www.lmi.no/wp-content/uploads/2024/03/Image.jpg https://www.lmi.no/wp-content/uploads/2024/03/Image.jpg https://www.lmi.no/2024/03/08/forskning-og-innovasjon-styrkes-pa-farmasi-ved-uio/ 2024-03-08T11:23:43+00:00 https://www.lmi.no/2024/03/08/lmi-ikke-til-a-miste-motet-av/ 2024-03-08T11:26:21+00:00 https://www.lmi.no/2024/03/08/stein-erik-hagen-lemper-ut-ultimovacs-aksjer/ 2024-03-08T12:20:45+00:00 https://www.lmi.no/2024/03/08/kan-blodprover-tidlig-avslore-risiko-for-demens/ 2024-03-08T12:22:21+00:00 https://www.lmi.no/2024/03/08/bedre-prioritering-og-tilgang-dette-er-ekspertgruppens-anbefalinger/ 2024-03-08T12:23:56+00:00 https://www.lmi.no/2024/03/08/ultimovacs-initium-studien-med-uv1-vaksinen-mot-foflekkreft-var-negativ-veldig-overrasket-og-skuffet/ 2024-03-08T12:25:11+00:00 https://www.lmi.no/2024/03/08/kan-bcg-vaksinen-beskytte-mot-alzheimers-sykdom/ 2024-03-08T12:26:58+00:00 https://www.lmi.no/2024/03/08/livmorkreft-mange-vil-bli-sykdomsfrie-og-kurert/ 2024-03-08T12:29:04+00:00 https://www.lmi.no/2024/03/08/inven2-direktoren-frykter-ikke-konsekvenser-for-norsk-biotek-sektor-etter-ultimovacs-skuffelsen/ 2024-03-08T12:35:10+00:00 https://www.lmi.no/2024/03/08/ny-novo-nordisk-pille-ga-stor-vektnedgang-pa-12-uker/ 2024-03-08T12:39:35+00:00 https://www.lmi.no/2024/03/11/authera-grunder-har-tatt-patent-pa-ny-antistoffteknologi/ 2024-03-11T10:09:09+00:00 https://www.lmi.no/2024/03/11/advarer-mot-ulovlige-slankebutikker/ 2024-03-11T10:28:06+00:00 https://www.lmi.no/2024/03/11/sats-pa-kjemi-ved-universitetene-for-a-styrke-legemiddelberedskapen/ 2024-03-11T10:31:46+00:00 https://www.lmi.no/2024/03/11/listhaug-til-lmis-generalforsamling/ 2024-03-11T10:36:55+00:00 https://www.lmi.no/wp-content/uploads/2024/01/i8ndjiru.png https://www.lmi.no/wp-content/uploads/2024/01/SYL_ekstrastort-1.jpg https://www.lmi.no/2024/03/11/redde-en-pasient-eller-redde-budsjettet/ 2024-03-11T10:43:21+00:00 https://www.lmi.no/2024/03/11/stein-erik-hagen-om-canicas-nedsalg-i-ultimovacs/ 2024-03-11T10:46:25+00:00 https://www.lmi.no/2024/03/11/joe-biden-i-state-of-the-union-tale-vi-har-vunnet-over-big-pharma/ 2024-03-11T10:55:33+00:00 https://www.lmi.no/2024/03/11/vi-er-ikke-gode-nok-til-a-implementere-ny-helseteknologi/ 2024-03-11T10:58:20+00:00 https://www.lmi.no/2024/03/11/vi-er-godt-i-gang-med-a-legge-til-rette-for-okt-bruk-og-utnyttelse-av-helsedata/ 2024-03-11T11:00:13+00:00 https://www.lmi.no/2024/03/11/vil-velferdsstaten-forvitre/ 2024-03-11T11:02:43+00:00 https://www.lmi.no/2024/03/11/arrangerte-helse-og-fremtid-for-tiende-gang/ 2024-03-11T11:53:08+00:00 https://www.lmi.no/wp-content/uploads/2024/03/IMG_0225-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/03/IMG_0225-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/03/IMG_0264-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/03/IMG_0306-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/03/IMG_0180.png https://www.lmi.no/2024/03/11/medwatch-helseindustrien-okte-eksporten-med-12-prosent-i-2023/ 2024-03-11T13:20:42+00:00 https://www.lmi.no/wp-content/uploads/2024/03/Monica-Larsen-MedWatch.png https://www.lmi.no/wp-content/uploads/2024/03/Monica-Larsen-MedWatch.png https://www.lmi.no/2024/03/12/dette-mener-helsepolitikere-er-det-viktigste-for-a-sikre-fremtidens-helsetjeneste/ 2024-03-12T08:06:56+00:00 https://www.lmi.no/2024/03/12/vi-er-ikke-gode-nok-til-a-implementere-ny-helseteknologi-2/ 2024-03-12T08:14:15+00:00 https://www.lmi.no/2024/03/12/et-mye-storre-problem-enn-pandemien/ 2024-03-12T08:23:42+00:00 https://www.lmi.no/2024/03/12/ultimovacs-flukten-fortsetter/ 2024-03-12T08:27:43+00:00 https://www.lmi.no/2024/03/12/medwatch-hagens-investeringsselskap-helt-ute-av-ultimovacs/ 2024-03-12T08:29:24+00:00 https://www.lmi.no/2024/03/12/tv2-populaer-medisin-kan-ha-ny-effekt/ 2024-03-12T08:31:04+00:00 https://www.lmi.no/2024/03/12/forlater-tv-2-blir-ny-radgiver-i-lmi/ 2024-03-12T13:53:47+00:00 https://www.lmi.no/wp-content/uploads/2024/03/IMG_7469.jpg https://www.lmi.no/wp-content/uploads/2024/03/Ina-T_liggende.jpg https://www.lmi.no/2024/03/04/prioritering-av-helsetiltak-vi-savner-nyanser-og-kontekst/ 2024-03-12T14:02:09+00:00 https://www.lmi.no/2024/03/13/forslag-om-gratis-kikhostevaksine-til-gravide-sendes-pa-horing/ 2024-03-13T11:18:07+00:00 https://www.lmi.no/2024/03/13/sykehusinnkjop-har-gjort-15-legemiddelanskaffelser-med-miljokrav/ 2024-03-13T11:20:59+00:00 https://www.lmi.no/2024/03/13/healthtalk-hva-betyr-ultimovacs-kollapsen-for-norsk-biotek-bransje/ 2024-03-13T11:24:38+00:00 https://www.lmi.no/2024/03/13/beslutningssystemet-ma-vaere-sa-robust-at-vi-sjelden-ma-gjore-unntak/ 2024-03-13T12:16:32+00:00 https://www.lmi.no/2024/03/11/thermo-fisher-satser-i-norge-takket-vaere-norske-innovasjoner/ 2024-03-13T15:00:00+00:00 https://www.lmi.no/wp-content/uploads/2024/03/tuva-og-kollegene-ved-dynacellect_2-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/03/tuva-og-kollegene-ved-dynacellect_2-scaled.jpg https://www.lmi.no/2024/03/14/brutte-frister-kostet-helsevesenet-hundrevis-av-millioner-i-aret/ 2024-03-14T08:13:16+00:00 https://www.lmi.no/2024/03/14/astrazeneca-kjoper-sjelden-selskap-i-milliardhandel/ 2024-03-14T08:29:26+00:00 https://www.lmi.no/2024/03/14/gsk-vant-kikhostevaksine-anbud/ 2024-03-14T08:31:57+00:00 https://www.lmi.no/2024/03/14/eu-har-godkjent-pfizers-pneumokokkvaksine-for-barn/ 2024-03-14T08:33:40+00:00 https://www.lmi.no/2024/03/14/rekordhoyt-antall-saker-i-neste-beslutningsforum-mote/ 2024-03-14T08:36:46+00:00 https://www.lmi.no/2024/03/14/lmis-nye-styre/ 2024-03-14T14:20:28+00:00 https://www.lmi.no/wp-content/uploads/2024/03/IMG_0245-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/03/IMG_0245-scaled.jpg https://www.lmi.no/2024/03/15/medwatch-dette-er-lmis-nye-styre/ 2024-03-15T08:19:00+00:00 https://www.lmi.no/2024/03/15/apotekforeningen-lite-hjelp-fra-stortinget-mot-legemiddelmangel/ 2024-03-15T08:22:11+00:00 https://www.lmi.no/2024/03/15/forskning-no-norsk-biovitskapleg-forsking-er-god/ 2024-03-15T08:31:23+00:00 https://www.lmi.no/2024/03/15/dagens-medisin-ny-alzheimer-behandling/ 2024-03-15T08:39:36+00:00 https://www.lmi.no/2024/03/15/stor-okning-i-cro-firmaer-i-norden-sammen-mot-felles-mal/ 2024-03-15T13:42:43+00:00 https://www.lmi.no/wp-content/uploads/2024/03/CRO-mote-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/03/CRO-mote-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/03/cro-mote-arrangementskomite_edited-scaled.jpg https://www.lmi.no/2024/03/18/et-ja-kan-endre-livet-til-johannes-2/ 2024-03-18T11:30:05+00:00 https://www.lmi.no/2024/03/18/paracet-i-fri-flyt-na-skal-overforbruket-bremses/ 2024-03-18T11:30:40+00:00 https://www.lmi.no/2024/03/18/sykehusinnkjop-felles-nordisk-anbod-skal-fa-bukt-med-antibiotikaresistens/ 2024-03-18T11:32:07+00:00 https://www.lmi.no/2024/03/18/lmi-haper-nytt-vurderingssystem-gir-raskere-innforing-av-nye-vaksiner/ 2024-03-18T11:39:48+00:00 https://www.lmi.no/2024/03/18/frykter-sveits-ras-for-norsk-biotek/ 2024-03-18T12:20:48+00:00 https://www.lmi.no/2024/03/18/innforer-ny-behandling-for-barn-med-alvorlig-epilepsi-det-er-vi-veldig-glade-for/ 2024-03-18T12:21:59+00:00 https://www.lmi.no/2024/03/18/beslutningsforum-disse-metodene-fikk-ja-til-innforing-2/ 2024-03-18T12:22:17+00:00 https://www.lmi.no/2024/03/18/listhaug-talte-til-lmis-medlemmer/ 2024-03-18T13:16:13+00:00 https://www.lmi.no/wp-content/uploads/2024/03/Listhaug-og-Skymoen-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/03/Listhaug-og-Skymoen-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/03/SpmSylviLeifRune-scaled.jpg https://www.lmi.no/2024/03/19/bekymret-over-shopping-av-fiskehelsepersonell/ 2024-03-19T10:09:49+00:00 https://www.lmi.no/2024/03/19/forste-injiserbare-immunterapi-innfores-i-norge/ 2024-03-19T10:10:30+00:00 https://www.lmi.no/2024/03/19/nytt-vapen-mot-brystkreft/ 2024-03-19T10:11:11+00:00 https://www.lmi.no/2024/03/19/kreftforeningen-skal-for-forste-gang-utvikle-medisiner/ 2024-03-19T10:12:11+00:00 https://www.lmi.no/2024/03/19/fortviler-etter-nei-vondt/ 2024-03-19T10:12:54+00:00 https://www.lmi.no/2024/03/19/nykode-melder-om-fremskritt-for-teknologi-som-kan-brukes-i-behandling-av-autoimmune-sykdommer/ 2024-03-19T10:13:34+00:00 https://www.lmi.no/2024/03/20/young-pharma-nytt-nettverk-for-alle-i-bransjen/ 2024-03-20T12:23:14+00:00 https://www.lmi.no/wp-content/uploads/2024/03/young-pharma-2.png https://www.lmi.no/wp-content/uploads/2024/03/Elisabeth-Hannisdahl-AbbVie.jpg https://www.lmi.no/wp-content/uploads/2024/03/Cecilie-Alstad-UCB_Crop.jpg https://www.lmi.no/2024/03/21/endringer-i-legemiddelberedskapsordningen-for-primaerhelsetjenesten/ 2024-03-21T10:45:44+00:00 https://www.lmi.no/wp-content/uploads/2024/01/Beredskapslagre-av-Dall-E.png https://www.lmi.no/2024/03/21/de-forste-resultatene-fra-impress-studien-er-klare/ 2024-03-21T11:46:47+00:00 https://www.lmi.no/wp-content/uploads/2024/03/Katarina-Puco-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/03/Katarina-Puco-2-scaled.jpg https://www.lmi.no/2024/03/21/livmorkreft-dette-bor-du-vite-om-symptomer-diagnose-og-behandling/ 2024-03-21T12:03:52+00:00 https://www.lmi.no/2024/03/21/fhi-utlevering-av-data-fra-helseregistrene-gar-raskere/ 2024-03-21T12:06:29+00:00 https://www.lmi.no/2024/03/21/bergenbio-gar-videre-med-hovedstudie/ 2024-03-21T12:08:00+00:00 https://www.lmi.no/2024/03/21/nykode-med-oppdaterte-overlevelsesdata-pa-vaksine-mot-livmorhalskreft/ 2024-03-21T12:21:57+00:00 https://www.lmi.no/2024/03/21/gilead-skal-firedoble-car-t-kapasiteten-innen-2026/ 2024-03-21T12:23:55+00:00 https://www.lmi.no/2024/03/21/ny-astmamedisin70-prosent-faerre-anfall/ 2024-03-21T12:25:06+00:00 https://www.lmi.no/2024/03/21/ny-lungekreftstudie-har-tatt-i-bruk-av-registerdata/ 2024-03-21T12:27:48+00:00 https://www.lmi.no/2024/03/21/overlege-frykter-antibiotikaresistent-gonore-i-norge/ 2024-03-21T12:29:40+00:00 https://www.lmi.no/2024/03/21/eus-legemiddelreform-klar-for-avstemning-i-eu-parlamentet/ 2024-03-21T12:30:45+00:00 https://www.lmi.no/2024/03/21/eline-18-far-epilepsimedisin-endeleg/ 2024-03-21T12:33:52+00:00 https://www.lmi.no/2024/03/21/livmorkreft-ekspert-om-jemperli-ja-en-milepael-for-vare-pasienter/ 2024-03-21T12:36:13+00:00 https://www.lmi.no/2024/03/21/beslutningsforum-godkjente-blodkreftlegemiddel-pa-rekordtid/ 2024-03-21T12:37:41+00:00 https://www.lmi.no/2024/03/21/astrazeneca-kjoper-radiofarmasi-selskap-i-milliardavtale/ 2024-03-21T12:38:40+00:00 https://www.lmi.no/2024/03/21/usa-novo-nordisk-fedmemiddel-forbigas-av-eli-lilly-medisin/ 2024-03-21T12:40:15+00:00 https://www.lmi.no/2024/03/21/bioarctic-grunder-lars-lannfelt-stor-tro-pa-at-vi-naermer-oss-a-kunne-bremse-alzheimer/ 2024-03-21T15:12:38+00:00 https://www.lmi.no/wp-content/uploads/2024/03/Bioarctic_hele-teamet-2_crop-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/03/Bioarctic_hele-teamet-2_crop-scaled.jpg https://www.lmi.no/2024/03/21/henter-erfaringer-fra-danmark/ 2024-03-22T08:45:06+00:00 https://www.lmi.no/wp-content/uploads/2024/03/IMG_1073_2-1.jpg https://www.lmi.no/wp-content/uploads/2024/03/IMG_1073_2-1.jpg https://www.lmi.no/wp-content/uploads/2024/03/IMG_1095_2.jpg https://www.lmi.no/wp-content/uploads/2024/03/IMG_1083_2.jpg https://www.lmi.no/wp-content/uploads/2024/03/IMG_1098_2.jpg https://www.lmi.no/wp-content/uploads/2024/03/IMG_1107_2.jpg https://www.lmi.no/2024/03/22/planlegger-menon-rapport-om-forsinket-innforing-av-legemidler/ 2024-03-22T10:22:09+00:00 https://www.lmi.no/wp-content/uploads/2024/03/hourglass-620397_1280.jpg https://www.lmi.no/wp-content/uploads/2024/03/hourglass-620397_1280.jpg https://www.lmi.no/2024/03/22/thor-medical-forventer-over-400-millioner-i-arlig-inntekt/ 2024-03-22T11:15:29+00:00 https://www.lmi.no/2024/03/22/forklarer-ny-bivirkning-kraftig-immunrespons/ 2024-03-22T11:16:28+00:00 https://www.lmi.no/2024/03/22/ina-tullut-er-ny-kom-radgiver-i-lmi/ 2024-03-22T11:17:28+00:00 https://www.lmi.no/2024/03/22/ultimovacs-sjokket-bekymrer-ikke-norske-biotek-ledere-har-tro-pa-egen-teknologi/ 2024-03-22T11:18:28+00:00 https://www.lmi.no/2024/03/22/digitalis-tar-paskeferie-2/ 2024-03-22T11:46:47+00:00 https://www.lmi.no/wp-content/uploads/2024/03/easter-3281582_1280.jpg https://www.lmi.no/wp-content/uploads/2024/03/easter-3281582_1280.jpg https://www.lmi.no/2024/04/02/apotekforeningen-norge-sparer-tre-milliarder-kroner-pa-medisinbytte/ 2024-04-02T09:27:37+00:00 https://www.lmi.no/2024/04/02/disse-ti-legene-fikk-mest-penger-av-legemiddelindustrien/ 2024-04-02T09:28:01+00:00 https://www.lmi.no/2024/04/02/sverige-og-danmark-etablerer-referanse-laboriatorium-for-antibiotikaresistens-i-eu/ 2024-04-02T09:28:24+00:00 https://www.lmi.no/2024/04/02/kunngjor-ny-anbudskonkurranse-pa-anitibiotika/ 2024-04-02T09:33:52+00:00 https://www.lmi.no/2024/04/02/antallet-kliniske-studier-i-norge-har-falt-pa-denne-avdelingen-peker-pilene-oppover/ 2024-04-02T09:38:37+00:00 https://www.lmi.no/2024/03/25/healhtalk-bransjeaktorer-har-fortsatt-tro-pa-norsk-biotek-men-mener-innsatsen-ma-okes/ 2024-04-02T09:41:49+00:00 https://www.lmi.no/2024/04/03/hemmelige-legemiddelpriser-er-et-demokratisk-problem/ 2024-04-03T07:00:01+00:00 https://www.lmi.no/2024/04/03/en-av-fire-kreftpasienter-har-fatt-tilbud-om-ny-behandling-gjennom-impress-studien/ 2024-04-03T07:01:37+00:00 https://www.lmi.no/2024/04/03/ma-sterkere-krutt-til-pa-helsedataomradet/ 2024-04-03T10:54:53+00:00 https://www.lmi.no/2024/04/03/lmis-helsedatagruppe-i-dagens-medisin-ma-sterkere-krutt-til/ 2024-04-03T11:05:04+00:00 https://www.lmi.no/wp-content/uploads/2024/04/dm-innlegg-helsedata.png https://www.lmi.no/wp-content/uploads/2024/04/dm-innlegg-helsedata.png https://www.lmi.no/wp-content/uploads/2024/04/Helsedata-samlet.png https://www.lmi.no/2024/03/19/helseoonomisk-fagdag-11-april/ 2024-04-04T09:47:38+00:00 https://www.lmi.no/wp-content/uploads/2024/03/helseok-innledere-collage-ny.jpg https://www.lmi.no/wp-content/uploads/2024/02/helseokonomisk-fagdag_crop.jpg https://www.lmi.no/2024/04/04/flatt-pa-oslo-bors-helseaksje-sendes-rett-opp/ 2024-04-04T10:32:57+00:00 https://www.lmi.no/2024/04/04/leger-farmasoyter-og-tannleger-foreslar-a-stoppe-salg-av-ibuprofen-utenfor-apotek/ 2024-04-04T10:33:48+00:00 https://www.lmi.no/2024/04/04/krav-til-mer-data-forsinker-esai-og-biogens-injiserbare-alzheimer-legemiddel/ 2024-04-04T10:34:30+00:00 https://www.lmi.no/2024/04/04/horingssvar-fra-lmi-til-forskrift-om-endringer-i-forskrift-om-nasjonalt-vaksinasjonsprogram/ 2024-04-04T18:08:04+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2024/04/05/styreleder-i-ultimovacs-disse-nye-studiene-vurderer-selskapet/ 2024-04-05T06:25:43+00:00 https://www.lmi.no/2024/04/05/stor-omstrukturering-i-msd-norge-blir-snart-100-ansatte/ 2024-04-05T06:28:44+00:00 https://www.lmi.no/2024/04/05/om-du-ikke-kan-stole-pa-legen-din/ 2024-04-05T06:33:26+00:00 https://www.lmi.no/2024/04/05/vil-fjerne-populaert-legemiddel-forventer-reaksjoner/ 2024-04-05T06:37:33+00:00 https://www.lmi.no/2024/04/05/fda-klare-for-a-vurdere-nye-persontilpassede-kreftvaksiner/ 2024-04-05T07:09:11+00:00 https://www.lmi.no/2024/04/05/ntnu-professor-lanserer-nytt-selskap/ 2024-04-05T07:14:08+00:00 https://www.lmi.no/2024/04/05/produksjonsdagen-2024-helseindustri-i-norge-en-historikk-a-bygge-videre-pa/ 2024-04-05T07:25:05+00:00 https://www.lmi.no/wp-content/uploads/2024/04/Produksjonsdagen-detalj.png https://www.lmi.no/wp-content/uploads/2024/04/produksjonsdagen-2024.png https://www.lmi.no/2024/04/04/politisk-samtale-pa-helseokonomisk-fagdag/ 2024-04-05T11:16:41+00:00 https://www.lmi.no/wp-content/uploads/2024/04/4-hoder-DIG-forside-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/04/bilde-16-9-2.jpg https://www.lmi.no/2024/04/08/de-har-gitt-svar-pa-flere-medisinske-gater-her-er-bergens-nye-forsoksdyr/ 2024-04-08T07:18:21+00:00 https://www.lmi.no/2024/04/08/bygget-milliardverdier-pa-kreftforskning-sa-treffer-den-perfekte-stormen/ 2024-04-08T07:26:30+00:00 https://www.lmi.no/2024/04/08/troblete-insulinbytte/ 2024-04-08T07:29:12+00:00 https://www.lmi.no/2024/04/08/alzheimer-detekteres-like-godt-i-blod-som-i-spinalvaeske/ 2024-04-08T07:31:53+00:00 https://www.lmi.no/2024/04/08/halden-pharma-er-nytt-lmi-medlem/ 2024-04-08T07:39:30+00:00 https://www.lmi.no/wp-content/uploads/2024/04/IMG_0736-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/04/IMG_0736-scaled.jpg https://www.lmi.no/2024/04/08/astrazeneca-immunterapi-lykkes-med-a-behandle-aggressiv-lungekreft/ 2024-04-08T07:40:07+00:00 https://www.lmi.no/2024/04/08/novartis-skal-soke-om-utvidet-pluvicto-bruk/ 2024-04-08T07:42:05+00:00 https://www.lmi.no/2024/04/08/oncoinvent-har-hentet-71-millioner-kroner-jakter-130-millioner-til/ 2024-04-08T07:43:23+00:00 https://www.lmi.no/2024/04/08/fda-godkjenner-nytt-antibiotikum-for-behandling-av-tre-infeksjoner/ 2024-04-08T07:44:43+00:00 https://www.lmi.no/2024/04/08/novo-nordisk-om-ozempic-mangel-vi-tar-denne-situasjonen-svaert-alvorlig/ 2024-04-08T07:46:15+00:00 https://www.lmi.no/2024/04/08/gehor-for-lmis-innspill-til-bedre-legemiddelberedskap/ 2024-04-08T13:51:01+00:00 https://www.lmi.no/wp-content/uploads/2024/04/Leif-Rune-og-Kjerkol_Helseberedskapsmeldingen-1280x960-1.jpg https://www.lmi.no/wp-content/uploads/2024/04/Leif-Rune-og-Kjerkol_Helseberedskapsmeldingen-1280x960-1.jpg https://www.lmi.no/2024/04/09/skymoen-inn-i-helseomsorg21-radet/ 2024-04-09T08:32:43+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Leif-Rune-Skymoen-glad-5942-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/04/Leif-Rune-og-Kjerkol_Helseberedskapsmeldingen-1280x960-1.jpg https://www.lmi.no/2024/04/09/stor-oppgang-i-bruken-av-slankemedisin-i-danmark/ 2024-04-09T08:54:15+00:00 https://www.lmi.no/2024/04/09/nye-metoder-for-kreftbehandling-krever-virkelighetsdata-i-saerklasse/ 2024-04-09T08:55:55+00:00 https://www.lmi.no/2024/04/09/usikre-tider-for-norske-kreftvaksiner-vil-teknologien-bli-viktig-i-fremtidens-kreftbehandling/ 2024-04-09T09:02:27+00:00 https://www.lmi.no/2024/04/09/fou-kutt-i-sanofi-rammer-verken-norske-eller-nordiske-ansatte/ 2024-04-09T10:28:08+00:00 https://www.lmi.no/2024/04/09/dette-er-det-nye-helseomsorg21-radet/ 2024-04-09T10:28:50+00:00 https://www.lmi.no/2024/04/09/halden-pharma-er-blitt-medlem-i-legemiddelinustrien/ 2024-04-09T10:29:40+00:00 https://www.lmi.no/2024/04/10/politikerne-om-fremtidens-kreftbehandling-og-helsenaering-teknologi-blir-kjempeviktig/ 2024-04-10T07:48:08+00:00 https://www.lmi.no/2024/04/10/ny-studie-fant-sammenheng-mellom-lite-sovn-og-diabetes-type-2/ 2024-04-10T07:54:09+00:00 https://www.lmi.no/2024/04/10/goy-a-hacke-helse/ 2024-04-10T07:57:41+00:00 https://www.lmi.no/2024/04/10/lytix-biopharma-henter-opptil-55-millioner-kroner/ 2024-04-10T08:00:34+00:00 https://www.lmi.no/2024/04/10/hold-av-datoen-drug-safety-forum-4-november/ 2024-04-10T09:24:51+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Drug-Safety-Forum-2023-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Drug-Safety-Forum-2023-scaled.jpg https://www.lmi.no/2024/04/10/basf-i-sandefjord-forsyner-verden-med-omega-3-legemiddel/ 2024-04-10T10:57:57+00:00 https://www.lmi.no/wp-content/uploads/2024/04/BASF-Alle-samlet.jpg https://www.lmi.no/wp-content/uploads/2024/04/BASF-Alle-samlet.jpg https://www.lmi.no/wp-content/uploads/2024/04/BASF-Hva.jpg https://www.lmi.no/wp-content/uploads/2024/04/BASF-hvem-og-hva.jpg https://www.lmi.no/wp-content/uploads/2024/04/BASF-hvem-og-hva-2.jpg https://www.lmi.no/wp-content/uploads/2024/04/BASF-hvem-1.jpg https://www.lmi.no/wp-content/uploads/2024/04/BASF-feiring.jpg https://www.lmi.no/wp-content/uploads/2024/04/BASF-Hvem-3.jpg https://www.lmi.no/wp-content/uploads/2024/04/BASF-Modell-tanker.jpg https://www.lmi.no/wp-content/uploads/2024/04/BASF-modell-3.jpg https://www.lmi.no/2024/04/11/vi-snakker-om-apne-overforinger-ikke-korrupsjon/ 2024-04-11T07:19:23+00:00 https://www.lmi.no/wp-content/uploads/2024/04/Skjermbilde-2024-04-11-091702.png https://www.lmi.no/wp-content/uploads/2024/04/Skjermbilde-2024-04-11-091702.png https://www.lmi.no/2024/04/11/novartis-kutter-700-stillinger-innen-legemiddelutvikling-berorer-ikke-norge/ 2024-04-11T07:21:04+00:00 https://www.lmi.no/2024/04/11/disse-er-med-i-det-nye-helseomsorg21-radet/ 2024-04-11T07:23:54+00:00 https://www.lmi.no/2024/04/11/hoyre-vil-ha-ny-handlingsplan-for-kliniske-studier/ 2024-04-11T07:24:36+00:00 https://www.lmi.no/2024/04/11/eli-lilly-starter-bygging-av-fabrikk-i-tyskland-vil-produsere-mer-fedmemedisin-i-europa/ 2024-04-11T07:28:56+00:00 https://www.lmi.no/2024/04/12/ny-kapital-og-endringer-i-ledelsen-i-curida/ 2024-04-12T09:35:13+00:00 https://www.lmi.no/wp-content/uploads/2024/04/Flyfoto-03-fra-vest-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/04/Flyfoto-03-fra-vest-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/04/Per-Nokkel7232-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/04/Klipper-snora-Curida-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/10/Podkast_Curida-og-Diatec-scaled.jpg https://www.lmi.no/2024/04/12/roche-test-for-tidlig-diagnostisering-av-alzheimers-far-saerstatus/ 2024-04-12T10:03:23+00:00 https://www.lmi.no/2024/04/12/de-store-norske-e-helse-aktorene-lover-apenhet-data-er-bedre-delt/ 2024-04-12T10:10:51+00:00 https://www.lmi.no/2024/04/12/la-frem-positive-data-for-msd-og-modernas-kreftvaksine/ 2024-04-12T10:13:29+00:00 https://www.lmi.no/2024/04/12/eu-parlamentet-stotter-legemiddelreform/ 2024-04-12T10:15:22+00:00 https://www.lmi.no/2024/04/12/abbvie-satser-tungt-flere-oppkjop-og-partnerskap-pa-kort-tid/ 2024-04-12T10:16:46+00:00 https://www.lmi.no/2024/04/12/anerkjent-kreftlege-ut-mot-protonsentrene-er-dette-riktig-prioritering/ 2024-04-12T10:18:31+00:00 https://www.lmi.no/2024/04/12/curida-trapper-opp-fabrikkinvesteringer-mye-hardt-arbeid-foran-oss/ 2024-04-12T10:23:53+00:00 https://www.lmi.no/2024/04/12/kjerkol-gar-av-som-statsrad-etter-vedtak-om-masteroppgaven/ 2024-04-12T10:27:14+00:00 https://www.lmi.no/2024/04/12/norske-forskere-leder-banebrytende-internasjonal-studie-utforsker-behandling-av-hjerneslag-i-oyet/ 2024-04-12T10:30:05+00:00 https://www.lmi.no/2024/04/12/enighet-om-at-prioriteringsmeldingen-ma-gjelde-for-hele-helsetjenesten/ 2024-04-12T10:40:37+00:00 https://www.lmi.no/wp-content/uploads/2024/04/Helseokonomisk-fagdag-panel-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/04/Helseokonomisk-fagdag-panel-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/04/Helseokonomisk-fagdag-Jon-Magnussen-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/04/Helseokonomisk-fagdag-panel-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/04/Helseokonomisk-fagdag-Bekeng-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/04/Helseokonomisk-fagdag-KK-scaled.jpg https://www.lmi.no/2024/04/04/lmi-med-innspill-til-eu-om-htar-forordningen/ 2024-04-15T09:15:07+00:00 https://www.lmi.no/wp-content/uploads/2024/04/EU-and-the-European-Commission-1.jpg https://www.lmi.no/wp-content/uploads/2024/04/European-Union-EU-and-the-European-Commission-1.jpg https://www.lmi.no/2024/04/15/kreftforeningen-apner-for-a-delta-i-beslutningsforum/ 2024-04-15T09:36:38+00:00 https://www.lmi.no/2024/04/15/mistenkte-svaert-alvorlige-bivirkninger-na-har-de-fatt-svar/ 2024-04-15T09:38:37+00:00 https://www.lmi.no/2024/04/15/en-av-fire-nordmenn-har-skjult-tilstand/ 2024-04-15T09:39:52+00:00 https://www.lmi.no/2024/04/15/ny-kreftbehandling-lanseres-i-norge-en-milepael/ 2024-04-15T09:43:18+00:00 https://www.lmi.no/2024/04/15/rallybio-inngar-big-pharma-samarbeid/ 2024-04-15T09:49:49+00:00 https://www.lmi.no/2024/04/15/dette-kan-redusere-kronisk-hodepine/ 2024-04-15T09:51:13+00:00 https://www.lmi.no/2024/04/15/tidligere-fastlege-jeg-har-medvirket-til-at-pasienter-har-blitt-avhengige/ 2024-04-15T10:03:58+00:00 https://www.lmi.no/2024/04/16/kraftig-kritikk-mot-regjeringens-helsestrategi-gar-i-helt-feil-retning/ 2024-04-16T07:31:48+00:00 https://www.lmi.no/2024/04/16/haper-regjeringen-raskt-avklarer-diabetes-pasienters-tilgang-til-virksomme-medisiner/ 2024-04-16T07:33:52+00:00 https://www.lmi.no/2024/04/16/nordmenn-onsker-rad-om-legemidler-fra-farmasoyt/ 2024-04-16T07:36:06+00:00 https://www.lmi.no/2024/04/16/roche-henter-ny-samfunnskontakt-fra-helsedirektoratet/ 2024-04-16T07:37:28+00:00 https://www.lmi.no/2024/04/16/novo-nordisk-etterlyser-finansierings-avklaring-for-diabetespille/ 2024-04-16T07:39:02+00:00 https://www.lmi.no/2024/04/16/verdien-pa-radforsks-borsportefolje-har-blitt-halvert-i-ar-blir-med-pa-bade-opp-og-nedturene/ 2024-04-16T07:41:10+00:00 https://www.lmi.no/2024/04/16/svenske-hansa-biopharma-hentet-374-millioner-kroner/ 2024-04-16T07:42:39+00:00 https://www.lmi.no/2024/04/16/diabetesmedisin-bremser-utviklingen-av-parkinsons-sykdom/ 2024-04-16T07:45:58+00:00 https://www.lmi.no/2024/04/16/diabetesmedisin-gir-ogsa-mindre-risiko-for-leversykdom/ 2024-04-16T07:46:53+00:00 https://www.lmi.no/2024/04/16/medlemmer-oppfordres-til-a-dele-miljo-og-baerekraftplaner-med-sykehusinnkjop/ 2024-04-16T09:47:23+00:00 https://www.lmi.no/wp-content/uploads/2024/04/Laila-Pagh-Skov-og-Anne-Margrethe-Hausken-Nordberg.png https://www.lmi.no/wp-content/uploads/2024/04/Laila-Pagh-Skov-og-Anne-Margrethe-Hausken-Nordberg.png https://www.lmi.no/2024/04/16/skymoen-i-horing-om-nasjonal-helse-og-samhandlingsplan/ 2024-04-16T11:19:57+00:00 https://www.lmi.no/wp-content/uploads/2024/04/LeifRuneHoring1.png https://www.lmi.no/wp-content/uploads/2024/04/LeifRuneHoring1.png https://www.lmi.no/2024/04/17/slik-fungerer-nortrials-inngangsport-til-kliniske-studier-i-norge/ 2024-04-17T09:29:16+00:00 https://www.lmi.no/2024/04/17/bergenbio-henter-138-millioner-kroner/ 2024-04-17T09:30:44+00:00 https://www.lmi.no/2024/04/17/atte-av-ti-nordmenn-onsker-norsk-legemiddelproduksjon/ 2024-04-17T09:35:40+00:00 https://www.lmi.no/2024/04/17/disse-legemiddelselskapene-omsatte-for-mest-i-2023/ 2024-04-17T09:36:51+00:00 https://www.lmi.no/2024/04/17/astrazeneca-bekrefter-imfinzi-med-i-hurtiginnforing-av-immunterapi-mot-kreft/ 2024-04-17T09:38:38+00:00 https://www.lmi.no/2024/04/17/modernas-patentsak-mot-pfizer-og-biontech-om-vaksine-settes-pa-pause/ 2024-04-17T09:39:35+00:00 https://www.lmi.no/2024/04/17/farmaceutene-vokser-i-industrien/ 2024-04-17T10:59:23+00:00 https://www.lmi.no/2024/04/17/studie-bekrefter-at-migrenetablett-er-effektiv-og-trygg/ 2024-04-17T11:04:36+00:00 https://www.lmi.no/2024/04/18/to-kreftmedisiner-vurdert-i-belsutningsforum-ett-avslag-og-en-anbefaling/ 2024-04-18T07:42:36+00:00 https://www.lmi.no/2024/04/18/salget-av-reseptfrie-smertestillende-gikk-ned-i-2023/ 2024-04-18T07:43:55+00:00 https://www.lmi.no/2024/04/18/mangel-pa-hormonplaster-og-gel-svaert-utfordrende-forsyningssituasjon/ 2024-04-18T07:46:07+00:00 https://www.lmi.no/2024/04/18/blodkreft-og-prostatakreft-disse-legemidlene-kan-bli-innfort-pa-mandag/ 2024-04-18T07:47:39+00:00 https://www.lmi.no/2024/04/18/nytt-middel-mot-pollenplager/ 2024-04-18T07:50:42+00:00 https://www.lmi.no/2024/04/18/lmi-sjefen-om-indirekte-curida-eierskap-etter-emisjon-sa-godt-som-helt-utvannet/ 2024-04-18T07:52:37+00:00 https://www.lmi.no/2024/04/18/utforsket-vinn-vinn-for-halden-pharma-og-norsk-helseindustri-satsing/ 2024-04-18T09:15:55+00:00 https://www.lmi.no/wp-content/uploads/2024/04/IMG_069411.jpg https://www.lmi.no/wp-content/uploads/2024/04/IMG_069411.jpg https://www.lmi.no/2024/04/17/horingssvar-pa-ekspertrapportene-om-prioritering-i-helse/ 2024-04-18T09:36:09+00:00 https://www.lmi.no/wp-content/uploads/2024/02/IMG_2514-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/IMG_2514-scaled.jpg https://www.lmi.no/2024/04/19/han-ble-lam-na-har-kunstig-intelligens-hjulpet-ham-til-a-ga-igjen/ 2024-04-19T07:58:37+00:00 https://www.lmi.no/2024/04/19/hap-i-horisonten-for-ultimovacs-fokus-pa-focus-og-dovacc-studiene/ 2024-04-19T08:02:45+00:00 https://www.lmi.no/2024/04/19/boehringer-ingelheim-skal-lansere-25-nye-legemidler-det-kommende-tiaret/ 2024-04-19T08:05:43+00:00 https://www.lmi.no/2024/04/19/mange-trenger-ikke-en-medisinsk-diagnose-for-a-lose-helseproblemene-sine/ 2024-04-19T08:08:59+00:00 https://www.lmi.no/2024/04/19/hun-er-ny-medisinsk-direktor-i-pfizers-nordiske-organisasjon/ 2024-04-19T08:10:25+00:00 https://www.lmi.no/2024/04/19/slankemedisin-kan-redusere-alvorlighetsgraden-av-sovnapne/ 2024-04-19T08:25:13+00:00 https://www.lmi.no/2024/04/19/nykode-har-startet-fase-2-studie-i-usa/ 2024-04-19T08:26:34+00:00 https://www.lmi.no/2024/04/19/lmis-arbeid-inn-mot-partiprogrammene-2025-2029/ 2024-04-19T09:22:33+00:00 https://www.lmi.no/wp-content/uploads/2024/04/Skjermbilde-2024-04-18-101055.png https://www.lmi.no/wp-content/uploads/2024/04/Skjermbilde-2024-04-18-101055.png https://www.lmi.no/2024/04/19/nye-ministere-utnevnes-i-statsrad-i-dag/ 2024-04-19T11:14:49+00:00 https://www.lmi.no/wp-content/uploads/2024/02/EksportsatsingHelse-33-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/02/EksportsatsingHelse-43-scaled.jpg https://www.lmi.no/2024/04/22/varsler-tilsyn-med-salg-av-viagra-pa-nett/ 2024-04-22T07:27:07+00:00 https://www.lmi.no/2024/04/22/beslutningsforum-skal-ta-stilling-til-en-rekke-kreftbehandlinger/ 2024-04-22T07:29:09+00:00 https://www.lmi.no/2024/04/22/island-inn-i-nordisk-legemiddelsamarbeid/ 2024-04-22T09:31:31+00:00 https://www.lmi.no/2024/04/22/nykode-starter-ny-livmorhalskreft-studie-med-sin-kreftvaksine-og-immunterapi-fra-roche/ 2024-04-22T09:33:18+00:00 https://www.lmi.no/2024/04/22/slik-mener-forskere-at-svangerskapskvalme-bor-behandles/ 2024-04-22T10:26:31+00:00 https://www.lmi.no/2024/04/22/kan-bli-milliardbelonning-for-fentanyl-vaksine/ 2024-04-22T10:27:50+00:00 https://www.lmi.no/2024/04/22/hurtigspor-for-immunterapi-ja-a-innfore-til-lever-og-galleveiskreft-behandling/ 2024-04-22T10:29:46+00:00 https://www.lmi.no/2024/04/23/abbvie-henter-ny-myndighetskontakt-fra-lmi/ 2024-04-23T07:36:42+00:00 https://www.lmi.no/2024/04/23/dmp-derfor-er-apotekene-tomme-for-hormonplaster/ 2024-04-23T07:37:49+00:00 https://www.lmi.no/2024/04/23/hurtigspor-sikrer-godkjenning-i-beslutningsforum/ 2024-04-23T07:38:54+00:00 https://www.lmi.no/2024/04/23/frida-naess-ulseth-er-ny-radgiver-i-lmi-2/ 2024-04-23T07:39:55+00:00 https://www.lmi.no/2024/04/23/slankemedisin-kan-kanskje-gjera-det-lettare-a-bli-gravid/ 2024-04-23T07:40:57+00:00 https://www.lmi.no/2024/04/23/beslutningsforum-sa-ja-til-legemidler-mot-prostatakreft-utsatte-benmargskreftbehandling/ 2024-04-23T07:42:18+00:00 https://www.lmi.no/2024/04/23/dette-er-vedtakene-i-beslutningsforum/ 2024-04-23T07:43:18+00:00 https://www.lmi.no/2024/04/23/etter-emisjonen-i-curida-sitter-elverum-kommune-igjen-med-smuler-ordforeren-svarer-ikke-pa-sporsmal-om-eierskapet/ 2024-04-23T07:45:33+00:00 https://www.lmi.no/2024/04/24/sykehusinnkjop-innforer-strengere-klimakrav/ 2024-04-24T07:19:29+00:00 https://www.lmi.no/2024/04/24/nortrials-flere-vil-gjore-studier-med-legemidler-og-medtek-utstyr/ 2024-04-24T07:20:43+00:00 https://www.lmi.no/2024/04/24/boehringer-ingelheim-inngar-milliardavtale-med-bioteknologiselskap-for-a-utvikle-legemidler-mot-leversykdommer/ 2024-04-24T07:22:32+00:00 https://www.lmi.no/2024/04/24/bakterier-som-er-resistente-mot-antibiotika-oker-markant-i-norge/ 2024-04-24T07:27:12+00:00 https://www.lmi.no/2024/04/24/forsker-pa-ny-ms-medisin/ 2024-04-24T07:28:10+00:00 https://www.lmi.no/2024/04/24/kommende-patentutlop-paforer-lundbeck-fire-milliarder-kroner-i-omsetningsfall/ 2024-04-24T07:30:52+00:00 https://www.lmi.no/2024/04/24/ekstraordinaer-generalforsamling-31-mai/ 2024-04-24T12:19:08+00:00 https://www.lmi.no/wp-content/uploads/2020/05/Andre-Breg%C3%A5rd_hjemmekontor_crop.jpg https://www.lmi.no/wp-content/uploads/2020/05/Andre-Breg%C3%A5rd_hjemmekontor_crop.jpg https://www.lmi.no/wp-content/uploads/2022/03/Martin-Haswell-185842-WEB-1.jpg https://www.lmi.no/2024/04/25/farmasoyter-passer-bra-til-styrearbeid/ 2024-04-25T08:16:34+00:00 https://www.lmi.no/2024/04/25/msd-med-kritikk-mot-beslutningsforum-stiller-sporsmal-ved-forklaring-etter-nei-til-keytruda-mot-foflekkreft/ 2024-04-25T08:18:13+00:00 https://www.lmi.no/2024/04/25/legeskepsis-svekker-utbredelsen-av-alzheimers-legemiddel-i-usa/ 2024-04-25T08:19:43+00:00 https://www.lmi.no/2024/04/25/fhi-hoy-oppslutning-om-barnevaksinasjonsprogrammet/ 2024-04-25T08:21:37+00:00 https://www.lmi.no/2024/04/25/studie-vaksiner-har-reddet-mer-enn-150-millioner-liv-de-siste-50-arene/ 2024-04-25T08:25:10+00:00 https://www.lmi.no/2024/04/25/eli-lillys-fedme-og-diabetesmiddel-gitt-i-multidosepenn-godkjent-i-europa/ 2024-04-25T08:27:36+00:00 https://www.lmi.no/2024/04/25/ekstraordinaer-generalforsamling-i-lmi-valgkomiteen-onsker-innspill/ 2024-04-25T09:52:48+00:00 https://www.lmi.no/wp-content/uploads/2024/04/LMI-styre-2024_crop.jpg https://www.lmi.no/wp-content/uploads/2024/04/LMI-styre-2024_crop.jpg https://www.lmi.no/2024/04/26/rettssak-om-covid-19-vaksiner-i-gang-i-storbritannia/ 2024-04-26T07:10:43+00:00 https://www.lmi.no/2024/04/26/lytix-far-gront-lys-for-fase-2-studie/ 2024-04-26T07:12:02+00:00 https://www.lmi.no/2024/04/26/astrazeneca-opplever-sterk-ettersporsel-etter-kreftlegemidler-i-forste-kvartal/ 2024-04-26T07:13:39+00:00 https://www.lmi.no/2024/04/26/eli-lilly-bekrefter-ansettelser-i-norge/ 2024-04-26T07:15:13+00:00 https://www.lmi.no/2024/04/26/stig-slordahl-gar-av-en-toppleders-jobb-a-sta-i-det/ 2024-04-26T07:19:13+00:00 https://www.lmi.no/2024/04/29/hva-gjor-hiv-medisinene-i-kroppen/ 2024-04-29T08:44:56+00:00 https://www.lmi.no/2024/04/29/studie-tre-faktorer-som-kan-pavirke-alzheimer-risiko/ 2024-04-29T08:46:32+00:00 https://www.lmi.no/2024/04/29/cannabis-virker-mot-kreft-ifolge-studie-men-er-det-sa-enkelt/ 2024-04-29T08:47:41+00:00 https://www.lmi.no/2024/04/29/den-stille-revolusjonener-hiv-epidemien-over-i-norge/ 2024-04-29T08:49:57+00:00 https://www.lmi.no/2024/04/29/tester-historisk-kreftsproyte-kan-bli-livreddende/ 2024-04-29T08:54:51+00:00 https://www.lmi.no/2024/04/29/farmasoyt-sveinung-stensland-tar-ikke-gjenvalg-til-stortinget/ 2024-04-29T08:58:03+00:00 https://www.lmi.no/2024/04/22/frida-naess-ulseth-er-ny-radgiver-i-lmi/ 2024-04-29T11:34:52+00:00 https://www.lmi.no/wp-content/uploads/2024/04/Design-uten-navn.png https://www.lmi.no/wp-content/uploads/2024/04/Design-uten-navn.png https://www.lmi.no/2024/04/29/kronikk-for-hver-krone-man-investerer-i-voksenvaksinasjonsprogram-far-man-19-kroner-tilbake/ 2024-04-29T11:58:15+00:00 https://www.lmi.no/wp-content/uploads/2024/04/skjermbilde-altinget-3.png https://www.lmi.no/wp-content/uploads/2024/04/skjermbilde-altinget-3.png https://www.lmi.no/2024/04/30/eu-lanserer-industriallianse-for-kritiske-legemidler/ 2024-04-30T07:09:56+00:00 https://www.lmi.no/2024/04/30/trenger-flere-avklaringer/ 2024-04-30T07:10:41+00:00 https://www.lmi.no/2024/04/30/oppfylling-av-fedmemiddel-lagre-pavirket-navamedics-kvartal/ 2024-04-30T07:11:43+00:00 https://www.lmi.no/2024/04/30/arctic-bioscience-matcher-fjoraret/ 2024-04-30T07:12:26+00:00 https://www.lmi.no/2024/05/02/gsks-vaksine-gir-langvarig-beskyttelse-mot-helvetesild/ 2024-05-02T07:11:12+00:00 https://www.lmi.no/2024/05/02/ema-inngar-avtale-om-a-dele-konfidensiell-informasjon-med-koreansk-myndighet/ 2024-05-02T07:13:36+00:00 https://www.lmi.no/2024/05/02/ny-slankemedisin-kan-ogsa-ha-god-effekt-pa-sovnapne/ 2024-05-02T07:17:54+00:00 https://www.lmi.no/2024/05/02/aspirin-beskyttet-ikke-mot-spredning-av-brystkreft-likevel/ 2024-05-02T07:31:01+00:00 https://www.lmi.no/2024/05/02/janssen-endrer-navn-til-johnson-johnson/ 2024-05-02T08:16:41+00:00 https://www.lmi.no/wp-content/uploads/2024/05/Anne-Sveaass-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/05/Anne-Sveaass-scaled.jpg https://www.lmi.no/2024/05/02/de-nye-bransjereglene-pa-3-minutter-2/ 2024-05-02T13:25:28+00:00 https://www.lmi.no/wp-content/uploads/2024/05/Ramona-branjeregler-skjermdump.png https://www.lmi.no/2024/05/02/horingssvar-fra-lmi-varig-rekvireringsrett-for-farmasoyter-og-sykepleiere/ 2024-05-02T14:10:34+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2024/05/03/sykehusinnkjop-lyser-ut-vaksineanbud-verdt-118-millioner/ 2024-05-03T10:25:32+00:00 https://www.lmi.no/2024/05/03/novartis-kjoper-radiofarmasi-selskap/ 2024-05-03T10:26:28+00:00 https://www.lmi.no/2024/05/03/presseorganisasjonene-kritiserer-ekspertutvalg-for-a-anbefale-hemmelige-legemiddelpriser/ 2024-05-03T10:27:36+00:00 https://www.lmi.no/2024/05/03/amgen-starter-fase-3-studier-med-fedme-og-diabetskandidat/ 2024-05-03T10:28:32+00:00 https://www.lmi.no/2024/05/03/insulife-studie-satt-pa-vent/ 2024-05-03T10:29:42+00:00 https://www.lmi.no/2024/05/03/novo-nordisk-oppjusterer-forventningene-til-2024/ 2024-05-03T10:30:37+00:00 https://www.lmi.no/2024/05/06/gar-fra-janssen-blir-pasientforeningsradgiver/ 2024-05-06T07:31:54+00:00 https://www.lmi.no/2024/05/06/stadig-faerre-far-eller-dor-av-kreftsykdommen-dette-peker-ous-legen-pa-som-arsakene/ 2024-05-06T07:33:33+00:00 https://www.lmi.no/2024/05/06/amgen-starter-fase-3-studier-med-fedme-og-diabeteskandidat/ 2024-05-06T07:34:45+00:00 https://www.lmi.no/2024/05/06/novo-nordisk-starter-ny-nyre-studie-med-legemiddelhap/ 2024-05-06T07:38:03+00:00 https://www.lmi.no/2024/05/06/i-ni-ar-var-marion-avhengig-av-opioidene-hun-fikk-av-legen/ 2024-05-06T08:05:29+00:00 https://www.lmi.no/2024/05/06/farmasistudenter-laerte-om-legemiddelovervaking-i-praksis/ 2024-05-06T08:06:48+00:00 https://www.lmi.no/wp-content/uploads/2024/05/Sanofi-studenter-1_crop.jpg https://www.lmi.no/wp-content/uploads/2024/05/Sanofi-studenter-1_crop.jpg https://www.lmi.no/wp-content/uploads/2024/05/Novartis_studenthospitering-5_crop-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/05/MSD-studenter.jpg https://www.lmi.no/2024/05/06/pamelding-til-ekstraordinaer-generalforsamling/ 2024-05-06T09:24:23+00:00 https://www.lmi.no/wp-content/uploads/2024/02/LMI-generelt-med-stortingGF2024.jpg https://www.lmi.no/2024/05/06/ectrims-kongressen-2024-presenterer-norge-som-studieland/ 2024-05-06T09:28:38+00:00 https://www.lmi.no/wp-content/uploads/2024/05/Kobenhavn_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/05/Kobenhavn_AdobeStock-scaled.jpeg https://www.lmi.no/2024/05/07/ny-utfordrer-i-behandlingen-av-fedme-amgens-maritide-med-lovende-resultater/ 2024-05-07T06:50:15+00:00 https://www.lmi.no/2024/05/07/pfizer-planlegger-en-aktiv-rolle-innen-fedme/ 2024-05-07T06:51:12+00:00 https://www.lmi.no/2024/05/07/ny-podcastdet-foregar-et-strategisk-spill-om-innforing-av-immunterapi-mot-kreft/ 2024-05-07T06:52:23+00:00 https://www.lmi.no/2024/05/07/til-danmark-for-a-laere-om-takeback-prosjektet/ 2024-05-07T07:44:12+00:00 https://www.lmi.no/wp-content/uploads/2024/05/IMG_1304.jpg https://www.lmi.no/wp-content/uploads/2024/05/IMG_1304.jpg https://www.lmi.no/2024/05/07/nytt-partnerskap-mellom-novo-nordisk-foundation-wellcome-og-gates-foundation/ 2024-05-07T09:02:12+00:00 https://www.lmi.no/wp-content/uploads/2024/05/Global-helse-og-klima_Adobe-Stock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/05/Global-helse-og-klima_Adobe-Stock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2015/05/helseindustrikonferansen-R%C3%B8ttingen.jpg https://www.lmi.no/2024/05/07/aksjefall-reduserte-ultimovacs-kostnader-med-21-millioner-kroner/ 2024-05-07T10:14:32+00:00 https://www.lmi.no/2024/05/08/mange-starter-for-sent-med-brystkreftbehandling/ 2024-05-08T07:36:20+00:00 https://www.lmi.no/2024/05/08/astrazeneca-har-sendt-oppsigelsesvarsel-til-200-svenske-forskere/ 2024-05-08T07:39:13+00:00 https://www.lmi.no/2024/05/08/ber-kreftlegene-ta-i-bruk-ny-blaerekreft-medisin-som-dobler-overlevelsen/ 2024-05-08T07:42:41+00:00 https://www.lmi.no/2024/05/08/artbio-inngar-ny-produksjonsavtale-i-usa/ 2024-05-08T07:46:19+00:00 https://www.lmi.no/2024/05/08/studie-vaksinasjon-ga-82-prosent-reduksjon-i-rs-innleggelser-hos-spedbarn/ 2024-05-08T07:47:49+00:00 https://www.lmi.no/2024/05/13/biontech-sikter-pa-kreftmarkedet-i-2026/ 2024-05-13T10:06:45+00:00 https://www.lmi.no/2024/05/13/agiana-pharmaceuticals-henter-penger-fra-inven2-og-amerikansk-biotek-selskap/ 2024-05-13T10:07:44+00:00 https://www.lmi.no/2024/05/13/foflekkreft-oker-mest-vi-er-fortsatt-ikke-gode-nok-pa-sunt-solvett/ 2024-05-13T10:08:36+00:00 https://www.lmi.no/2024/05/13/novo-nordisk-naermer-seg-fase-3-data-med-blodermiddel-spas-milliardsalg/ 2024-05-13T10:09:30+00:00 https://www.lmi.no/2024/05/13/eli-lilly-selger-fedmemedisin-direkte-til-kunde/ 2024-05-13T10:10:56+00:00 https://www.lmi.no/2024/05/13/blaerekreftforeningen-krever-rask-handling-for-livsforlengende-behandling/ 2024-05-13T10:12:06+00:00 https://www.lmi.no/2024/05/13/rallybio-i-gang-med-fase-2-studie-i-andre-halvdel-av-2024/ 2024-05-13T10:12:57+00:00 https://www.lmi.no/2024/05/13/ny-studie-om-depresjon-bor-utforskes/ 2024-05-13T10:14:18+00:00 https://www.lmi.no/2024/05/13/keytruda-moter-ikke-malene-i-livmorkreft-studie/ 2024-05-13T10:15:08+00:00 https://www.lmi.no/2024/05/13/takeda-skal-bruke-ti-milliarder-kroner-pa-omstrukturering/ 2024-05-13T10:16:10+00:00 https://www.lmi.no/2024/05/13/forskere-kan-ha-funnet-alzheimers-arsak-svaert-interessante/ 2024-05-13T10:17:11+00:00 https://www.lmi.no/2024/05/13/novo-nordisk-inngar-forskningssamarbeid-med-amerikansk-bioteselskap-om-fedmebehandlinger/ 2024-05-13T10:18:27+00:00 https://www.lmi.no/2024/05/13/meld-deg-pa-helseforetakenes-e-laeringskurs-om-samarbeid-med-leverandorer/ 2024-05-13T10:36:21+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Lars-Alnaes-5698-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/05/DwlSAwVQCFsJJzRWZAQzYCYDBFlTAANVCQcBDlxcVhZSUgUABVUGAFEHVVIAVgAEDGYBW0AUEl0bKzZ1Iw.jpg https://www.lmi.no/wp-content/uploads/2023/01/Lars-Alnaes-5698-scaled.jpg https://www.lmi.no/2024/05/13/alis-endring-legemiddelindustri-omfattes-ikke/ 2024-05-13T11:41:40+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Ramona-Melanie-Eichenberger-5639-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Ramona-Melanie-Eichenberger-5639-scaled.jpg https://www.lmi.no/2024/05/14/regjeringen-foreslar-forbud-mot-parallelleksport-av-legemidler/ 2024-05-14T07:15:14+00:00 https://www.lmi.no/2024/05/14/vestre-til-kamp-mot-lange-ventetider-gir-2-milliarder-til-sykehusene/ 2024-05-14T07:16:15+00:00 https://www.lmi.no/2024/05/14/sa-fly-forbanna-atjeg-vil-saksoke-staten/ 2024-05-14T07:17:40+00:00 https://www.lmi.no/2024/05/14/departementet-vil-viderefore-covid-vaksinering-i-apotek/ 2024-05-14T07:18:59+00:00 https://www.lmi.no/2024/05/14/vaksine-gir-nytt-hap-i-kampen-mot-aggressiv-hjernekreft/ 2024-05-14T07:20:04+00:00 https://www.lmi.no/2024/05/14/bernie-sanders-med-bonn-til-danmark-legg-prispress-pa-novo-nordisk/ 2024-05-14T07:21:10+00:00 https://www.lmi.no/2024/05/14/norsk-hudkreftlege-har-aldri-for-fatt-sa-rask-tilgang-pa-immunterapi/ 2024-05-14T07:22:30+00:00 https://www.lmi.no/2024/05/14/dmp-vil-forenkle-den-overveldende-legemiddelinformasjonen/ 2024-05-14T07:23:31+00:00 https://www.lmi.no/2024/05/14/studie-pa-hemofili-legemiddel-nar-nytt-endepunkt/ 2024-05-14T07:24:49+00:00 https://www.lmi.no/2024/05/14/nykode-utvider-samarbeidet-med-msd/ 2024-05-14T07:25:45+00:00 https://www.lmi.no/2024/05/14/invitasjon-til-nho-geneos-arskonferanse-sammen-om-losningene/ 2024-05-14T08:30:34+00:00 https://www.lmi.no/wp-content/uploads/2024/05/Skjermbilde-2024-05-14-101751.png https://www.lmi.no/wp-content/uploads/2019/04/Almlid.jpg https://www.lmi.no/2024/05/14/kurs-om-kliniske-studier/ 2024-05-14T08:53:00+00:00 https://www.lmi.no/wp-content/uploads/2024/05/kurs-om-kliniske-studier.png https://www.lmi.no/wp-content/uploads/2024/05/kurs-om-kliniske-studier.png https://www.lmi.no/2024/05/14/medlemsmote-og-generalforsamling-i-dra-forum-2/ 2024-05-14T09:42:25+00:00 https://www.lmi.no/wp-content/uploads/2024/05/Kunstig-intelligens-KI-AI-Adobe-STock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/05/Kunstig-intelligens-KI-AI-Adobe-STock-scaled.jpeg https://www.lmi.no/2024/05/14/lmis-innspill-til-stortingsmelding-om-forskningssystemet/ 2024-05-14T11:47:30+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2024/05/14/nodvendige-bevilginger-til-metodevurdering-av-vaksiner/ 2024-05-14T11:47:45+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Leif-Rune-Skymoen-glad-5942-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Leif-Rune-Skymoen-glad-5942-scaled.jpg https://www.lmi.no/2024/05/08/nodvendig-forbud-mot-parallelleksport-av-legemidler/ 2024-05-16T07:47:42+00:00 https://www.lmi.no/wp-content/uploads/2020/08/Penger-legemidler-scaled.jpeg https://www.lmi.no/wp-content/uploads/2020/08/Penger-legemidler-scaled.jpeg https://www.lmi.no/2024/05/16/reagerer-pa-vestres-ozempic-tiltak-for-darlig/ 2024-05-16T08:00:30+00:00 https://www.lmi.no/2024/05/16/fagdirektor-om-blaerekreft-behandling-ikke-anledning-til-a-forskrive-denne-na/ 2024-05-16T08:03:41+00:00 https://www.lmi.no/2024/05/16/diabetesforbundet-om-blaresept-nekt-til-ozempic-vi-er-bekymret/ 2024-05-16T08:05:43+00:00 https://www.lmi.no/2024/05/16/bayer-kuttet-1500-stillinger-i-forste-kvartal-nedbemanning-ogsa-i-norge/ 2024-05-16T08:08:26+00:00 https://www.lmi.no/2024/05/16/lundbeck-henter-ny-konserndirektor-fra-bayer/ 2024-05-16T08:09:43+00:00 https://www.lmi.no/2024/05/16/kronikk-prisavtaler-for-legemidler-kan-redusere-usikkerheten/ 2024-05-16T08:12:24+00:00 https://www.lmi.no/2024/05/16/astrazeneca-nadde-mal-i-covid-studie/ 2024-05-16T08:13:41+00:00 https://www.lmi.no/2024/05/16/roches-fedmehap-gir-betydelig-vekttap-i-fase-1-studie/ 2024-05-16T08:18:06+00:00 https://www.lmi.no/2024/05/16/far-forlenget-kontrakt-som-antibiotika-leverandor-til-norske-sykehus/ 2024-05-16T08:19:30+00:00 https://www.lmi.no/2024/05/16/norske-helseforskere-i-front-for-klima/ 2024-05-16T08:29:00+00:00 https://www.lmi.no/2024/05/16/debatt-men-bioteknologien-var-ikke-dod/ 2024-05-16T11:39:19+00:00 https://www.lmi.no/2024/05/16/debatt-men-bioteknologien-var-ikke-dod-2/ 2024-05-16T11:49:12+00:00 https://www.lmi.no/wp-content/uploads/2024/05/Skjermbilde-2024-05-16-134359.jpg https://www.lmi.no/wp-content/uploads/2024/05/Skjermbilde-2024-05-16-134359.jpg https://www.lmi.no/2024/05/21/bred-enighet-om-at-alternative-prisavtaler-er-en-god-losning/ 2024-05-21T07:16:45+00:00 https://www.lmi.no/wp-content/uploads/2024/05/IMG_1356.jpg https://www.lmi.no/wp-content/uploads/2024/05/IMG_1356.jpg https://www.lmi.no/2024/05/21/oppfordrer-forskere-og-legemiddelindustri-til-a-beregne-klimaavtrykk-i-kliniske-studier/ 2024-05-21T08:10:16+00:00 https://www.lmi.no/2024/05/21/legemiddelprodusent-vil-at-flere-skal-fa-dekket-slankesproyte/ 2024-05-21T08:43:57+00:00 https://www.lmi.no/2024/05/21/trenger-a-korte-ned-tidendet-tar-a-innga-en-avtale/ 2024-05-21T08:51:42+00:00 https://www.lmi.no/2024/05/21/forskere-vil-bruke-ki-i-kampen-mot-kreft-og-andre-sykdommer/ 2024-05-21T10:52:42+00:00 https://www.lmi.no/2024/05/21/astrazeneca-bygger-ny-fabrikk-i-singapore-til-15-milliarder-dollar/ 2024-05-21T10:55:26+00:00 https://www.lmi.no/2024/05/22/dmp-med-forslag-til-prisrevuderingsrekkefolge-for-2025/ 2024-05-22T07:52:13+00:00 https://www.lmi.no/wp-content/uploads/2024/05/609863.jpg https://www.lmi.no/2024/05/22/astrazeneca-planlegger-a-lansere-20-legemidler/ 2024-05-22T08:15:25+00:00 https://www.lmi.no/2024/05/22/eli-lilly-vokser-raskere-enn-novo-nordisk/ 2024-05-22T08:16:45+00:00 https://www.lmi.no/2024/05/22/sanofi-inngar-samarbeid-med-openai-og-biotek-selskap/ 2024-05-22T08:19:29+00:00 https://www.lmi.no/2024/05/22/norges-forslag-om-a-forby-parallelleksport-av-legemidler-moter-sterk-kritikk-i-danmark-et-sykdomstegn/ 2024-05-22T08:26:01+00:00 https://www.lmi.no/2024/02/29/lmi-samler-bransjen-i-arendalsuka/ 2024-05-22T13:24:21+00:00 https://www.lmi.no/wp-content/uploads/2023/08/A85B847D-3C85-4672-BDA6-CB6AABF47844-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/A85B847D-3C85-4672-BDA6-CB6AABF47844-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/peggy-og-OE-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/09/IMG_5713-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/E6A5E26C-5E42-4504-83E5-C7494B91F963-scaled.jpeg https://www.lmi.no/2024/05/23/lokker-slag-studier-til-norge/ 2024-05-23T08:32:07+00:00 https://www.lmi.no/wp-content/uploads/2024/05/Gruppebilde-Basel_crop-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/05/Gruppebilde-Basel_crop-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/05/Ambassadoren-Basel-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/05/Forsamlingen-lytter-Basel-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/05/Mingling-Basel-scaled.jpg https://www.lmi.no/2024/05/23/mer-enn-60-000-nordmenn-kan-ha-demens-uten-a-vite-om-det/ 2024-05-23T08:51:32+00:00 https://www.lmi.no/2024/05/23/storbrann-hos-novo-nordisk-i-kobenhavn/ 2024-05-23T08:52:45+00:00 https://www.lmi.no/2024/05/23/induct-vurderer-samarbeid-med-internasjonalt-legemiddelselskap/ 2024-05-23T08:53:41+00:00 https://www.lmi.no/2024/05/23/beslutningsforums-mai-mote-skal-vurdere-12-behandlinger/ 2024-05-23T08:54:50+00:00 https://www.lmi.no/2024/05/23/over-halvparten-av-unge-voksne-slutter-pa-adhd-medisin/ 2024-05-23T08:55:40+00:00 https://www.lmi.no/2024/05/23/skal-vurdere-medisiner-mot-brystkreft-cystisk-fibrose-og-malaria/ 2024-05-23T08:56:37+00:00 https://www.lmi.no/2024/05/23/bayer-gar-i-klinikk-med-xofigo-arvtager/ 2024-05-23T08:58:14+00:00 https://www.lmi.no/2024/05/23/disse-norske-legene-reiser-til-verdens-storste-kreftkongress-i-chicago/ 2024-05-23T09:00:05+00:00 https://www.lmi.no/2024/05/23/mdma-ved-depresjon-vi-opplever-stor-interesse-for-studien/ 2024-05-23T09:01:02+00:00 https://www.lmi.no/2024/05/23/ny-runde-med-kostnadskutt-i-pfizer/ 2024-05-23T09:01:54+00:00 https://www.lmi.no/2024/05/24/legemiddelselskapene-slik-far-vi-flere-kliniske-studier-til-norge/ 2024-05-24T08:28:00+00:00 https://www.lmi.no/2024/05/24/biontech-og-genmab-skal-legge-frem-viktige-data-fra-lungekreftstudie/ 2024-05-24T08:29:46+00:00 https://www.lmi.no/2024/05/24/han-kaller-det-en-skjult-folkesykdom-vi-ma-vakne/ 2024-05-24T08:31:23+00:00 https://www.lmi.no/2024/05/24/beslutningsforum-sa-forelopig-ja-na-skal-saken-opp-pa-ny/ 2024-05-24T08:32:39+00:00 https://www.lmi.no/2024/05/24/parallellhandel-er-nyttig-for-frihandel-og-kan-fungere-som-en-sikkerhetsventil/ 2024-05-24T08:35:50+00:00 https://www.lmi.no/2024/05/24/forsker-pa-legemiddelmangel-mener-forbud-mot-parallelleksport-kan-sla-tilbake-pa-norge/ 2024-05-24T08:36:56+00:00 https://www.lmi.no/2024/05/24/hele-sju-kreftmedisiner-vurdert-i-beslutningsforum-tre-anbefalinger-tre-avslag-og-en-utsettelser/ 2024-05-24T08:38:43+00:00 https://www.lmi.no/2024/05/24/risikodeling-er-ikke-et-godt-argument-for-nye-prisavtaler-likevel-kan-de-spille-en-viktig-rolle/ 2024-05-24T08:41:23+00:00 https://www.lmi.no/2024/05/24/lmi-pa-scenen-under-nho-geneos-arskonferanse/ 2024-05-24T09:11:08+00:00 https://www.lmi.no/wp-content/uploads/2024/05/Geneo-LR-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/05/Geneo-LR-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/05/Geneo-AM-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/05/Geneo-Agnete-2-scaled.jpg https://www.lmi.no/2024/05/24/vil-du-lede-lmis-arbeid-innen-pasienttilgang/ 2024-05-24T09:29:08+00:00 https://www.lmi.no/wp-content/uploads/2024/02/LMI-generelt-med-stortingGF2024.jpg https://www.lmi.no/wp-content/uploads/2024/02/LMI-generelt-med-stortingGF2024.jpg https://www.lmi.no/2024/05/27/slankemiddel-forslag-moter-motstand/ 2024-05-27T09:12:05+00:00 https://www.lmi.no/2024/05/27/medisinmangel-kan-bli-permanent-dette-er-legens-rad/ 2024-05-27T09:12:59+00:00 https://www.lmi.no/2024/05/27/nordiske-sykehus-danner-historisk-allianse/ 2024-05-27T09:14:51+00:00 https://www.lmi.no/2024/05/27/dmp-har-ingen-dokumentasjon-pa-at-eksport-har-fort-til-legemiddelmangel/ 2024-05-27T09:19:13+00:00 https://www.lmi.no/2024/05/27/ozempic-reduserer-risikoen-for-alvorlig-sykdom-og-dod-ved-kronisk-nyresykdom/ 2024-05-27T09:20:16+00:00 https://www.lmi.no/2024/05/27/norsk-presisjonsmedisinstudie-25-prosent-av-pasientene-fikk-tilbud-om-eksperimentell-medisin/ 2024-05-27T09:24:49+00:00 https://www.lmi.no/2024/05/27/bayer-sjefen-sier-selskapet-bruker-mer-penger-pa-rettssaker-enn-pa-forskning-og-utvikling/ 2024-05-27T09:26:20+00:00 https://www.lmi.no/2024/05/27/ingen-enighet-om-global-pandemiavtale/ 2024-05-27T09:29:00+00:00 https://www.lmi.no/2024/05/27/ny-godkjenning-for-alzheimer-legemiddel/ 2024-05-27T09:29:54+00:00 https://www.lmi.no/2024/05/27/fdas-ekspertpanel-anbefaler-ikke-godkjenning-av-nytt-insulin-ved-type-1-diabetes/ 2024-05-27T09:30:46+00:00 https://www.lmi.no/2024/05/27/nytt-e-laeringskurs/ 2024-05-27T12:18:13+00:00 https://www.lmi.no/wp-content/uploads/2024/05/Elaering-illustrasjon-dig-forside.png https://www.lmi.no/wp-content/uploads/2024/05/Elaering-illustrasjon-inni-sak.png https://www.lmi.no/2024/05/28/informasjonsmote-om-relansering-av-finose/ 2024-05-28T08:37:49+00:00 https://www.lmi.no/wp-content/uploads/2024/05/JNHB-launch-June-3rd-002-fr.jpg https://www.lmi.no/wp-content/uploads/2024/05/JNHB-launch-June-3rd-002.jpg https://www.lmi.no/2024/05/28/medisin-mot-brystkreft-fikk-nei-veldig-skuffet/ 2024-05-28T08:48:30+00:00 https://www.lmi.no/2024/05/28/jobber-pa-spreng-mot-den-glemte-kreftformen/ 2024-05-28T08:49:47+00:00 https://www.lmi.no/2024/05/28/cf-medisiner-innfort-til-yngre-barn-til-det-beste-for-bade-pasientene-og-samfunnet/ 2024-05-28T08:50:54+00:00 https://www.lmi.no/2024/05/28/beslutningsforum-nei-til-blodkreft-medisin-et-slag-i-ansiktet-for-pasientene/ 2024-05-28T08:52:06+00:00 https://www.lmi.no/2024/05/28/beslutningsforum-sier-ja-til-atte-og-nei-til-fire-legemidler/ 2024-05-28T08:52:55+00:00 https://www.lmi.no/2024/05/28/hurtigspor-for-immunterapi-beslutningsforum-sier-ja-til-spiserorskreft-legemiddel/ 2024-05-28T08:53:46+00:00 https://www.lmi.no/2024/05/28/novo-nordisk-sjefen-behandling-med-wegovy-trenger-ikke-a-vaere-livsvarig/ 2024-05-28T08:54:32+00:00 https://www.lmi.no/2024/05/28/alternative-prisavtaler-kan-fremme-tilgang-til-behandling/ 2024-05-28T08:55:58+00:00 https://www.lmi.no/2024/05/28/medlemsmote-om-arets-wait-rapport/ 2024-05-28T09:40:08+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Karoline-Knutsen-5809-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/01/Karoline-Knutsen-5809-scaled.jpg https://www.lmi.no/2024/05/28/nortrials-feiret-2-ar-dette-viktige-arbeidet-ma-fortsette/ 2024-05-28T14:00:48+00:00 https://www.lmi.no/wp-content/uploads/2024/05/Ellen-Lonning-Arnesen.jpg https://www.lmi.no/wp-content/uploads/2024/05/Ellen-Lonning-Arnesen.jpg https://www.lmi.no/wp-content/uploads/2024/05/Signe-1.jpg https://www.lmi.no/wp-content/uploads/2024/05/Panel-1.jpg https://www.lmi.no/wp-content/uploads/2024/05/Salen-2.jpg https://www.lmi.no/wp-content/uploads/2024/05/NorTrials-6.jpg https://www.lmi.no/wp-content/uploads/2024/05/Terje-Rootwelt-1.jpg https://www.lmi.no/wp-content/uploads/2024/05/Ole-Aleksander-Opdalshei.jpg https://www.lmi.no/wp-content/uploads/2024/05/Panel-1.jpg https://www.lmi.no/wp-content/uploads/2024/05/NorTrials-49.jpg https://www.lmi.no/wp-content/uploads/2024/05/Ole-Aleksander-Opdalshei.jpg https://www.lmi.no/wp-content/uploads/2024/05/Aslaug-Helland.jpg https://www.lmi.no/wp-content/uploads/2024/05/Rasmus-Goll.jpg https://www.lmi.no/wp-content/uploads/2024/05/Henrik-Schirmer.jpg https://www.lmi.no/wp-content/uploads/2024/05/NorTrials-21.jpg https://www.lmi.no/wp-content/uploads/2024/05/Jan-Gunnar-Skogas.jpg https://www.lmi.no/wp-content/uploads/2024/05/Inger-Marie-Skoie.jpg https://www.lmi.no/wp-content/uploads/2024/05/Nina-Jebsen.jpg https://www.lmi.no/wp-content/uploads/2024/05/Feasability_Marte-Frigstad.jpg https://www.lmi.no/wp-content/uploads/2024/05/Feasability_Johannes-Rolin.jpg https://www.lmi.no/wp-content/uploads/2024/05/Marianne-Pilgaard.jpg https://www.lmi.no/wp-content/uploads/2024/05/Panel-2_2.jpg https://www.lmi.no/wp-content/uploads/2024/05/Mia-Bengtstrom.jpg https://www.lmi.no/2024/05/29/stortinget-vil-ha-tiltak-mot-parallelleksport-i-mangelsituasjoner/ 2024-05-29T08:57:10+00:00 https://www.lmi.no/wp-content/uploads/2023/02/48974317152_31063e182d_o-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/48973585938_88eb09a699_o-scaled.jpg https://www.lmi.no/2024/05/29/starter-ny-studie-med-bergenbio-legemiddel/ 2024-05-29T09:07:57+00:00 https://www.lmi.no/2024/05/29/almirall-starter-norden-lansering-av-legemiddel-i-norge/ 2024-05-29T09:09:21+00:00 https://www.lmi.no/2024/05/29/johnson-johnson-kjoper-eksemkandidat-for-milliardbelop/ 2024-05-29T09:10:33+00:00 https://www.lmi.no/2024/05/29/flertall-pa-stortinget-vil-ha-lov-om-rasjonering-av-legemidler/ 2024-05-29T09:11:49+00:00 https://www.lmi.no/2024/05/29/hpv-vaksinasjon-reduserer-risikoen-for-flere-krefttyper-hos-menn-og-kvinner/ 2024-05-29T09:14:25+00:00 https://www.lmi.no/2024/05/29/dette-er-verdens-10-storste-legemidler-og-de-10-storste-i-norge/ 2024-05-29T09:15:36+00:00 https://www.lmi.no/2024/05/29/tydelige-lmi-spor-i-hoks-innstilling-til-nasjonal-helse-og-samhandlingsplan/ 2024-05-29T11:43:17+00:00 https://www.lmi.no/wp-content/uploads/2023/02/48973585938_88eb09a699_o-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/02/48974317152_31063e182d_o-scaled.jpg https://www.lmi.no/2024/05/30/fortsetter-a-folge-planen-og-kutter-kostnader/ 2024-05-30T07:31:39+00:00 https://www.lmi.no/2024/05/30/bayer-topp-pa-norgesbesok-vi-bygger-pa-en-arv/ 2024-05-30T07:32:10+00:00 https://www.lmi.no/wp-content/uploads/2024/05/Bayer_Rommel.jpg https://www.lmi.no/wp-content/uploads/2024/05/Bayer_Rommel.jpg https://www.lmi.no/wp-content/uploads/2024/05/Bayer-Lunch-Oslo-City-Hall-28.05.2024.jpg https://www.lmi.no/2024/05/30/msd-kjoper-eyebio-for-opptil-30-milliarder-kroner/ 2024-05-30T07:32:37+00:00 https://www.lmi.no/2024/05/30/stor-mangel-er-fryktelig-frustrert/ 2024-05-30T07:34:41+00:00 https://www.lmi.no/2024/05/30/bayer-topper-pa-norgesbesok-slik-skal-xofigo-arven-leve-videre/ 2024-05-30T07:35:51+00:00 https://www.lmi.no/2024/05/30/feasabilityportalen-fra-foresporsel-til-oppstart/ 2024-05-30T07:37:34+00:00 https://www.lmi.no/2024/05/31/vestlige-selskaper-star-bak-den-kinesiske-biotekboomen/ 2024-05-31T08:15:01+00:00 https://www.lmi.no/2024/05/31/msd-kjoper-eyebio-for-a-styrke-pipelinen/ 2024-05-31T08:16:02+00:00 https://www.lmi.no/2024/05/31/bedre-livskvalitet-for-trippel-negativ-brystkreftpasienter/ 2024-05-31T08:17:10+00:00 https://www.lmi.no/2024/05/31/norske-forskere-med-viktig-funn-i-behandling-av-type-1-diabetes-hos-barn/ 2024-05-31T08:18:06+00:00 https://www.lmi.no/2024/05/31/pluvia-far-orphan-drug-status-i-europa/ 2024-05-31T08:19:03+00:00 https://www.lmi.no/2024/05/31/keytruda-er-verdens-mestselgende-legemiddel/ 2024-05-31T08:25:42+00:00 https://www.lmi.no/2024/05/31/circio-sikter-mot-partnerskap-starter-emisjon-for-a-styrke-genterapiplattform/ 2024-05-31T08:26:47+00:00 https://www.lmi.no/2024/05/31/ny-styreleder-i-lmi/ 2024-05-31T08:27:02+00:00 https://www.lmi.no/wp-content/uploads/2022/11/ge-cathrine.png https://www.lmi.no/wp-content/uploads/2024/05/ge-cathrine-1.png https://www.lmi.no/wp-content/uploads/2024/02/Andreea-Mocofan.jpg https://www.lmi.no/wp-content/uploads/2024/05/Skjermbilde-2024-05-31-091115.png https://www.lmi.no/2024/05/31/kliniske-studier-vi-trenger-en-handlingsplan-som-forer-til-handling/ 2024-05-31T08:28:26+00:00 https://www.lmi.no/2024/05/31/forskere-kan-ha-funnet-handbrekket-pa-et-potensielt-farlig-virus/ 2024-05-31T08:29:25+00:00 https://www.lmi.no/2024/05/31/lytix-sjefen-om-forste-kvartal-naermer-seg-avgjorende-fase-2-resultater/ 2024-05-31T08:30:15+00:00 https://www.lmi.no/2024/05/31/covid-19-kobles-til-storre-risiko-for-allergi-ifolge-stor-studie/ 2024-05-31T08:31:05+00:00 https://www.lmi.no/2024/05/31/disse-firmaene-sponser-flest-studier-pa-norske-sykehus/ 2024-05-31T08:31:57+00:00 https://www.lmi.no/2024/06/02/hvordan-handteres-egentlig-usikkerheten-i-resultatbaserte-prisavtaler/ 2024-06-02T20:14:00+00:00 https://www.lmi.no/2024/06/02/norsk-lungekreftlege-aldri-sett-sa-gode-data/ 2024-06-02T20:15:23+00:00 https://www.lmi.no/2024/06/02/amerikansk-bioteknologiselskap-trumfer-keytruda-i-fase-3-studie/ 2024-06-02T20:16:27+00:00 https://www.lmi.no/2024/06/02/msd-leder-an-med-fou-satsing-men-mener-norges-helseindustri-ambisjoner-ma-folges-opp/ 2024-06-02T20:17:44+00:00 https://www.lmi.no/2024/06/02/chmp-anbefaler-14-nye-legemidler-gir-tommel-opp-for-chikungunya-vaksine/ 2024-06-02T20:18:55+00:00 https://www.lmi.no/2024/06/02/malrettet-cellegift-mot-lungekreft-ma-tilbake-til-tegnebrettet/ 2024-06-02T20:21:15+00:00 https://www.lmi.no/2024/06/02/impress-nesten-halvparten-av-pasientene-har-hatt-effekt-av-ny-medisin/ 2024-06-02T20:22:19+00:00 https://www.lmi.no/2024/06/03/ny-styreleder-i-lmi-cathrine-thomassen-tar-over-2/ 2024-06-03T10:36:27+00:00 https://www.lmi.no/2024/06/03/blodkreftlegemiddel-halverer-nesten-risikoen-for-sykdomsprogresjon-eller-dod/ 2024-06-03T13:24:26+00:00 https://www.lmi.no/2024/06/03/har-forskere-funnet-et-forsvar-mot-et-av-verdens-farligste-rusmidler/ 2024-06-03T13:25:57+00:00 https://www.lmi.no/2024/06/04/benchmark-utvider-teamet/ 2024-06-04T10:27:50+00:00 https://www.lmi.no/2024/06/04/to-ferske-ansettelser-i-takeda-norge/ 2024-06-04T10:28:51+00:00 https://www.lmi.no/2024/06/04/flyttet-til-sveits-%e2%81%a0vurderer-a-flytte-hjem-igjen/ 2024-06-04T10:29:35+00:00 https://www.lmi.no/2024/06/04/anne-sveaass-ny-jj-sjef-en-uredd-eventyrer/ 2024-06-04T12:39:19+00:00 https://www.lmi.no/wp-content/uploads/2024/06/Anne-Sveaass_portrett-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/Anne-Sveaass_portrett-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/Anne-i-Sveits-kopi-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/Anne-pa-vulkanen-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/Anne-i-Kongo_vulkan-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/Anne-i-Kongo_vulkan-2_gaute-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/Anne-i-Kongo_gorilla-1.jpg https://www.lmi.no/wp-content/uploads/2024/06/Anne-i-Kongo_babygorilla.jpg https://www.lmi.no/wp-content/uploads/2024/06/Anne-i-Kongo_vulkan-3.jpg https://www.lmi.no/2024/05/29/informasjonsmote-med-nye-metoder-og-dmp-om-ny-htar-prosess/ 2024-06-04T16:16:09+00:00 https://www.lmi.no/wp-content/uploads/2024/05/European-Union-EU-and-the-European-Commission-1.jpg https://www.lmi.no/wp-content/uploads/2024/05/European-Union-EU-and-the-European-Commission-1.jpg https://www.lmi.no/2024/06/05/aslaug-helland-og-kjetil-tasken-fremmer-impress-og-prime-rose-pa-asco/ 2024-06-05T08:04:46+00:00 https://www.lmi.no/2024/06/05/nye-data-om-medisiner-mot-benmargskreft-hadde-tatt-det-i-bruk-i-morgen-om-vi-kunne/ 2024-06-05T08:07:34+00:00 https://www.lmi.no/2024/06/05/astrazeneca-med-positive-data-pa-to-lungekreftstudier/ 2024-06-05T08:08:16+00:00 https://www.lmi.no/2024/06/07/sykdomsmodifiserende-behandling-mot-alzheimer-kan-gi-store-innsparinger/ 2024-06-07T09:39:21+00:00 https://www.lmi.no/wp-content/uploads/2024/06/Alzheimer-rapport-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/Alzheimer-rapport-scaled.jpg https://www.lmi.no/2024/06/07/legemiddelmangel-en-betydelig-utfordring-i-norge/ 2024-06-07T10:25:37+00:00 https://www.lmi.no/2024/06/07/inger-lill-47-gar-pa-slankesproyter-absolutt-ingen-quick-fix/ 2024-06-07T10:26:52+00:00 https://www.lmi.no/2024/06/07/tribune-therapeutics-signerer-avtale-med-eli-lilly/ 2024-06-07T10:27:54+00:00 https://www.lmi.no/2024/06/07/slankemedisiner-med-sjokkokning-en-revolusjon/ 2024-06-07T10:28:58+00:00 https://www.lmi.no/2024/06/07/astrazeneca-fullforer-kjop-av-kanadiske-fusion-pharmaceuticals/ 2024-06-07T10:30:00+00:00 https://www.lmi.no/2024/06/07/eksportsatsing-onsker-stotteordninger-ogsa-til-lonnsomme-bedrifter/ 2024-06-07T10:31:26+00:00 https://www.lmi.no/2024/06/07/ny-rensemetode-tar-knekken-pa-antibiotikaresistente-bakterier/ 2024-06-07T10:35:36+00:00 https://www.lmi.no/2024/06/07/privat-kreftlege-vil-starte-behandlinger-basert-pa-asco-studier-umiddelbart/ 2024-06-07T10:36:35+00:00 https://www.lmi.no/2024/06/07/svensk-legemiddelindustri-henter-toppsjef-fra-det-offentlige/ 2024-06-07T10:37:28+00:00 https://www.lmi.no/2024/06/10/farmasoyt-anne-sveaass-har-tatt-over-ledelsen-i-johnson-johnson-i-norge/ 2024-06-10T08:36:27+00:00 https://www.lmi.no/2024/06/10/en-gruppe-kreftpasienter-kan-trolig-reddes-av-banebrytende-behandling/ 2024-06-10T08:37:20+00:00 https://www.lmi.no/2024/06/10/fhi-storste-utbruddet-av-kikhoste-pa-over-ti-ar/ 2024-06-10T08:38:23+00:00 https://www.lmi.no/2024/06/10/andreea-mocofan-er-den-nye-msd-norge-sjefen-man-trenger-litt-vennlig-konkurranse-internt/ 2024-06-10T08:39:24+00:00 https://www.lmi.no/2024/06/10/geir-hetland-blir-styremedlem-i-oslo-cancer-cluster/ 2024-06-10T08:40:13+00:00 https://www.lmi.no/2024/06/10/snart-kan-du-kanskje-ta-vaksiner-som-nesespray/ 2024-06-10T08:43:36+00:00 https://www.lmi.no/2024/06/10/han-skal-sikre-at-vi-har-bedre-beredskap-under-neste-pandemi/ 2024-06-10T08:44:31+00:00 https://www.lmi.no/2024/06/10/ragnhild-ma-snart-ut-med-10-000-i-maneden-for-medisinen-ma-rydde-opp/ 2024-06-10T08:45:28+00:00 https://www.lmi.no/2024/06/10/fda-innkaller-til-mote-om-eli-lillys-alzheimer-behandling/ 2024-06-10T08:46:15+00:00 https://www.lmi.no/2024/06/10/kopiprodusenter-i-kina-star-klare-for-wegovy-patentutlop/ 2024-06-10T08:49:04+00:00 https://www.lmi.no/2024/06/10/bruken-oker-kraftig-blant-unge-ingen-vet-hvorfor/ 2024-06-10T08:49:16+00:00 https://www.lmi.no/2024/06/10/produksjonsdagen-2024-en-industrihistorie-a-bygge-videre-pa/ 2024-06-10T11:34:30+00:00 https://www.lmi.no/wp-content/uploads/2024/06/PD_Panelet-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/PD_professoren-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/PD_Panelet-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/PD_per-thoresen-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/PD-ordstyrer-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/PD_salen-scaled.jpg https://www.lmi.no/2024/06/11/forskere-oppdaget-tegn-pa-demens-opptil-ni-ar-for-symptomene-dukket-opp/ 2024-06-11T11:07:25+00:00 https://www.lmi.no/2024/06/11/sylvi-listhaug-%e2%81%a0-cornelias-historie-er-helt-grusom/ 2024-06-11T11:09:20+00:00 https://www.lmi.no/2024/06/11/novo-nordisk-fikk-medhold-i-sak-om-ulovlig-reklame/ 2024-06-11T11:11:38+00:00 https://www.lmi.no/2024/06/11/eli-lilly-med-lovede-data-for-tirzepatid-i-behandling-av-mash/ 2024-06-11T11:12:45+00:00 https://www.lmi.no/2024/06/11/pfizer-og-jj-konkurrerer-om-samme-indikasjon-i-beslutningsforum/ 2024-06-11T11:13:58+00:00 https://www.lmi.no/2024/02/07/lei-av-pakningsvedlegg-pa-papir/ 2024-06-11T11:14:35+00:00 https://www.lmi.no/wp-content/uploads/2024/02/Facebook-Ad-karusell-1080-x-1080-px-AM.png https://www.lmi.no/wp-content/uploads/2024/02/Facebook-Ad-karusell_1080x1080-SIDE-2-310124.png https://www.lmi.no/2024/06/11/nykode-med-oppdaterte-resultater-pa-kreftvaksine-studie/ 2024-06-11T11:15:04+00:00 https://www.lmi.no/2024/06/12/god-tilgang-pa-astma-og-allergimedisiner/ 2024-06-12T07:10:16+00:00 https://www.lmi.no/2024/06/12/dove-opal-sandy-1-kan-hore-etter-genterapi-det-er-det-naermeste-man-kommer-magi-i-virkeligheten/ 2024-06-12T07:12:07+00:00 https://www.lmi.no/2024/06/12/roche-far-europeisk-markedsforingstillatelse-for-lungekreftbehandling/ 2024-06-12T07:16:28+00:00 https://www.lmi.no/2024/06/12/doblet-inntektene-internt-eiendomssalg-ga-palla-pharma-overskudd/ 2024-06-12T07:19:31+00:00 https://www.lmi.no/2024/06/12/medisin-tall-blir-verre-%e2%81%a0-dette-gar-ikke-lenger-lmi-kommenterer/ 2024-06-12T07:21:10+00:00 https://www.lmi.no/2024/06/12/novo-nordisk-toppsjefen-i-usa-ma-mulig-vitne-i-senatet-om-hoye-legemiddelpriser/ 2024-06-12T07:22:44+00:00 https://www.lmi.no/2024/06/12/eu-sikrer-seg-40-millioner-doser-av-vaksine-mot-fugleinfluensa/ 2024-06-12T07:23:53+00:00 https://www.lmi.no/2024/06/12/skymoen-i-vg-dette-gar-ikke-lenger/ 2024-06-12T09:32:17+00:00 https://www.lmi.no/wp-content/uploads/2024/06/vg-wait-6.png https://www.lmi.no/wp-content/uploads/2024/06/vg-wait-5.png https://www.lmi.no/wp-content/uploads/2024/06/LR-i-vg-wait-ny.png https://www.lmi.no/2024/06/12/vi-trenger-et-ventetidslofte-ogsa-pa-legemidler/ 2024-06-12T09:41:10+00:00 https://www.lmi.no/wp-content/uploads/2024/06/WAIT-BILDE-DIG-Nyhetssak-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/WAIT-BILDE-Nyhet-scaled.jpg https://www.lmi.no/2024/06/12/kronikk-vi-trenger-et-ventetidslofte-ogsa-pa-legemidler/ 2024-06-12T10:56:38+00:00 https://www.lmi.no/wp-content/uploads/2024/06/LR-i-altinget.png https://www.lmi.no/wp-content/uploads/2024/06/LR-i-altinget.png https://www.lmi.no/2024/06/13/esmo-konferansen-i-barcelona-presenterer-norge-som-studieland/ 2024-06-13T08:53:52+00:00 https://www.lmi.no/wp-content/uploads/2024/06/Barcelona_adobe-stock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/06/Barcelona_adobe-stock-scaled.jpeg https://www.lmi.no/2024/06/13/tiden-fra-ema-godkjennelse-til-norge-tar-legemidler-i-bruk-i-det-offentlige-oker/ 2024-06-13T10:06:19+00:00 https://www.lmi.no/2024/06/13/norske-kreftpasienter-venter-nesten-600-dager-for-tilgang-pa-nye-medisiner/ 2024-06-13T10:07:28+00:00 https://www.lmi.no/2024/06/13/novo-nordisk-om-mulig-stevning-av-amerikansk-konsernsjef-vi-har-flere-ganger-sagt-at-fruergaard-er-villig-til-a-vitne/ 2024-06-13T10:08:37+00:00 https://www.lmi.no/2024/06/13/ultimovacs-med-utvidede-overlevelsesdata-fra-foflekkreftstudie/ 2024-06-13T10:10:13+00:00 https://www.lmi.no/2024/06/13/mener-fedmemarkedet-vil-femdobles-til-987-milliarder-kroner-i-2030/ 2024-06-13T10:11:40+00:00 https://www.lmi.no/2024/06/13/skymoen-i-dagsnytt-18/ 2024-06-13T11:31:55+00:00 https://www.lmi.no/wp-content/uploads/2024/06/Skjermbilde-2024-06-13-130418.png https://www.lmi.no/wp-content/uploads/2024/06/Skjermbilde-2024-06-13-130418.png https://www.lmi.no/2024/06/14/frustrert-over-lang-ventetid-pa-nye-medisiner/ 2024-06-14T08:05:43+00:00 https://www.lmi.no/2024/06/14/dansk-fedmesuksess-gir-rekrutteringstrobbel-for-legemiddelselskaper-i-sor-sverige/ 2024-06-14T08:06:51+00:00 https://www.lmi.no/2024/06/14/helsedirektoratet-slar-alarm-om-dosering-kritisk-feil/ 2024-06-14T08:11:36+00:00 https://www.lmi.no/2024/06/14/pfizer-om-mislykket-behandling-med-genterapi-vi-er-ekstremt-skuffet/ 2024-06-14T08:12:43+00:00 https://www.lmi.no/2024/06/14/ny-behandling-for-benmargskreft-til-vurdering-kommer-til-a-bety-kjempemye-for-pasientene/ 2024-06-14T08:13:52+00:00 https://www.lmi.no/2024/06/14/etterlyser-flere-grep-for-a-sikre-raskere-innforing-av-nye-legemidler/ 2024-06-14T08:15:07+00:00 https://www.lmi.no/2024/06/14/astrazeneca-far-ja-i-usa-for-diabetesmedisin-til-pediatriske-pasienter/ 2024-06-14T08:16:15+00:00 https://www.lmi.no/2024/06/14/snart-kan-livet-til-jesper-8-bli-snudd-pa-hodet/ 2024-06-14T08:19:24+00:00 https://www.lmi.no/2024/06/17/norges-storste-studie-pa-benmargskreft-frida-presenterer-nye-data-pa-eha-i-madrid/ 2024-06-17T08:12:40+00:00 https://www.lmi.no/2024/06/17/celleterapi-er-kostnadseffektiv-klokt-valg-av-helsemyndighetene/ 2024-06-17T08:13:59+00:00 https://www.lmi.no/2024/06/17/astrazenecas-norgessjef-skulle-i-hvert-fall-ikke-bli-selger/ 2024-06-17T08:15:29+00:00 https://www.lmi.no/2024/06/17/vil-ta-knekken-pa-bruken-tenk-deg-om-for-du-tar/ 2024-06-17T08:16:39+00:00 https://www.lmi.no/2024/06/17/schjesvold-tror-ny-car-t-er-like-effektiv-som-carvykti-og-gir-faerre-bivirkninger/ 2024-06-17T08:17:41+00:00 https://www.lmi.no/2024/06/17/ostfold-overlege-om-ny-studie-dette-er-beste-behandling-av-kll/ 2024-06-17T08:19:29+00:00 https://www.lmi.no/2024/06/17/beslutningsforum-avgjor-pa-mandag-holder-nye-lymfekreft-data-til-et-ja-for-tepkinly/ 2024-06-17T08:20:34+00:00 https://www.lmi.no/2024/06/17/kjemper-for-a-overleve-umenneskelig/ 2024-06-17T08:21:51+00:00 https://www.lmi.no/2024/06/17/flere-enn-ventet-dode-i-vestlige-land-i-2022-eksperter-avviser-at-det-skyldes-vaksinen/ 2024-06-17T08:22:57+00:00 https://www.lmi.no/2024/06/17/jeg-vil-sa-gjerne-leve-videre/ 2024-06-17T08:24:00+00:00 https://www.lmi.no/2024/06/17/medlemsmote-i-nho-geneo/ 2024-06-17T08:59:11+00:00 https://www.lmi.no/wp-content/uploads/2024/06/ventetidsloftet-forste-mote-kopi.jpg https://www.lmi.no/wp-content/uploads/2024/06/ventetidsloftet-forste-mote-kopi.jpg https://www.lmi.no/2024/06/18/sjokkert-etter-nei-til-ny-medisin-vi-strakk-oss-langt-pa-pris/ 2024-06-18T07:49:11+00:00 https://www.lmi.no/2024/06/18/den-storste-nyheten-for-norske-myelomatose-pasienter-kanskje-noensinne/ 2024-06-18T07:50:52+00:00 https://www.lmi.no/2024/06/18/slik-begrunner-rootwelt-og-spreng-ja-og-nei-vedtakene-i-beslutningsforum/ 2024-06-18T07:52:11+00:00 https://www.lmi.no/2024/06/18/beslutningsforum-innforer-benmargskreftbehandling/ 2024-06-18T07:54:30+00:00 https://www.lmi.no/2024/06/18/oslo-cancer-cluster-soker-midler-til-ki-prosjekt/ 2024-06-18T07:57:29+00:00 https://www.lmi.no/2024/06/18/malet-med-forebyggende-helsearbeid-er-a-unnga-at-noe-skjer/ 2024-06-19T08:59:15+00:00 https://www.lmi.no/wp-content/uploads/2024/06/DM-Arena-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/DM-Arena-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/DM-arena-3-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/DM-arena-2-scaled.jpg https://www.lmi.no/2024/06/19/datasystem-for-a-hente-ut-resepter-pa-apoteker-var-nede-i-flere-timer/ 2024-06-19T09:07:41+00:00 https://www.lmi.no/2024/06/19/ny-brann-hos-novo-nordisk-i-danmark/ 2024-06-19T09:09:13+00:00 https://www.lmi.no/2024/06/18/belgia-inviterte-til-norsk-belgisk-samarbeid-innen-livsvitenskap/ 2024-06-19T09:10:26+00:00 https://www.lmi.no/wp-content/uploads/2024/06/Belgia-3-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/Belgia-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/Belgia-4-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/Belgia-3-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/Belgia-6-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/Belgia-5-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/Belgia-7-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/Belgia-8-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/Belgia-11-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/belgia-10-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/Belgia-2-scaled.jpg https://www.lmi.no/2024/06/20/debatt-novo-nordisk-har-ikke-dokumentert-noen-exit-strategi/ 2024-06-20T10:26:29+00:00 https://www.lmi.no/2024/06/20/medisinmangel-setter-mange-i-en-vanskelig-situasjon/ 2024-06-20T10:28:00+00:00 https://www.lmi.no/2024/06/20/i-danmark-gjenvinnes-25-prosent-av-medisinske-penner-arlig-na-jobbes-det-for-a-fa-ordningen-til-norge/ 2024-06-20T11:01:37+00:00 https://www.lmi.no/2024/06/21/legemiddelbransjen-frykter-for-industrien-i-europa/ 2024-06-21T10:16:24+00:00 https://www.lmi.no/2024/06/21/industrien-har-betalt-ut-flere-hundre-millioner-kroner-til-helsepersonell-og-organisasjoner/ 2024-06-21T10:19:01+00:00 https://www.lmi.no/2024/06/21/migrenetablett-far-blaresept-vi-har-ventet-lenge-pa-dette/ 2024-06-21T10:20:06+00:00 https://www.lmi.no/2024/06/21/dette-er-verdens-ti-best-betalte-legemiddeltopper/ 2024-06-21T10:21:49+00:00 https://www.lmi.no/2024/06/21/novo-nordisk-betaler-ut-mest-til-helsepersonell-og-organisasjoner/ 2024-06-21T10:22:52+00:00 https://www.lmi.no/2024/06/21/medie-utvidelse-av-novo-nordisk-fabrikk-i-usa-kan-skape-1000-arbeidsplasser/ 2024-06-21T10:24:29+00:00 https://www.lmi.no/2024/06/21/nykode-styrker-satsingen-pa-autoimmune-sykdommer-vil-etablere-datterselskap/ 2024-06-21T10:25:40+00:00 https://www.lmi.no/2024/06/21/who-advarer-mot-ulovlige-kopier-av-diabeteslegemiddel-i-flere-land/ 2024-06-21T10:26:52+00:00 https://www.lmi.no/2024/06/21/ble-toppsjef-etter-tre-tiar-i-ge-healthcare-jeg-er-veldig-glad-i-mennesker/ 2024-06-21T10:30:45+00:00 https://www.lmi.no/2024/06/21/jan-frich-blir-ny-administrerende-direktor-i-helse-midt-norge/ 2024-06-21T10:31:40+00:00 https://www.lmi.no/2024/06/21/markerer-jubileum-med-ny-produksjonslinje/ 2024-06-21T10:32:43+00:00 https://www.lmi.no/2024/06/23/medisin-dyrest-i-fattige-eu-land/ 2024-06-23T11:45:38+00:00 https://www.lmi.no/2024/06/24/medisin-krise-%e2%81%a0-det-plager-meg/ 2024-06-24T07:33:10+00:00 https://www.lmi.no/2024/06/24/smertestillende-advarsel-til-flere-tusen-nordmenn/ 2024-06-24T07:34:18+00:00 https://www.lmi.no/2024/06/24/oncoinvent-far-fast-track-status-i-usa/ 2024-06-24T08:16:41+00:00 https://www.lmi.no/2024/06/20/oversikt-over-arendalsuka/ 2024-06-24T08:39:30+00:00 https://www.lmi.no/wp-content/uploads/2024/06/Arendalsuka-ute-3-1-1280x960-1.jpg https://www.lmi.no/2024/06/24/offensiv-50-aring-i-elverum/ 2024-06-24T11:58:33+00:00 https://www.lmi.no/wp-content/uploads/2024/06/LR-og-ole-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/Forsamlingen-kopi.jpg https://www.lmi.no/wp-content/uploads/2024/06/Solvar-kopi.jpg https://www.lmi.no/wp-content/uploads/2024/06/Per-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/CEO-kopi.jpg https://www.lmi.no/wp-content/uploads/2024/06/LR-kopi.jpg https://www.lmi.no/wp-content/uploads/2024/06/Christian-kopi.jpg https://www.lmi.no/wp-content/uploads/2024/06/Brustad-kopi.jpg https://www.lmi.no/wp-content/uploads/2024/06/Snorklipp-kopi.jpg https://www.lmi.no/wp-content/uploads/2024/06/Presse-kopi.jpg https://www.lmi.no/wp-content/uploads/2024/06/Omvisning-kopi.jpg https://www.lmi.no/wp-content/uploads/2024/06/Ny-prodlinje-kopi-1.jpg https://www.lmi.no/2024/06/24/hoyre-topper-besokte-halden-pharma/ 2024-06-24T13:53:12+00:00 https://www.lmi.no/wp-content/uploads/2024/06/IMG_5877-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/IMG_5877-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/IMG_1927-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/IMG_1929-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/IMG_1918-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/IMG_1910-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/IMG_1908-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/IMG_1904-2-scaled.jpg https://www.lmi.no/2024/06/25/ordkrig-om-legemiddel-korrupsjon-svaert-problematisk/ 2024-06-25T09:43:38+00:00 https://www.lmi.no/2024/06/25/novo-nordisk-investerer-43-milliarder-kroner-i-usa/ 2024-06-25T09:45:42+00:00 https://www.lmi.no/2024/06/25/suspenderer-legemidler-i-sverige-og-danmark-etter-lab-fusk/ 2024-06-25T09:46:56+00:00 https://www.lmi.no/2024/06/25/ny-medisin-for-blodersykdom-kan-gi-ny-vekst-i-novo-nordisk-hemofilivirksomhet/ 2024-06-25T09:48:10+00:00 https://www.lmi.no/2024/06/25/50-ar-med-medisinfabrikk-i-elverum-ma-sorge-for-at-vi-produserer-mer-legemidler-i-norge/ 2024-06-25T09:49:12+00:00 https://www.lmi.no/2024/06/25/legepresidenten-om-industriutbetalinger-positivt-at-samhandlingen-oker/ 2024-06-25T09:50:30+00:00 https://www.lmi.no/2024/06/25/nye-fhi-tall-dyre-legemidler-til-kreft-leddgikt-og-ms-skiller-seg-ut/ 2024-06-25T09:51:57+00:00 https://www.lmi.no/2024/06/25/navamedic-har-signert-avtale-med-finsk-legemiddelselskap/ 2024-06-25T09:53:08+00:00 https://www.lmi.no/2024/06/25/regulatorisk-hostmote-2024/ 2024-06-25T10:40:21+00:00 https://www.lmi.no/wp-content/uploads/2022/06/regulatorisk-hostmote-2021_linn-camilla-scaled.jpg https://www.lmi.no/wp-content/uploads/2021/11/Regulatorisk-hostmote-2-scaled.jpg https://www.lmi.no/2024/06/25/legemiddelindustrien-kan-bidra-til-en-mer-baerekraftig-allmennlegetjeneste/ 2024-06-25T12:09:30+00:00 https://www.lmi.no/wp-content/uploads/2024/06/Anne-M-i-stortinget-2.png https://www.lmi.no/wp-content/uploads/2024/06/Anne-M-i-stortinget-2.png https://www.lmi.no/wp-content/uploads/2024/06/Anne-M-i-stortinget-1.png https://www.lmi.no/2024/06/26/private-kreftklinikker-far-rabatter-pa-medisiner-fra-legemiddelselskaper/ 2024-06-26T08:31:11+00:00 https://www.lmi.no/2024/06/26/har-vedtatt-lov-om-medisinrasjonering/ 2024-06-26T08:32:44+00:00 https://www.lmi.no/2024/06/26/novo-nordisk-rival-utfordrer-med-lovende-data/ 2024-06-26T08:33:50+00:00 https://www.lmi.no/2024/06/26/legane-ma-skrive-ut-billigare-medisinar/ 2024-06-26T08:41:12+00:00 https://www.lmi.no/2024/06/14/lanserte-eksportsatsingen-pa-helseindustrien/ 2024-06-26T18:37:49+00:00 https://www.lmi.no/wp-content/uploads/2024/06/Kick_off-eksportsatsing.jpg https://www.lmi.no/wp-content/uploads/2024/06/Kick_off-eksportsatsing.jpg https://www.lmi.no/2024/06/27/novo-nordisk-studie-med-blodtrykkskandidat-flopper/ 2024-06-27T07:48:10+00:00 https://www.lmi.no/2024/06/27/big-pharma-selskap-tar-i-bruk-ai-for-a-bekjempe-multiresistente-bakterier/ 2024-06-27T07:49:39+00:00 https://www.lmi.no/2024/06/27/arctic-bioscience-med-nye-data-pa-legemiddelkandidat-mot-psoriasis/ 2024-06-27T07:50:44+00:00 https://www.lmi.no/2024/06/27/konsernsjefen-i-novo-nordisk-skal-vitne-for-senatskomite-i-september/ 2024-06-27T07:52:17+00:00 https://www.lmi.no/2024/06/27/europeiske-helsemyndigheter-oppfordrer-til-a-ikke-bruke-fedmemidler-av-kosmetiske-arsaker/ 2024-06-27T07:53:13+00:00 https://www.lmi.no/2024/06/25/slik-jobber-vi-for-pasientenes-rettigheter/ 2024-06-27T07:55:00+00:00 https://www.lmi.no/wp-content/uploads/2024/06/pasientseminar-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/pasientseminar-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/06/pasientseminar-2-scaled.jpg https://www.lmi.no/2024/06/27/eli-lilly-saksoker-seks-nye-selskap-for-salg-av-piratkopierte-legemidler/ 2024-06-27T07:56:36+00:00 https://www.lmi.no/2024/06/27/veikart-og-eksportsatsing-pa-helseindustrien-hva-na/ 2024-06-27T10:38:15+00:00 https://www.lmi.no/2024/06/27/voksenvaksinasjon/ 2024-06-27T10:45:06+00:00 https://www.lmi.no/2024/06/27/venterommet-har-vi-rett-resept/ 2024-06-27T12:20:43+00:00 https://www.lmi.no/2024/06/28/legemiddelforbruket-oker-jevnt/ 2024-06-28T10:17:13+00:00 https://www.lmi.no/2024/06/28/suspenderer-legemidler-etter-laboratoriefeil-vil-unnga-mangelsituasjoner/ 2024-06-28T10:18:24+00:00 https://www.lmi.no/2024/06/28/novo-nordisk-innforer-ansettelsesstopp-i-enkelte-avdelinger/ 2024-06-28T10:20:16+00:00 https://www.lmi.no/2024/06/28/gsk-far-begrenset-amerikansk-anbefaling-for-rsv-vaksine/ 2024-06-28T10:22:34+00:00 https://www.lmi.no/2024/06/28/lmis-arbeid-med-wait-rapporten/ 2024-06-28T12:56:02+00:00 https://www.lmi.no/wp-content/uploads/2024/06/Skjermbilde-2024-06-13-130418.png https://www.lmi.no/wp-content/uploads/2024/06/Skjermbilde-2024-06-13-130418.png https://www.lmi.no/2024/07/01/lykke-pa-reisen-team-rynkeby/ 2024-07-01T07:56:55+00:00 https://www.lmi.no/wp-content/uploads/2024/07/Rynkeby-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/07/Rynkeby-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/07/Rynkeby-3-scaled.jpg https://www.lmi.no/2024/07/01/sanofi-nedbemanner-ogsa-i-norge/ 2024-07-01T10:50:35+00:00 https://www.lmi.no/2024/07/01/stoppar-salet-av-ozempic-som-slankemedisin/ 2024-07-01T10:51:27+00:00 https://www.lmi.no/2024/07/01/ny-lungekreft-behandling-resultatene-er-enestaende/ 2024-07-01T10:52:14+00:00 https://www.lmi.no/2024/07/01/dmp-direktor-audun-haga-gar-av/ 2024-07-01T10:53:00+00:00 https://www.lmi.no/2024/07/01/politisk-oppror-mot-medisin-treghet/ 2024-07-01T10:53:37+00:00 https://www.lmi.no/2024/07/02/raser-etter-endring-dette-er-en-skam/ 2024-07-02T07:45:14+00:00 https://www.lmi.no/2024/07/02/bard-hoksrud-frp-om-beslutningsforum-utspill-jeg-blir-provosert/ 2024-07-02T07:46:52+00:00 https://www.lmi.no/2024/07/02/motte-helseministeren-om-ventetid-pa-legemidler/ 2024-07-02T13:31:16+00:00 https://www.lmi.no/wp-content/uploads/2024/07/front-vestre.jpg https://www.lmi.no/wp-content/uploads/2024/07/vestre-1_tvetene-nfd-scaled.jpg https://www.lmi.no/2024/07/03/novo-nordisk-faller-etter-joe-biden-krav-om-lavere-priser-pa-wegovy-og-ozempic/ 2024-07-03T11:35:04+00:00 https://www.lmi.no/2024/07/03/endrer-reglene-for-populaer-slankemedisin-diskriminering/ 2024-07-03T11:36:00+00:00 https://www.lmi.no/2024/07/03/disse-mottok-de-storste-utbetalingene-fra-industrien-i-2020-2021-og-2022/ 2024-07-03T11:39:11+00:00 https://www.lmi.no/2024/07/03/hoyre-funderer-kan-bade-offentlige-og-private-aktorer-utfore-metodevurderinger/ 2024-07-03T11:40:29+00:00 https://www.lmi.no/2024/07/03/sjefsonkolog-kritiserer-lang-ventetid-i-nye-metoder-systemet-men-advarer-mot-nedlegging/ 2024-07-03T11:42:09+00:00 https://www.lmi.no/2024/07/04/legemidler-suspenderes-som-folge-av-feil-knyttet-til-indisk-laboratorium-uakseptabelt/ 2024-07-04T10:18:26+00:00 https://www.lmi.no/2024/07/04/usa-godkjenner-donanemab-mot-tidlig-alzheimers-sykdom/ 2024-07-04T10:19:30+00:00 https://www.lmi.no/2024/07/04/gjor-oppkjop-i-skottland-og-irland-stim-tredobler-staben/ 2024-07-04T10:20:41+00:00 https://www.lmi.no/2024/07/05/usikker-fremtid-for-titusenvis-av-pasienter-slik-skal-ozempic-planen-spare-inn-730-millioner-kroner/ 2024-07-05T08:45:01+00:00 https://www.lmi.no/2024/07/05/forste-malrettede-kols-medisin-eu-godkjent-viktig-for-noen-fa-pasienter/ 2024-07-05T08:46:03+00:00 https://www.lmi.no/2024/07/05/ny-alzheimers-medisin-kan-fa-gront-lys-i-sommer-mye-optimisme/ 2024-07-05T08:46:49+00:00 https://www.lmi.no/2024/07/05/fortsatt-behov-for-rydding-i-resepter/ 2024-07-05T08:47:54+00:00 https://www.lmi.no/2024/07/05/kritiseres-for-unodig-omfattende-metodevurderinger-slik-svarer-dmp/ 2024-07-05T08:48:40+00:00 https://www.lmi.no/2024/07/05/overkjorer-eget-medisin-organ-etter-614-dager/ 2024-07-05T08:49:28+00:00 https://www.lmi.no/2024/07/05/digitalis-tar-sommerferie/ 2024-07-05T12:15:21+00:00 https://www.lmi.no/wp-content/uploads/2024/07/An-illustration-showing-a-communication-team-on-summer-vacation.jpg https://www.lmi.no/wp-content/uploads/2024/07/An-illustration-showing-a-communication-team-on-summer-vacation.jpg https://www.lmi.no/2024/06/26/helsedata/ 2024-08-05T12:46:50+00:00 https://www.lmi.no/2024/08/05/helsedata-har-gitt-oss-mer-kunnskap-om-psoriasisbehandling-i-norge/ 2024-08-05T13:58:27+00:00 https://www.lmi.no/wp-content/uploads/2020/10/Psoriasis-scaled.jpeg https://www.lmi.no/wp-content/uploads/2020/10/Psoriasis-scaled.jpeg https://www.lmi.no/wp-content/uploads/2020/10/Silje-Solberg_crop.jpg https://www.lmi.no/wp-content/uploads/2020/10/Fredrik-Arneberg_crop.jpg https://www.lmi.no/wp-content/uploads/2024/08/Mari-Overgaard_Foto-Tori-Gjendal-scaled.jpg https://www.lmi.no/2024/08/05/eli-lillys-fedmemiddel-viser-lovende-resultater-mot-hjerte-og-karsykdommer/ 2024-08-05T17:47:04+00:00 https://www.lmi.no/2024/08/05/chmp-anbefaler-a-trekke-markedsforingstilatelsen-til-lever-middel/ 2024-08-05T17:52:10+00:00 https://www.lmi.no/2024/08/05/flere-forskerstemmer-skeptiske-til-trearsstudie-av-lecanemab/ 2024-08-05T17:54:57+00:00 https://www.lmi.no/2024/08/05/svardal-boe-mener-industrien-har-et-ansvar-for-a-motvirke-legemiddelmangel-vil-ha-mer-europeisk-samarbeid/ 2024-08-05T17:57:18+00:00 https://www.lmi.no/2024/08/05/legemidler-i-avlop-skader-miljoet-na-ma-produsentene-betale/ 2024-08-05T17:59:08+00:00 https://www.lmi.no/2024/08/05/fra-overhalla-til-verdenstoppen-pharmaq-sprenger-alle-rekorder/ 2024-08-05T18:02:40+00:00 https://www.lmi.no/2024/08/05/serenne-er-den-eneste-voksne-i-norge-som-far-denne-medisinen/ 2024-08-05T18:04:00+00:00 https://www.lmi.no/2024/08/05/bms-omprioriterer-pipeline-og-stopper-fase-3-studie/ 2024-08-05T18:10:01+00:00 https://www.lmi.no/2024/08/05/norske-legemiddelprodusenter-vil-gjerne-bidra-til-norsk-beredskap-men-da-kreves-det-politisk-vilje/ 2024-08-05T18:11:07+00:00 https://www.lmi.no/2024/08/06/msd-sjef-andreea-mocofan-fra-romania-til-norge-with-love/ 2024-08-06T07:44:15+00:00 https://www.lmi.no/wp-content/uploads/2024/08/Andreea-Mocofan-portrett-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Andreea-Mocofan-portrett-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Andreea-racing.jpg https://www.lmi.no/wp-content/uploads/2024/08/Andreea-pullups.jpg https://www.lmi.no/wp-content/uploads/2024/08/Andreea-kite.jpg https://www.lmi.no/wp-content/uploads/2024/08/Andreea-team.jpg https://www.lmi.no/2024/08/06/hoyaktuell-som-ny-dmp-direktor-dette-sier-trygve-ottersen-om-spekulasjonene/ 2024-08-06T10:58:02+00:00 https://www.lmi.no/2024/08/07/studie-vaksine-kan-redusere-risiko-for-demens/ 2024-08-07T07:26:54+00:00 https://www.lmi.no/2024/08/07/nytt-ema-program-skal-stotte-oppunder-medisinsk-utstyr-til-sjeldne-prosedyrer/ 2024-08-07T07:28:48+00:00 https://www.lmi.no/2024/08/07/novartis-og-viatris-anklaget-av-henrietta-lacks-etterkommere-for-ulovlig-fortjeneste/ 2024-08-07T07:30:23+00:00 https://www.lmi.no/2024/08/07/novo-nordisk-har-blitt-et-av-de-500-storste-selskapene-i-verden-malt-i-salg/ 2024-08-07T07:33:58+00:00 https://www.lmi.no/2024/08/07/populaer-slankemedisin-kan-ha-overraskende-effekt-pa-roykesug/ 2024-08-07T07:37:45+00:00 https://www.lmi.no/2024/08/07/ultimovacs-mislykkes-med-nok-en-kreftstudie-analytiker-tror-det-er-slutten-for-selskapet/ 2024-08-07T07:40:06+00:00 https://www.lmi.no/2024/08/07/novo-nordisk-avslutter-andre-kvartal-med-stort-overskudd/ 2024-08-07T07:50:13+00:00 https://www.lmi.no/2024/08/08/gjenvinning-av-injeksjonspenner-vil-ikke-gronnvaske-legemiddelindustrien/ 2024-08-08T08:18:52+00:00 https://www.lmi.no/2024/08/08/sovnekspert-mener-melatonin-bor-vaere-siste-losning-for-dognville-barn/ 2024-08-08T08:21:39+00:00 https://www.lmi.no/2024/08/08/stadig-flere-barn-far-antidepressiver-na-advarer-eksperter/ 2024-08-08T08:27:50+00:00 https://www.lmi.no/2024/08/08/sykehusinnkjop-vil-kutte-utslipp-med-75-prosent-innen-2030-slik-skal-de-gjore-det/ 2024-08-08T08:28:59+00:00 https://www.lmi.no/2024/08/08/studie-har-undersokt-hvor-godt-nettsteder-om-sykdommer-opplyser-om-industristotte/ 2024-08-08T08:30:48+00:00 https://www.lmi.no/2024/08/08/adhd-medisinering-fra-kortvarige-effekter-til-langsiktige-gevinster/ 2024-08-08T08:33:57+00:00 https://www.lmi.no/2024/08/08/svensk-alzheimer-forsker-har-mistet-troen-pa-ema/ 2024-08-08T08:34:56+00:00 https://www.lmi.no/2024/08/08/amgen-satser-tyngre-pa-fedmehap/ 2024-08-08T08:37:28+00:00 https://www.lmi.no/2024/06/19/lmi-i-arendalsuka/ 2024-08-08T10:23:16+00:00 https://www.lmi.no/wp-content/uploads/2023/08/Arendalsuka-ute-3-1-1280x960-1.jpg https://www.lmi.no/2024/08/08/oppdatert-oversikt-lmi-og-medlemmene-i-arendalsuka/ 2024-08-08T10:28:21+00:00 https://www.lmi.no/wp-content/uploads/2024/06/Arendal-Adobe-stock-1280x852.jpeg https://www.lmi.no/2024/08/08/lege-og-koronaforsker-oppfordrer-flere-til-a-ta-oppfriskningsdoser-av-koronavaksinen/ 2024-08-08T10:48:28+00:00 https://www.lmi.no/2024/08/09/mangler-tiltak-mot-legemiddelmangel/ 2024-08-09T06:58:32+00:00 https://www.lmi.no/2024/08/09/palestinske-barn-pa-flukt-lider-av-lus-skabb-og-utslett/ 2024-08-09T07:05:02+00:00 https://www.lmi.no/2024/08/09/eli-lilly-med-overraskende-sterke-resultater-for-fedme-og-diabeteslegemidler/ 2024-08-09T07:08:14+00:00 https://www.lmi.no/2024/08/09/novartis-far-fda-godkjenning-for-legemiddel-til-behandling-av-nyresykdom/ 2024-08-09T07:12:35+00:00 https://www.lmi.no/2024/08/09/norsk-studie-brystkreft-test-har-fort-til-redusert-cellegiftbruk/ 2024-08-09T07:29:01+00:00 https://www.lmi.no/2024/08/09/lmi-lo-og-nho-i-dagens-medisin-veikart-og-eksportsatsing-pa-helse-hva-na/ 2024-08-09T08:54:44+00:00 https://www.lmi.no/wp-content/uploads/2024/08/skjermbilde-innlegg-mw-aug-24.png https://www.lmi.no/wp-content/uploads/2024/08/Skjermbilde-medwatchinnlegg-aug-24.png https://www.lmi.no/2024/08/09/internasjonal-interesse-for-norske-helsedata-etter-privat-offentlig-melanom-prosjekt/ 2024-08-09T13:44:57+00:00 https://www.lmi.no/wp-content/uploads/2024/08/Gry-Festervoll-BMS-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Melanom_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2024/08/Gry-Festervoll-BMS-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Melanom-faktaboks.png https://www.lmi.no/wp-content/uploads/2024/08/Trude-Robsahm-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Giske-Ursin-2-scaled.jpg https://www.lmi.no/2024/08/12/oslo-science-hub-tar-form/ 2024-08-12T08:02:08+00:00 https://www.lmi.no/wp-content/uploads/2024/08/06-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Science-Hub-Bilde_ovenfra_2.jpg https://www.lmi.no/wp-content/uploads/2024/08/Thomas_London.jpeg https://www.lmi.no/wp-content/uploads/2024/08/Bilde_interior.png https://www.lmi.no/2024/08/12/suter-til-lmi/ 2024-08-12T08:06:10+00:00 https://www.lmi.no/wp-content/uploads/2024/08/barbara-suter-bredde-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/barbara-suter-bredde-scaled.jpg https://www.lmi.no/2024/08/12/eus-investeringsfond-setter-inn-210-millioner-kroner-i-sintef-investerer-i-helseapp/ 2024-08-12T08:13:03+00:00 https://www.lmi.no/2024/08/12/lege-og-grunder-blir-ny-statssekretaer-i-hod/ 2024-08-12T08:14:04+00:00 https://www.lmi.no/2024/08/12/novartis-topp-veronika-vil-ikke-jobbe-med-en-haug-med-veronikaer/ 2024-08-12T08:15:23+00:00 https://www.lmi.no/2024/08/12/nytt-hap-for-pcos-kvinner-et-gjennombrudd/ 2024-08-12T08:16:57+00:00 https://www.lmi.no/2024/08/12/altinget-anbefaler-15-helsearrangementer-pa-arendalsuka-altinget-helse/ 2024-08-12T08:18:06+00:00 https://www.lmi.no/2024/08/13/skymoen-i-vg-om-ny-rapport/ 2024-08-13T14:31:17+00:00 https://www.lmi.no/wp-content/uploads/2024/08/Skjermbilde-2024-08-13-161642.png https://www.lmi.no/wp-content/uploads/2024/08/Skjermbilde-2024-08-13-161642.png https://www.lmi.no/2024/08/13/pasienter-tapte-over-3000-kvalitetsjusterte-levear-i-2023-enighet-om-at-alle-parter-ma-ta-grep/ 2024-08-14T10:33:11+00:00 https://www.lmi.no/wp-content/uploads/2024/08/LMI-Venterommet-56-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Venterommet-56-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Venterommet-52-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Venterommet-23-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Venterommet-18-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Venterommet-31-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Venterommet-36-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/LMI-Venterommet-47-scaled.jpg https://www.lmi.no/2024/08/14/barbara-suter-blir-leder-for-pasienttilgang-i-lmi/ 2024-08-14T14:05:52+00:00 https://www.lmi.no/2024/08/14/historisk-2023-for-ge-healthcares-norske-selskap-okte-inntektene-med-tre-milliarder-kroner/ 2024-08-14T14:07:13+00:00 https://www.lmi.no/2024/08/14/1-av-2-pasienter-har-opplevd-legemiddelmangel/ 2024-08-14T14:08:24+00:00 https://www.lmi.no/2024/08/14/norge-ma-bli-bedre-pa-salg-om-eksportsatsingen-skal-fungere-mener-innovasjon-norge-direktoren/ 2024-08-14T14:10:28+00:00 https://www.lmi.no/2024/08/14/ventetid-pa-nye-medisiner-koster-liv-over-6000-pasienter-rammet-i-2023/ 2024-08-14T14:12:49+00:00 https://www.lmi.no/2024/08/14/sa-mye-taper-norske-pasienter-pa-ventetid-for-nye-medisiner/ 2024-08-14T14:13:51+00:00 https://www.lmi.no/2024/08/14/amgen-skal-apne-ki-senter-med-3000-ansatte-i-india/ 2024-08-14T14:15:17+00:00 https://www.lmi.no/2024/08/14/pillejubel-%e2%81%a0-na-kan-jeg-overleve/ 2024-08-14T14:16:59+00:00 https://www.lmi.no/2024/08/14/mener-det-ma-tas-kraftige-grep-om-mal-for-kliniske-studier-skal-nas/ 2024-08-14T14:18:15+00:00 https://www.lmi.no/2024/08/14/usman-mushtaqs-ildprove-som-statssekretaer-vi-ma-slutte-a-tenke-at-det-er-mer-sexy-a-investere-i-spesialisthelsetjenesten/ 2024-08-14T14:19:31+00:00 https://www.lmi.no/2024/08/14/nykode-far-patent-pa-kreftvaksine-i-usa/ 2024-08-14T14:20:34+00:00 https://www.lmi.no/2024/08/15/fersk-rapport-verdiskapingen-per-ansatt-i-medtek-og-lab-bransjen-oker/ 2024-08-15T08:36:11+00:00 https://www.lmi.no/2024/08/15/mener-norge-lider-av-trust-issues-mot-legemiddelindustrien/ 2024-08-15T08:37:11+00:00 https://www.lmi.no/2024/08/15/ekspertene-roper-varsko-om-hodepine-lidelser-i-norge/ 2024-08-15T08:38:19+00:00 https://www.lmi.no/2024/08/15/kapitalmangel-og-kompetanseflukt-bremser-veksten-i-norsk-helsenaering/ 2024-08-15T08:39:24+00:00 https://www.lmi.no/2024/08/15/statssekretaeren-letter-pa-sloret-planen-er-at-prioriteringsmeldingen-kommer-til-paske/ 2024-08-15T08:41:14+00:00 https://www.lmi.no/2024/08/15/eks-sentralbanksjef-olsen-lonnsomt-a-innfore-et-fornuftig-voksenvaksinasjonsprogram/ 2024-08-15T10:47:31+00:00 https://www.lmi.no/wp-content/uploads/2024/08/Oystein-Olsen-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Oystein-Olsen-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Marit-Teigen-Haugane-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Anne-Spurkland-og-salen-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Richard-Bergstrom-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Are-Stuwitz-Berg-scaled.jpg https://www.lmi.no/wp-content/uploads/2024/08/Panel-voksenvaksinasjonsprogram-scaled.jpg https://www.lmi.no/2024/08/16/investor-norge-trenger-to-ting-for-a-lykkes-med-helsenaeringen/ 2024-08-16T10:21:05+00:00 https://www.lmi.no/2024/08/16/i-mal-med-historiske-prisforhandlinger-pa-legemidler/ 2024-08-16T10:21:59+00:00 https://www.lmi.no/2024/08/16/alzheimer-legemiddel-godkjent-i-de-forente-arabiske-emirater/ 2024-08-16T10:23:01+00:00 https://www.lmi.no/2024/08/16/norge-mener-ny-kreftbehandling-er-for-dyr-gunhild-51-betalte-for-den-med-egne-penger/ 2024-08-16T10:23:51+00:00 https://www.lmi.no/2024/08/16/legemiddelselskap-gir-legemiddel-gratis-til-kreftpasient-har-en-plikt-til-a-forsoke-a-hjelpe/ 2024-08-16T10:24:42+00:00 https://www.lmi.no/2024/08/19/frp-og-mdg-samde-om-slankemedisin-vil-endre-reglane/ 2024-08-19T12:39:26+00:00 https://www.lmi.no/2024/08/19/rootwelt-slar-tilbake-blir-frustrert-over-pastander-om-ensidig-prisfokus/ 2024-08-19T12:40:24+00:00 https://www.lmi.no/2024/08/19/navamedic-har-milliardmal-i-sikte/ 2024-08-19T12:41:27+00:00 https://www.lmi.no/2024/08/19/legemiddelselskap-gir-legemiddel-gratis-til-kreftpasient-har-en-plikt-til-a-forsoke-a-hjelpe-2/ 2024-08-19T12:42:25+00:00 https://www.lmi.no/2024/08/19/novo-nordisk-investerer-24-milliarder-kroner-i-ny-fabrikk/ 2024-08-19T12:43:19+00:00 https://www.lmi.no/2024/08/19/bor-vi-vaere-redde-for-apekopper/ 2024-08-19T12:44:39+00:00